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Abstract
English
Caveolae, the characteristic plasma membrane invaginations present in
many cells, have been associated with numerous functions that still remain
debated. Taking into account the particular abundance of caveolae in cells
experiencing mechanical stress, it was proposed that caveolae constitute a
membrane reservoir and buﬀer the membrane tension upon mechanical stress.
The present work aimed to check this proposition experimentally. First, the
inﬂuence of caveolae on the membrane tension was studied on mouse lung
endothelial cells in resting conditions using tether extraction with optically
trapped beads. Second, experiments on cells upon acute mechanical stress
showed that caveolae serve as a membrane reservoir buﬀering surges in mem-
brane tension in their immediate, ATP- and cytoskeleton-independent ﬂat-
tening and disassembly. Third, caveolae incorporated in membrane vesicles
also showed the tension buﬀering. Finally, in a physiologically more relevant
case, human muscle cells were studied, and it was shown that mutations with
impaired caveolae which are described in muscular dystrophies render mus-
cle cells less resistant to mechanical stress. In Summary the present work
provides experimental evidence for the hypothesis that caveolae buﬀer the
membrane tension upon mechanical stress. The fact that this was observed
in cells and membrane vesicles in an ATP and cytoskeleton independent
manner reveals a passive, mechanically driven process. This could be a leap
forward in the comprehension of the role of caveolae in the cell, and in the
understanding of genetic diseases like muscular dystrophies.
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Français
Cavéoles sont des invaginations caractéristiques de la membrane plas-
mique présents dans beaucoup de types cellulaires. Ils sont liées à plusieurs
fonctions cellulaires, ce qui sont encore débattues. Prenant compte de limportance
des cavéoles dans les cellules soumises au stress mécanique, les cavéoles sont
proposées de constituer un réservoir membranaire et de tamponner la ten-
sion membranaire pendant des stresses mécaniques. Cette étude a eu le but
de tester cette hypothèse expérimentalement. En premier, linﬂuence des
cavéoles sur la tension membranaire au repos a été étudiée sur des cellules
endothéliales du poumon de la souris. Puis, on a montré que les cavéoles
tamponnent l augmentation de la tension membranaire après lapplication
dun stress mécanique. En suite, la réalisation des vésicules membranaires
contenant des cavéoles a permit de montrer leur rôle comme réservoir mem-
branaire dans un système simpliﬁé. Finalement, dans un contexte physi-
ologiquement plus relevant, létude des cellules musculaires a montrée que
les mutations du cavéolin associées aux dystrophies musculaires rendent les
cellules moins résistante aux stresses mécaniques. En conclusion, cette étude
supporte l'hypothèse que les cavéoles tamponnent la tension membranaire
pendant des stresses mécaniques. Le fait que cela se passe dans les cellules et
les vésicules indépendamment dATP et du cytosquelette révèlent un proces-
sus passif et mécanique. Cela pourrait servir à une meilleure compréhension
du rôle des cavéoles dans la cellule et les maladies génétiques comme les
dystrophies musculaires.
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Deutsch
Caveolae sind charakteristische Plasmamembraneinstülpungen, die in vie-
len Zelltypen vorkommen und deren biologische Funktion umstritten ist.
Ihre besondere Form und ihre Häuﬁgkeit in Zellen, die stets mechanischen
Belastungen ausgesetzt sind, führten zu der Annahme, dass Caveolae die
Plasmamembran vor mechanischen Belastungen schützen und als Membran-
reservoir dienen. Dies sollte mit dieser Dissertation experimentell geprüft
werden. Zunächst wurde der Einﬂuss der Caveolae auf die Membranspan-
nung von Zellen im Normalzustand untersucht. Dann wurden die Zellen
mechanisch belastet. Mit Fluoreszensmikroskopie wurde das Verschwinden
von Caveolae nach Strecken der Zellen oder nach einem hypo-osmotischen
Schock beobachtet. Messungen der Membranspannung vor und unmittelbar
nach dem hypo-osmotischem Schock zeigten, dass Caveolae einen Anstieg der
Membranspannung verhindern, unabhängig von ATP und dem Cytoskelett.
Die Erzeugung von Membranvesikel mit Caveolae erlaubte es, diesen Ef-
fekt der Caveolae in einem vereinfachten Membransystem zu beobachten.
Schliesslich wurden Muskelzellen untersucht. Zellen, die genetisch bedingt
weniger Caveolae haben und mit Muskelschwundkrankheiten in Verbingung
stehen, waren mechanisch weniger belastbar als gesunde Zellen. Zusammen-
fassend wird mit dieser Dissertation die These bestärkt, dass Caveolae einem
Anstieg der Membranspannungen entgegenwirken. Dass dies in Zellen und in
Vesikeln unabhängig von Energie und Cytoskelett geschieht, lässt auf einen
passiven, mechanisch getriebenen Prozess schliessen. Diese Erkenntnis trägt
zum Verständnis der Rolle von Caveolae in Zellen bei und kann dem besseren
Verständnis von Krankheiten bedingt durch Caveolin-Mutationen, wie z.B.
Muskelschwundkrankheiten, dienen.
4
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Part I
Introduction
10
My Ph. D. project focused on the mechanical role of caveolae, small
plasma membrane invaginations, in cell tension homeostasis. It was pursued
in the framework of a close cooperation between the physics and biology de-
partments of the Institut Curie, in which biological and physical approaches
were combined. Measurements of physical properties of plasma membranes
were conducted on living cells, and combined with genetic or chemical cell
modiﬁcations. This work will be introduced by presenting ﬁrst the physical
background of lipid membranes in model systems, and in the cellular envi-
ronment. Then, we will summarize the current biological knowledge about
caveolae. This part will end with a theoretical outlook on the possible role
of caveolae in cell membrane mechanics.
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Chapter 1
Physical Description of Cellular
Membranes
In this chapter basic physics of pure lipid bilayers will be ﬁrst described,
before moving to systems that are closer to the biological reality (i.e. lipid
bilayers with embedded proteins).
1.1 Membrane Physics at Equilibrium
Membranes are quasi two dimensional objects, which can be deformed by:
• shear
• stretch/compression
• bending
12
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Figure 1.1: Structures formed by different lipids: (a) inverted conical lipids, such as de-
tergent molecules, lysophospholipids and polyphosphoinositides; (b) cylindrical-shaped lipids,
such as phosphatidylcholine and sphingomyelin; (c) conical lipids, such as diacylglycerol and
PE. from Janmey and Kinnunen [2006]
In the following we will consider the case of a pure lipid bilayer, which is
∼ 5nm thick, and in which a single lipid occupies an area of ∼ 0.7µm2.
(Lipowsky and Sackmann [1995]). Lipids consist of a hydrophilic head and
a hydrophobic tail. When dissolved in aqueous solution, it is energetically
favorable to shield the tail from the water molecules, while the heads prefer to
be oriented towards the aqueous solution. This property of the lipids makes
them self assemble into bilayers or micelles (Zimmerberg and Kozlov [2006];
Janmey and Kinnunen [2006])(Fig 1.1). Theoretical models of membrane
deformations were developed in the 1970's by Helfrich (1973) and Canham
(1970)(Helfrich [1973], Canham [1970]) (Fig 1.2).
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Figure 1.2: Schematic examples of membrane deformations. (A) A lipid bilayer membrane
has a typical a thickness of ∼ 5nm. (B) In plane membrane deformations: shear (top) and
stretch (bottom). (C) Bending results in an out of plane deformation and is described by its
two principal curvatures C1 and C2.
1.1.1 Elastic Membrane Properties
Shear is the deformation of the membrane resulting from the action of
two parallel, but opposite directed forces at constant area. The associated
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density of energy per unit area (Hshear) can be deduced from Hook's law:
Hshear =
1
2
µ(λ2 + λ−2 − 2) (1.1.1)
with λ = (L0 + ∆L)/L0 the lateral extension rate (L0 is the initial length
of the membrane prior to deformation) and µ (in J/m2) the shear modulus.
In the case of ﬂuid lipid bilayers Hshear can be omitted because µ = 0. In
the case of cellular membranes composed of a lipid membrane in interaction
with a cytoskeleton, µ 6= 0. For example µ was measured to be 6 · 10−6J/m2
for red blood cells (Mohandas and Evans [1994], Hénon et al. [1999]).
Extension/Compression is the deformation of the membrane with a
change ∆A of its membrane area. The associated areal density of energy
Hext can be expressed as:
Hext =
1
2
Ka(
∆A
A
)2 (1.1.2)
with the elastic area compressibility modulus Ka and the relative area defor-
mation ∆A/A. Lipid bilayers are in general poorly compressible and extensi-
ble. Ka is of the order of 200mN/m (Kwok and Evans [1981]), and depends
weakly on the lipid chain length or the degree of insaturation (Rawicz et al.
[2008]). Increasing the cholesterol concentration of membranes can increase
Ka about 2 − 5 fold (Needham and Nunn [1990]). Upon a few percent of
extension, lysis occurs by pore opening. The order of magnitude of the lysis
tension s about 10−3N/m (Evans et al. [2003]; Sandre et al. [1999]).
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Bending Bending results in a deformation of the membrane out of its
plane, and the corresponding areal energy density can be described as:
Hbend =
1
2
κ (C1 + C2 − C0)2 + κGC1C2 (1.1.3)
with the two principal membrane curvatures C1 =
1
R1
, and C2 =
1
R2
repre-
senting the shape of the membrane along the two axes at a given point in
the membrane, and with the spontaneous curvature C0 which is considered
to be isotropic. κ is the bending rigidity modulus of the membrane, and κG
is the Gaussian curvature modulus, both expressed in J or units of thermal
energy (kBT ). The term C1 +C2 is the total curvature, and the term C1 ·C2
represents the Gaussian curvature. In the case of closed membranes, the
Gauss-Bonnet theorem claims that the Gaussian curvature is an invariant,
i.e. its integral does not change until its topology changes (e.g. creation of
pores in the membrane). Recently, Baumgart and coworkers measured the
Gaussian bending modulus (κG = 10−19J = 25kBT ) in analyzing the shape
of phase separated vesicles (Baumgart et al. [2003]). Since the topology of
vesicles and cells does not change in our experiments, this Gaussian term
can be omitted. The bending rigidity modulus, κ, describes the energy cost
required to deform a membrane out of its plane. κ is an intrinsic property
of the membrane, ranging typically between 10− 100kBT . It depends on the
membrane composition, as well as on the nature of each lipid, like the degree
of saturation or the length of the aliphatic chains (Evans and Rawicz [1990],
Rawicz et al. [2000], Rawicz et al. [2008]). To get an overview of the values
of κ in various lipid membranes, and of the diﬀerent techniques used to mea-
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sure κ, please see (Marsh [2006]). Since bending involves the compression
and expansion of the two layers of the membrane, κ can be related to the
compressibility modulus Ka via:
κ = Kah
2/ce (1.1.4)
with the membrane bilayer thickness h and a prefactor ce, which accounts for
the coupling between both monolayers (ce = 48 for uncoupled and ce = 12 for
completely coupled monolayers)(Bloom et al. [2009], Rawicz et al. [2000]).
The spontaneous curvature is another intrinsic membrane property, which
describes the curvature that the membrane would attain in the absence of
external constraints. A membrane made of two identical lipid layers would
have no spontaneous curvature. As soon as the two layers are diﬀerent in their
composition or in their distribution of lipids and proteins, the spontaneous
curvature can become non zero, typically of order of a fraction of nm−1
(Kooijman et al. [2005]). The insertion of proteins like epsin or amphiphysin
into one leaﬂet of the bilayer (Zimmerberg and Kozlov [2006], Campelo et al.
[2008]) or the clustering of lipids induced by the binding of proteins can
also induce spontaneous curvature of order of (∼ 1/50nm−1) (Römer et al.
[2007]).
1.1.2 Mathematical Description of the Membrane
Helfrich and Canham proposed a theoretical description of membranes by
introducing a Hamiltonian with membrane bending as the major energy con-
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tribution (Helfrich [1973], Canham [1970]):
H =
∫
dA
1
2
[κ(c1 + c2 − c20 + κGc1c2)] (1.1.5)
However, in order to achieve a more detailed description of the state of the
membrane, the tension of the membrane has to be considered, too.
1.1.3 Membrane Tension
The lateral membrane tension, σ, is a parameter of particular interest in the
present work. It describes the stress associated to a change of membrane
area, σ = ∂F/∂A, and can be related to the elastic modulus Ka:
σ = Ka(
∆A
A
). (1.1.6)
This description holds and is useful at the macroscopic scale, but it does not
take into account that the deﬁnition of the area becomes delicate for thin
membranes under low tension. In this case, the lipid bilayer has a thickness
of h ∼ 5nm and will be thus subjected to thermal ﬂuctuations at the molec-
ular and microscopic scale (Fricke et al. [1986]), which results in a technical
impossibility to resolve optically the real membrane area. Thus, membrane
area can be stored and released without any visible change resulting in a non
linear relationship between applied stress and observed area. One way to
resolve this problem is to describe it in analogy to the unfolding of a poly-
mer in solution (Helfrich and Servuss [1984]; Evans and Rawicz [1990]). To
stretch a Gaussian polymer, one has ﬁrst to overcome the entropic energy
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for unfolding before getting into the enthalpic regime, where the extension
aﬀects the molecular bonds.
Entropic Regime
To ﬁnd a relation between the change in area and the membrane tension, one
has ﬁrst to relate the membrane ﬂuctuations with other membrane properties.
Considering a square membrane patch of edge length L under zero tension,
one can estimate the maximum amplitude of ﬂuctuations (umax) using the
Canham-Helfrich Hamiltonian combined with the equipartition of energy (for
more details see (Helfrich [1973], Helfrich and Servuss [1984])
umax ∝
√
kBT
κ
L (1.1.7)
to be of the order of 3µm with κ = 10kBT and L = 10µm. Including the
membrane tension, one obtains with the same approach (Helfrich and Servuss
[1984])
umax ∝
√
kBT
σ
ln
L
a
. (1.1.8)
with a being a molecular size of the order of ∼ nm. Regarding the same
square membrane patch (κ = 10kBT, L = 10µm) under a typical value of
membrane tension (σ = 10−6N
m
) and molecular size (a = 0, 5nm) the maximal
amplitude of the membrane ﬂuctuations decreases to 0, 6µm. Membrane
tension thus reduces the amplitude of thermal ﬂuctuations.
More generally, a relationship between the relative membrane area stored in
ﬂuctuations, α =
∆A
A
, and the membrane tension, σ, can be obtained by
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ﬂuctuation spectrum analysis (Helfrich and Servuss [1984]):
α =
∆A
A
=
kBT
8piκ
ln
pi2/a2 + σ/κ
pi2/L2 + σ/κ
. (1.1.9)
In the case of zero tension, this equation simpliﬁes to
α =
kBT
8piκ
ln
L2
a2
, (1.1.10)
and reveals the excess area to be about 8% in our example (κ = 10kBT, a =
0, 5nm,L = 10µm). At low membrane tension, i.e. in the range κpi2  σ 
κpi2
a2
, equation (1.1.9) can be simpliﬁed to
α =
kBT
8piκ
ln
κpi2
σa2
. (1.1.11)
at σ = 10−6N
m
the excess area is about 6%. It is of note that in the entropic
regime, the excess area ∆A is the diﬀerence between the microscopic (A) and
the observed membrane area (Aobs), and that the microscopic area remains
constant.
Enthalpic Regime
As seen above, membrane tension increase in the entropic regime smoothens
out membrane ﬂuctuations. Further increase of σ will lead to a stretch of
the lipid bilayer, i.e. the area per lipid molecule will have to increase. The
dominant contribution is then governed by the elastic modulus and given by:
∆A
A
=
σ
Ka
. (1.1.12)
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The combination of both the contributions from the enthalpic and entropic
regimes gives the general equation relating excess area and membrane tension
(Evans and Rawicz [1990]):
α =
∆A
A
=
kBT
8piκ
ln
κpi2
σa2
+
σ
Ka
. (1.1.13)
Note that an alternative approach for the deﬁnition of the membrane ten-
sion was recently proposed by Fournier (Fournier et al. [2001]). Here the
eﬀective membrane tension is associated to the change of optically resolved
membrane area, which makes the ad hoc introduction of stretching elasticity
unnecessary. The obtained relationship between excess area and membrane
tension is identical to equation 1.1.13.
1.2 Techniques to Measure Mechanical
Properties of Membranes
Various techniques have been developed to assess the mechanical properties
of membranes at the microscopic or macroscopic scale. Amongst them, one
may mention the vesicle edge detection, where the shape of a ﬂuctuating
membrane vesicle is recorded using rapid video microscopy, and analysis of
the ﬂuctuation spectrum provides estimates of the bending rigidity (Faucon
et al. [1989], Meleard et al. [1998], Pécréaux et al. [2004], Faris et al. [2009]).
Another approach analyzes the ﬂuctuations at one point of the vesicle using
optical tweezers (Betz et al. [2009]). In the following, we will focus on two
other methods, namely the micropipette aspiration, and the tether pulling
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method that were extensively used in the present work.
1.2.1 The Micropipette Aspiration Technique
In the end of the 1970's, Evans introduced the micropipette aspiration tech-
nique on red blood cells (Waugh and Evans [1979]) and giant unilamellar
vesicles (GUV's)(Kwok and Evans [1981]) to monitor the membrane excess
area with respect to the applied membrane tension. This enables to deter-
mine the bending rigidity κ and the membrane extension modulus Ka using
equation 1.1.13. The basic principle consists in aspirating a ﬂuctuating vesi-
cle in a glass micropipette (typical diameter of ∼ 3− 5µm). The membrane
tension σ, which is tuned by the aspiration pressure, can thus be varied over
orders of magnitude. In parallel, the length of the aspirated portion of the
vesicle (called "tongue") allows a measure of the excess area α. For proper
quantitative analysis, the following requirements have to be met: (Drury and
Dembo [1999]):
• the volume of the vesicle remains constant
• the vesicle contains a constant number of lipids
• the membrane does not adhere to the pipette
• the aspirated tongue is longer than the pipette radius Rpip.
More precisely, the membrane tension imposed by the micropipette aspiration
to the vesicle can be derived using the Laplace law:
σ =
∆PRpip
2(1−Rpip/Rves) (1.2.1)
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with ∆P the hydrostatic pressure diﬀerence between the inside and the out-
side of the pipette, and Rpip and Rves the radii of the pipette and the vesicle,
respectively. In practice, the hydrostatic pressure is set by varying the height
of a water reservoir connected to the micropipette (see materials and meth-
ods section for more details). The change of excess membrane area, i.e.
the change of the length of the tongue ∆L = L − L0 can be linked to the
change of total membrane area before (A0) and after (Aasp) aspiration using
geometrical arguments (Kwok and Evans [1981]):
Aasp − A0
A0
=
(Rpip/Rves)
2 − (Rpip/Rves)3
2Rpip
∆L. (1.2.2)
Reminding that the relative excess area stored in ﬂuctuations is α =
A− Aobs
A
,
with A the microscopic area and Aobs the observed area, this value will be
maximal (α0) in the case of a non aspirated vesicle (σ0). Increasing the mi-
cropipette aspiration, and thus the applied membrane tension σ > σ0 will
lead to a decrease of the relative excess area α < α0 following equation 1.1.11.
The relation (α0 − α) = Aasp−A0A0 allows linking the measurable parameters
Rpip, Rves and ∆L to the membrane tension, and to the bending rigidity and
the extension moduli (Evans and Rawicz [1990], Rawicz et al. [2000], Fournier
et al. [2001]):
α0 − α = kBT
8piκ
ln
σ
σ0
+
σ
Ka
(1.2.3)
At low tension the logarithmic term dominates, giving access to κ through a
linear ﬁt of the ln(σ) vs. (α0−α) plot. At higher tension, the linear term will
dominate, which allows to deduce Ka via a linear ﬁt of the σ vs. (α0 − α)
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Figure 1.3: Left: Video micrograph of a vesicle area expansion test. (a) The vesicle at low
tension. (b) The vesicle at high tension. The change in projection length ∆Lp is proportional to
the change in apparent surface area ∆A. Right: Examples of apparent area expansion mea-
sured over tensions from 0.001 to 8mN/m for two vesicles made from C18:0/1 and diC18:3
PC. (c) Linear plot of tension versus apparent area expansion. The initial soft-exponential
rise of tension with area expansion reveals smoothing of thermal shape fluctuations, which is
followed by the onset of linear increase in tension as the bilayer begins to stretch. (d) Semi
log plot of tension versus apparent area expansion. Slopes of the linear fits (dashed lines)
applied to the range of very low tensions yield elastic bending moduli kc (x 8pi/kBT ) for each
bilayer (kc = 0, 9 · 10−19J for C18:0/1 and kc = 0, 4 · 10−19J for diC18:3). The solid curves
in A and B are the fit of the elastic compressibility relation 1.2.3 over the entire four-order-of-
magnitude range of tension, using the values of bending elasticity and a common value of the
direct expansion modulus (KA = 230mN/m) for both lipid vesicles. From Rawicz et al. [2000]
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plot. A representation of such an experiment is shown in Fig 1.3. This
technique has been widely used, especially by the Evans' group, to measure
mechanical properties of synthetic and biological membranes (Mohandas and
Evans [1994], Hochmuth [2000], Manneville et al. [2001], Herant et al. [2005],
Tian et al. [2007], Rawicz et al. [2008]).
1.2.2 Tether Extraction
Another way to achieve information about mechanical membrane properties
consists in extracting tethers by the application of a "point" force on the
membrane. Tethers were ﬁrst observed in the early 1970's on red blood
cells attached on a glass slide and submitted to shear ﬂows (Hochmuth
et al. [1973]). Variations of this approach involved the introduction of mi-
cropipettes to control the membrane tension (Hochmuth and Evans [1982]),
the study of artiﬁcial membranes (Waugh [1982], Rossier et al. [2003]) or the
use of gravity instead of shear ﬂow (Bo and Waugh [1989]). Tethers have also
been formed by using of kinesin motors walking on microtubules (Roux et al.
[2002], Koster et al. [2003]), beads attached to sensitive force probes such as
the biomembrane force probe (Heinrich et al. [2005]) or magnetic tweezers
(Heinrich and Waugh [1996]) or optical tweezers (Dai et al. [1998], Koster
et al. [2003] Cuvelier et al. [2005]). In the present work, we have used optical
tweezers: optically trapped beads serve as handles to extract tethers from
adherent cells as well as from membrane vesicles aspirated in a micropipette.
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1.2.3 Force and Radius of a Tether
In this section, the experimental situation of a tether extracted from an
aspirated vesicle (Fig 1.4) will be discussed, because this case has been ex-
tensively investigated both from a theoretical and experimental point of view
(Svetina et al. [1998], Evans and Yeung [1994], Derényi et al. [2002], Powers
et al. [2002], Rossier et al. [2003]).
Rt
tL
f
Figure 1.4: Scheme of an aspirated vesicle with radius Rv from which a tether of radius Rt
and length Lt is extracted under the application of the tether force ft.
The free energy , Ft, of a tether (i.e. a cylindrical membrane tube) can
be written:
Ft =
pi
Rt
κLt + 2pirσlLt − fLt (1.2.4)
with Rt the tether radius, Lt the tether length, and f the force required
to hold the tether at constant length. This term reﬂects the competition
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between the bending rigidity leading term, which favors small curvatures,
and the membrane tension leading term tending to minimize the tether area.
At equilibrium, at constant tether length, the tether force f0 and the tether
radius R0 are obtained by the free energy with respect to Rt and Lt, respec-
tively:
f0 = 2pi
√
2κσ (1.2.5)
R0 =
√
κ
2σ
(1.2.6)
One may remark that f0 and R0 only depend on the bending rigidity and the
membrane tension, but not on the tether length Lt providing σ is ﬁxed. 1.2.6
was experimentally checked by Heinrich and Waugh using magnetic tweezers
(Heinrich and Waugh [1996]). For typical values for the bending rigidity,
κ = 10kBT , and the membrane tension, σ = 10−6Nm , the equilibrium force
is about 10 pN and the radius about 140nm. If the membrane tension does
not remain constant or is not set by micropipette aspiration, during tether
extraction, the tether force becomes length dependent according to (Cuvelier
et al. [2005]):
L ' Rv ftRv
16piκ
{ kBT
κ
ln
ft
f0
+
f 2t + f
2
0
piκKa
} (1.2.7)
Tether Nucleation
Tether pulling is mainly composed of two phases: nucleation and elongation.
The nucleation process has been studied theoretically by Derenyi and col-
leagues (Derényi et al. [2002]) and experimentally by Koster et al. (Koster
et al. [2005]). First, the ﬂat membrane is deformed to a catenoïd shape,
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which is the minimal surface between two spheres. At this stage, the force
to elongate the catenoïd depends linearly on its length. At larger defor-
mations, nucleation into a cylindrical membrane tube (i.e. tether) becomes
energetically favorable and the tether elongation becomes independent from
its length. The transition between the ﬂat membrane and the tether is ac-
companied by a force overshoot, whose amplitude depends on the size of the
adhesion patch of the membrane to the bead (Fig 1.5).
Tube radius
Tu
be
 le
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A B
Figure 1.5: Right: The force on the bead during tether nucleation for different pulls. The
three curves correspond to the three patches in shown in the panel above. In each pull the
stage is moved for 20sec (10µm) during which the force grows until at fover a tether is formed
and the force drops to f0. After the stage movement has stopped, the patch size is evaluated
in fluorescence (at the break), and subsequently the stage is moved back 10µm while the
tether retracts.Koster et al. [2005]
In the case of living cells, the nucleation process also involves membrane
from cytoskeleton detachment. Depending on the tether pulling velocity,
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tether force traces may or may not exhibit force overshoots (Heinrich et al.
[2005]). In the present work, only tethers will be considered which were
preformed and elongated further.
Dynamics of Tether Extraction
Equation 1.2.6 can be reﬁned by considering additional contributions appli-
cable in speciﬁc situations:
• Asymmetry between the two leaﬂets:
When the membrane area of the tether is large in respect to the vesicle
area, the diﬀerence between the outer and inner leaﬂet becomes signif-
icant. For a tether of the length 100µm and taking 5nm for the bilayer
thickness, the diﬀerential area is about 3µm2. The supplementary con-
tribution to the force is
fnlb =
2piκr
e
α,
where α is the diﬀerence of membrane area between the two leaﬂets,
and κr the nonlocal bending modulus (Bozic et al. [1992], Raphael
and Waugh [1996]). Experimentally, kr ≈ 3κ (Svetina et al. [1998]),
and ∆fnlb is thus in the range of 1 pN , and still small compared to the
typically observed tether forces (10−50 pN). Moreover, it is a transient
eﬀect, because the ﬂip-ﬂop process of lipids will equilibrate the number
of lipids within minutes (Svetina et al. [1998]).
• Viscous friction:
Experimentally tethers are not extracted inﬁnitely slowly. The viscous
friction between the two leaﬂets of the membrane, which arises upon
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extraction at ﬁnite pulling velocity v, has to be considered. Since the
ﬂow of lipids into the tether is equal for the two monolayers, the lipids
in the inner leaﬂet have a diﬀerent distance to go than the ones in the
outer leaﬂet. Evans and Yeung (Evans and Yeung [1994]) have shown
that the additional force ∆fv can be expressed as
∆fv = ηm e
2 ln(
R
rt
) · vpull,
where ηm is the viscosity between the two leaﬂets, R is the radius of the
vesicle and vpull is the velocity of tether elongation. For vpull = 0, 5µm/s
(as used in our experiments) and ηm = 0, 002
pNs
µm
((Hochmuth et al.
[1996]), one obtains ∆fv ∼ 0, 03pN , which is negligible. Note however
that these estimates are only valid for pure lipid bilayers.
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Chapter 2
From Vesicles to Cells
The equations and techniques presented in the previous section were experi-
mentally validated on synthetic lipid membrane systems, especially on giant
unilamellar vesicles (GUVs). These systems are well suited to study physical
parameters, and to test theoretical assumptions, since the lipid composition
of the membrane and their geometry can be controlled. Additionally, due to
the size of GUVs (diameter ∼ 10 − 30µm), they can easily be manipulated
and subjected to mechanical forces in a controlled and tunable manner.
In contrast to model systems, the cellular plasma membrane is a complex
dynamic system with a large diversity of lipids and proteins organized as
an asymmetric bilayer and constantly subjected to renewal. In the present
work, we will exploit the knowledge obtained on model systems to explore the
mechanical properties of the cellular plasma membrane by using the tether
pulling technique based on optical tweezers. We will ﬁrst describe brieﬂy the
physicist's view of a cell. In particular, we will focus on the plasma mem-
brane and the diﬀerences that we can anticipate as compared with pure lipid
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Figure 2.1: Sketch of an animal cell depicting its main compartments and structures. From
Wikipedia Encyclopedia
bilayers.
2.1 Structure of the Cell
The basic building unit of living organisms is the cell. Although organisms
consist of a single cell type (i.e. embryonic stem cells) at the very beginning,
these cells are able to divide and diﬀerentiate into a large variety of cell types
with diﬀerent shapes, and specializations for diﬀerent tasks. However, the
general organizing mechanisms, and the machinery needed for proper cell
function are similar in the diﬀerent cell types. Eukaryotic cells (i.e. cells
with a nucleus like plant, fungi and animal cells) are typically of the size of
5 − 50µm. Interestingly, even at these small scales, there is a clear orga-
nization of spatially and functionally separated intracellular compartments
(organelles) to address diﬀerent cellular functions. In these compartments,
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diﬀerent components and functions are segregated from each other: DNA
storage in the nucleus, ATP production in the mitochondria, synthesis of
proteins and lipids in the endoplasmic reticulum, and sorting of proteins for
their ﬁnal destinations in the Golgi apparatus. A simpliﬁed sketch of an
animal cell is presented in Fig 2.1.
Figure 2.2: Sketch of the cellular plasma membrane depicting its main components and
interaction partners. adapted from Singer and Nicolson [1972]
Cells, and the organelles within them, are separated from each other and
from the outside world by thin membranes. The main building blocks of these
cellular membranes are lipids and proteins (Fig 2.2). The plasma membrane
lies on another important cellular component, the cytoskeleton.
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2.2 Cytoskeleton of Cells
The main function of the cytoskeleton is to maintain the cell shape, to drive
cell motility (in using structures like pseudopods or ﬂagella). It also plays an
important role in transport processes (intracellular transport, endocytosis,
and exocytosis) and in cell division. It is a dynamic structure containing
three main kinds of polymer ﬁlaments (in eukaryotic cells): microtubules,
intermediate ﬁlaments and actin ﬁlaments. (Fig 2.3, Fletcher and Mullins
[2010])
Microtubules are hollow cylinders of about 25nm diameter, commonly
built up by 13 protoﬁlaments, made by polymers of α and β tubulin. They
bind GTP for polymerization and show a very dynamic behavior. Micro-
tubules are organized in the centrosome and represent the stiﬀest cytoskeletal
component (persistence length ∼ 1mm)(Bretscher [1991]).
Intermediate ﬁlaments have a diameter of 8 − 11nm and are less rigid
than microtubules. They organize the internal three dimensional structure of
the cell (e.g. the nuclear envelope) and can be made of proteins like vimentin
(Strelkov et al. [2003]).
Actin ﬁlaments have a persistence length of ∼ 13, 5µm, a diameter of
7nm, and are made of two actin chains organized in a helicoidal structure.
Actin ﬁlaments are highly concentrated beneath the cell membrane, and form
the actin cortex, which interacts directly with the cell membrane, controls
the cell shape and some endocytic processes.
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Figure 2.3: (a) Neurons are specialized eukaryotic cells that extend long processes to form
connections in the nervous system. Like other eukaryotic cells, neurons have a cytoskeleton
that consists of three main polymers: microtubules (green), intermediate filaments (purple)
and actin filaments (red). (b) The neuronal axon is a long membrane-bounded extension, in
which neurofilaments (a class of intermediate filament in neurons) form a structural matrix
that embeds microtubules, which transport materials from the cell body to the axon terminals
at the synapse. (c) The growth cone contains dendritic actin filament networks and paral-
lel actin-filament filopodia. (d) Microtubules consist of 13 protofilaments of tubulin dimers
arranged in a hollow tube. (e) Neurofilaments have flexible polymer arms that repel neighbor-
ing neurofilaments and determine the radius of the axon. (f) Actin filaments are arranged into
networks. These networks can have many architectures, including the branched structures de-
picted here, which are formed by the Arp2/3 complex (blue). The diameters of microtubules,
intermediate filaments and actin filaments are within a factor of three of each other; the dia-
grams in (d), (e) and (f) are drawn approximately to scale. But the relative flexibilities of these
polymers differ markedly, as indicated by their persistence lengths: from least to most flex-
ible, microtubules (5000µm), actin filaments (13, 5µm) and intermediate filaments (0, 5µm).
adapted from Fletcher and Mullins [2010]
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2.2.1 Actin Filaments
Dynamics of Polymerization and Depolymerization Actin ﬁlaments
are polarized. Due to the arrowhead pattern created when myosin binds
actin, the rapidly growing end of a ﬁlament is called the barbed end, the
slowly growing one the pointed end. The polymerization of actin requires
hydrolysis from ATP to ADP (i.e. energy consumption), and is regulated by
the chemical equilibrium between the concentration of actin monomers and
actin ﬁlaments. The process of continuous addition of actin monomers to
the barbed end of the ﬁlament and its depolymerization at the pointed end
is called treadmilling. In vitro studies of the concentration of unpolymerized
actin found in cells (10−100µM), and determined elongation rates of barbed
ends of ∼ 0.3−3µm/s, that is ∼ 100−1000 subunits/s. To control this pro-
cess, cells use two mechanisms including proteins that bind monomeric actin
and modify its polymerization properties (e.g. proﬁlin, thymosin-β 4)(Chuat
et al. [1996]), and capping proteins that prevent the polymerization from the
monomers by adding to the ﬁlament ends (e.g. gelsolin). Furthermore, sev-
eral proteins promote actin nucleation (e.g. Arp 2/3) by forming complexes
with membrane proteins (e.g. the signaling pathway through WASp/Scar
to Arp 2/3 complex)(Fletcher and Mullins [2010], Pollard et al. [2000]). A
schema is displayed in Fig. 2.4.
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Figure 2.4: Cartoons showing actin-based movements. (A) Clathrin-mediated endocytosis at fungal actin
patches. (B) Formation of branched filament networks nucleated by Arp2/3 complex, which is used for three of these
types of movement, those depicted in (A), (F), and (G). (C) Transport of membrane-bound vesicles, organelles, and
RNAs from the mother cell to the daughter cell by class V myosins in budding yeast. (D) Cytokinesis in animal cells by
constriction of a contractile ring of actin filaments and myosin II. (E) Cytokinesis in fission yeast. The contractile ring
of actin filaments and myosin II forms by condensation of nodes. (F) The Listeria bacterium stimulates the assembly
of an actin filament comet tail to push it through the cytoplasm of a host animal cell. (G) Locomotion of an animal cell
by assembly of actin filaments at the leading edge and retraction of the tail. from Pollard and Cooper [2009]
Besides the WASP-pathway, there are other proteins which connect the
actin ﬁlaments to the cell membrane, e.g. phosphatidylinositol 4,5-biphosphate
(PIP2), ﬁlamin or ezrin. The elasticity of the actin cytoskeleton is due to
both the cross linking of actin ﬁlaments involving proteins called cross link-
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ers like α-actinin or ezrin, and to the work of molecular motors, especially
myosin II enabling the contraction of the cytoskeleton (Paluch et al. [2006]).
2.2.2 Actin Cortex Impairing Drugs
Several drugs are known to interfere with actin treadmilling by distinct mech-
anisms.
• Cytochalasin D caps the barbed end of actin ﬁlaments preventing
both assembly and disassembly of subunits. Owing to the dynamic
nature and to additional severing of actin ﬁlaments, cytochalasin D
treatment leads ultimately to actin ﬁlament disassembly(Fujimoto et al.
[2000]; Franki et al. [1992]; Cooper [1987]; Schliwa [1982]).
• Latrunculin A/B forms complexes with actin monomers and thereby
shifts the chemical equilibrium between actin monomers and ﬁlaments,
which results in depolymerization of actin ﬁlaments (Wakatsuki et al.
[2001]).
• Jasplakinolide stabilizes actin ﬁlaments in retaining phosphatic groups
from the ATP hydrolysis in the ﬁlament. Since the addition of further
actin monomers on the barbed end is not aﬀected, jasplakinolide in-
duces actin ﬁlament polymerization until the pool of actin monomers is
depleted (Holzinger and Meindl [1997], Senderowicz et al. [1995] Bubb
et al. [1994]).
Note that the drug eﬀects described above are valid for the concentrations
used in our experiments (C ∼ 0, 1−1µM). Some subtle eﬀects of these drugs
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might arise at other concentrations.
2.3 Cellular Membranes
Cellular membranes are made of many diﬀerent lipids and they contain em-
bedded and associated proteins (Fig. 2.2). Cell membranes are very thin
(∼ 5nm), and are therefore ﬂexible (i.e. easily deformed by forces in the pN
regime).
Figure 2.5: The lipids found in the plasma membrane. Abbreviations: PI, phosphatidyli-
nositol; PIP, phosphatidylinositol phosphate; PIP2, PtdIns(4,5)P2; PIP3, phosphatidylinositol
(3,4,5)-trisphosphate. from Janmey and Kinnunen [2006]
Membrane proteins either interact with each other or with specialized
lipids (Zimmerberg and Kozlov [2006]). In addition, proteins that are solu-
ble in the cytosol (i.e. the intracellular ﬂuid) can interact directly with the
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membrane lipids or proteins. A crucial property of lipid bilayers is their two-
dimensional liquid nature (above a certain temperature). This allows the
lateral diﬀusion of molecules in the membrane, which is essential for proper
cell functioning. Even though the bilayer behaves in many respects as a
two-dimensional ﬂuid, the molecular mobility within the membrane can be
restricted by several factors. First, the lipid bilayer of cellular plasma mem-
branes has an asymmetric lipid and protein composition, which is actively
maintained through transport of lipids by proteins (ﬂippases) from one layer
to the other (Buton et al. [1996])(Fig 2.5 B). Second, membranes may contain
substructures often referred to as rafts (Hancock [2006], Simons and Toomre
[2000]). Depending on the lipid composition of the membranes, phase sepa-
ration between liquid ordered and liquid disordered phase domains may be
induced. Third, the underlying cortical cytoskeleton and associated proteins
limit the diﬀusion of molecules in the membrane by creating some obstacles
(fences) (Kusumi et al. [2005]).
2.4 Membrane Area and Membrane Tension
Regulation
The role of the cytoskeleton in determining the viscoelasticity of a cell and in
governing cell motility, growth and development has been extensively stud-
ied in the past decades (Park et al. [2005], Vogel and Sheetz [2006], Geiger
et al. [2001], Stamenovic and Wang [2000]). While the cell membrane was
often considered to be a passive border between the interior of the cell and
40
the outside world, it has recently become evident that the plasma membrane
plays also an active role in various cellular processes Morris and Homann
[2001].
In this context, important parameters are the membrane surface area and
the lateral membrane tension which are interconnected and related to pro-
cesses like the release (exocytosis) or uptake (endocytosis) of cargo, to cell
migration or to the repair of the cell membrane. Sheetz and coworkers
showed in red blood cells, that a hypo-osmotic shock- hence a stretch of
the membrane surface area- increased the membrane tension and resulted
in a decrease of endocytosis. Contrary, stimulation of exocytosis dropped
the membrane tension which was later (after 5 min of stimulation) compen-
sated by increased endocytosis (Dai et al. [1997]). A similar observation
was also done on cells under mitosis, where endocytosis was impaired at
high membrane tension during mitosis, but started again after the mitosis
when membrane area increased and membrane tension was low (Raucher and
Sheetz [1999]). Thus, reduction of membrane area increases membrane ten-
sion and impairs endocytosis, and exocytosis increases the membrane area
and lowers the membrane tension. Another mean to control the membrane
tension and to resist mechanical stresses consists in the cytoskeleton under-
neath the plasma membrane (Sheetz et al. [2006], Mills and Morris [1998]).
In moluscan neuron cells, mechanosensitive channels are more sensitive to
membrane stretch after disruption of the underlying cytoskeleton. At the
other hand, force mediated F-actin recruitment at the plasma membrane of
ﬁbroblasts increases the membrane rigidity (Glogauer et al. [1997]). A third
way to manage rapid increases of membrane area consists in the release of
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excess membrane area stored in folds or invaginations at the plasma mem-
brane. Electro physiologic measurements of the capacitance of whole cells
revealed that erythrocytes can undergo swelling upon hypo-osmotic shock
in smoothing their membrane. Mast cells and lymphocytes were reported to
double their volume at constant capacitance (Solsona et al. [1998], Ross et al.
[1994]). In skeletal muscle cells almost half of the membrane area is stored
in caveolae (with a density of ∼ 40µm2), which may ensure the enormous
large membrane stretches of muscle cells in action by ﬂattening (Dulhunty
and Franzini-Armstrong [1975]). The subject of the present work is the role
of caveolae as a membrane reservoir, and how this is related to the membrane
tension.
2.5 Tether Extraction From Cells
The theory of tether pulling presented in the previous chapter was developed
and experimentally validated for lipid vesicles. The complexity of the cellular
plasma membrane and its interaction with the cytoskeleton make it neces-
sary to examine how this formalism is changed for living cells. Sheetz and
colleagues have studied the eﬀect of the interaction between plasma mem-
brane and cytoskeleton on the membrane tension, especially the role of PIP2
(phosphatidylinositol 4,5-bisphosphate), a small GTPase in the cell mem-
brane, as a regulator of cytoskeleton - cell membrane adhesion (Sheetz et al.
[2006], Raucher et al. [2000]). Similar studies were also conducted on cells
treated with diverse drugs aﬀecting the actin cytoskeleton, the microtubules
or the membrane lipid composition (Raucher and Sheetz [1999], Hochmuth
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et al. [1996]). To explain the tether force measurements on cells, an addi-
tional term, which accounts for the cytoskeleton - cell membrane adhesion,
is introduced into the free energy of the tether, i.e.
Ft =
pi
r
κl + 2pirlσ + 2pirlW0 − fl (2.5.1)
This leads to an equilibrium tether force given by:
f ∗ = 2pi
√
2(σ +W0)κ = 2pi
√
2σeff κ (2.5.2)
where W0 is the cytoskeleton-membrane adhesion energy density (J/m2). It
can be considered for tether pulling experiments on cells in normal conditions
that W0 contributes to about 75 % to the eﬀective tether force and σ to the
remaining 25 % (Sheetz [2001]). It is worth noting that the adhesion of the
cytoskeleton to the membrane is described by a single continuum parameter,
W0, and that more detailed models of the underlying molecular processes are
still missing. For example protein - lipid and protein - protein interactions
within the membrane may lead to compartmentalization and self assembly of
peculiar structures like membrane invaginations, which are likely to alter the
properties of the cell membrane (Zimmerberg and Kozlov [2006]; Hinrichsen
et al. [2006]). The mechanical role of these structures is poorly understood,
but there is growing evidence that cells control the membrane tension and
contain some membrane reservoirs to allow fast stretching without membrane
rupture (e.g. in muscle cells). Since these cells contain a large amount
of membrane invaginations called caveolae, P. Sens proposed a theoretical
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model how those invaginations could play the role of a membrane reservoir
and inﬂuence the plasma membrane mechanical properties (Sens and Turner
[2005]). The theoretical model will be described in section 4 (page 74). But
ﬁrst will be presented some basic biological knowledge about caveolae.
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Chapter 3
Caveolae
3.1 The Deﬁnition of Caveolae
Caveolae are small Ω - shaped invaginations of 50-80 nm diameter. They
were described for the ﬁrst time in the 1950's, when Palade and Yamada ob-
served small, cave-like membrane invaginations of mouse cells with electron
microscopy (Palade [1953], Yamada [1955]). In the 1990s, the identiﬁca-
tion of the caveolin protein family necessary for caveola formation boosted
the insights into the molecular structure of caveolae, which are additionally
rich in cholesterols, glycosphingolipids and sphingomyelins (Monier et al.
[1995]). Even more recently, additional proteins were discovered, called the
cavin-protein family, whose interaction with caveolins is important for the
formation and shape of budded caveolae (Hansen and Nichols [2010]). An
example of caveolae and of its composition is shown in Fig 3.1.
45
BA
B
C
Figure 3.1: (A) Electron micrograph of an ultrathin cryosection obtained from a mouse lung endothelial cell
showing invaginations typical for caveolae. Bar = 200nm. by G. Raposo (B) Deep etch electron microscopy image
showing cell membrane caveolae from the inside in mouse lung endothelial cells. Bar = 200nm. by M. Morone
(C) The schema indicates how caveolin is inserted into the caveolar membrane, with the N and C termini facing the
cytoplasm and a putative "hairpin" intramembrane domain embedded within the membrane bilayer. The scaffolding
domain, a highly conserved region of caveolin, might have a role in cholesterol interactions through conserved basic
(+) and bulky hydrophobic residues (red circles). The C-terminal domain, which is close to the intramembrane domain,
is modified by palmitoyl groups that insert into the lipid bilayer. from Parton et al. [2006]
Although caveolae are known since more than 50 years, their biological
function is still under debate. They are proposed to play a role in signal-
ing, transcytosis, endocytosis, cell migration, mechanical sensing, lipid and
cholesterol transport, tumor suppression or promotion, depending on the
studied cell type (Goetz et al. [2008], Parton and Simons [2007]). In con-
trast to this, the focus of the present work was to experimentally check
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the hypothesis that caveolae act as a membrane reservoir and constitute a
mean of membrane tension buﬀering (Sens and Turner [2005], (Dulhunty
and Franzini-Armstrong [1975])). In the following, a short description will
be given how caveolin and cavin proteins were identiﬁed and what their char-
acteristics are. An updated description of the caveolin-proteins can be found
in (Goetz et al. [2008] and Parton and Simons [2007]), and for the cavin-
proteins read (Nabi [2009] and Hansen and Nichols [2010]).
3.2 The Caveolin Protein Family
The ﬁrst protein which was found to be necessary for caveola formation is
called caveolin, and was discovered in the early 1990s by several research
groups. Rothberg and coworkers found an antibody which labeled a 22kDa
protein and associated to caveolae proved by ultra structural immunogold
electron microscopy. Rapid freeze techniques were used to observe a ﬂatten-
ing of caveolae after treatment of cells with ﬁllipin and nystatin accompanied
by the dissociation of the 22kDa protein. Due to the intimate association
of this protein to caveolae it was called caveolin (Rothberg et al. [1992]).
In an attempt to study the vesicle transport and sorting between the apical
and basolateral membrane of epithelial cells, Simons and coworkers cloned
a protein called VIP-21 (vesicular integral protein of 21kDa), which was
found in the membrane of the trans Golgi-vesicles (Kurzchalia et al. [1992]).
It turned out, that this protein had the identical sequence as the caveolin
protein found by Rothberg, thereby showing, that it is at the same time a
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structural component of caveolae, and plays a role in the vesicular traﬃc. In
the following further iso-forms of caveolin were found, which were grouped
in the caveolin protein family: the ubiquitously expressed caveolin-1 (former
VIP-21) and caveolin-2 (Scherer et al. [1996]) as well as the muscle speciﬁc
caveolin-3 (Way and Parton [1996]. In the following caveolin proteins will be
called cav1, cav2 and cav3.
3.2.1 The Structure of Caveolin
Cav1 is a 178 amino acid protein, which is expressed in most cell types, but
especially in endothelial, epithelial, cardiac muscle cells and adipocytes (Vo-
gel et al. [1998], Thorn et al. [2003]). Cav2 contains 161 amino acids and is
co expressed with cav1 (Scherer et al. [1996]). Cav3 is made of 151 amino
acids and is speciﬁc for muscle cells. Additionally to the full length proteins
(α isoform), both cav1 and cav2 have shorter sized isoform. The β isoform
of cav1 lacks the ﬁrst 32 amino acids, and the β and γ isoforms of cav2 are
less studied. A detailed compare of the amino acid sequence of the three
caveolin-family members is shown in Fig 3.2.
48
Figure 3.2: Compare of the amino acid sequence of human cav1, cav2, and cav3. Se-
quences of identical amino acids are underlined red. from Razani et al. [2002]
As mentioned above, the cav1 protein is made of 178 amino acids, and
its single regions together with their interaction with other proteins or lipids
will be described in the following. Even if the studies were done with the full
length caveolin-1, the most remarks stay true for the other members of the
caveolin protein family (Parton et al. [2006]).
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Figure 3.3: Topology model of cav1. Helical and buried regions have been predicted
from primary structure. The model assumes that charged groups (green) have access to the
membrane surface and tryptophan residues (W) are hydrogen bonded. Note that tryptophan
residues stay within one helical turn of either the cytosolic (W85, W98, W128) or the exterior
(W115) membrane interface. Aromatic residues tend to stay together (black numbers indicate
their position in rotational degrees relative to the first aromatic residue of each segment). Seg-
ment 80− 95 qualifies as an in- plane amphipathic membrane anchor and might compensate
for the effect of segment 95 − 110 being shorter than segment 110 − 130. Aromatic residues
are depicted in yellow, known surface accessible residues in red, and the palmitoyl moieties
are to scale. (Numbers correspond to murine caveolin-1. from Parton et al. [2006]
The protein has a hairpin structure with a cytosolic N- and C- terminus
and a central, which is buried into the lipid bilayer of the Golgi or the plasma
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membrane. The end of the N-terminus is marked by a serine S80 in cav1 fol-
lowed by a scaﬀolding domain (CSD) of about 20 amino acids at residues
82 − 101 (in cav2 54 − 73, and 55 − 74 in cav3), which facilitates interac-
tion with other caveolin proteins and numerous other proteins, such as src
family tyrosine kinases, growth factor receptors, G-protein-coupled receptors
(GPCRs), G proteins and endothelial nitric oxide synthase (eNOS) (Quest
et al. [2008], Head and Insel [2007]). At the other hand, it is considered that
the CSD of caevolins forming a caveola are close to or buried into the plasma
membrane, and thus cannot interact anymore with other proteins. A part of
the CSD contains also a potential cholesterol recognition and/or interaction
amino acid consensus (CRAC) motif (residues 94−101, Epand et al. [2005]).
This motif is not implicated in a direct 1 : 1 interaction with cholesterol, but
it is considered to improve the binding of cav1 to the plasma membrane and
dense cholesterol packing in caveolae. Residues 101−126 are amphiphilic and
thus buried into the lipid bilayer of the plasma membrane. Three cysteins are
on the C-terminus at residues 133, 143, and 156. The palmytoilation of these
sites is not necessary for membrane binding of caveolin, but is considered to
stabilize it. (Fig 3.3)
3.3 The Cavin Protein Family
First, the caveolin proteins were considered as the one and only necessary to
form caveolae, but in 2008 and 2009, the cavin protein family was identiﬁed
to be essential for the formation and shape of caveolae. The work of Vinten
and colleagues in 2001 showed some evidence for a protein associated to cave-
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olae (Vinten et al. [2001]), but it was Parton and coworkers to show that a
protein formerly known as polymerase I and transcript release factor (PTRF)
is necessary for successful formation of budded caveolae at the plasma mem-
brane. Further they reported that in the absence of cavin1 budded caveolae
are not detectable via EM, and that the amount of diﬀusing cav1 proteins
in the plasma membrane increases(Hill et al. [2008]). Short time after, three
other proteins were found to be implied in shaping caveolae (Liu and Pilch
[2008], Aboulaich et al. [2004], McMahon et al. [2009], Bastiani et al. [2009]).
As a result of these ﬁndings, the four proteins with their newly discovered
role in caveola formation were regrouped in the cavin protein family. All
cavins have numerous phosphorylation sites, giving rise to interaction with
PKC, and bind to immobilized phosphatidylserine. Due to this, cavins also
appear often with multiple bands in western blots, which made it until now
impossible to measure their molecular weight, but estimated values are 55
kDa for cavin1, 72kDa for cavin2, 43kDa for cavin3, and 43kDa for cavin4.
They share a PEST (proline, glutamic acid, serine, and threonine-rich) do-
mains, and also have a leukine zipper domain (aa 50 - 98 in cavin1, aa 52 -
100 in cavin2, and aa 20 - 78 in cavin3) through which they might bind to the
cav1 or cav3 protein (Hansen et al. [2009]). It is interesting that the cavins
were not identiﬁed earlier as caveola related proteins, which might have been
due to their weak binding to the caveolar membrane, and hence the technical
diﬃculty to detect the interaction.
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3.3.1 Cavin1
Cavin1 was ﬁrst identiﬁed in a yeast two-hybrid screen, where it was shown
to interact in the nucleus with both the transcription-termination factor-
I and the polymerase-I, and to enable polymerase-I transcription. That's
why it was initially called polymerase I and transcription release factor
(PTRF)(Grummt [1999], Leary and Huang [2001]). Whether there is a link
between the caveola associated localization of cavin1 and its role in the nu-
cleus, will have to be studied in the future.
The ﬁrst hint for an interaction of cavin1 and caveolae was given by Vin-
ten and colleagues who identiﬁed cavin1 as a caveola protein and observed
a correlation between the expression of cav1, cavin1 and the abundance of
caveolae. (Vinten et al. [2005], Voldstedlund et al. [2001]). They also showed,
that cavin1 interacts with both cav1 and cav3, and that its distribution at the
plasma membrane is broader than the one of caveolins. Hill and coworkers
showed using FRET (ﬂuorescence resonance energy transfer) between ﬂuo-
rescently tagged cavin1 and cav1 molecules that they have to be in close
contact to form budded caveolae, and that in the absence of cavin1 the frac-
tion of free diﬀusing cav1 in the plasma membrane increases, whereas the
cellular amount of cav1 decreases.(Hill et al. [2008])
3.3.2 Cavin2
Cavin2 was separately identiﬁed as a phosphatidylserine (PS)-binding pro-
tein from human platelets (Burgener et al. [1990]) and as a serum deprivation
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response (SDPR) (Gustincich and Schneider [1993]). A ﬁrst report of asso-
ciation of cavin2 to caveolae was given in 2000 (Rybin et al. [2000]). The
group of Nichols showed in 2009, that cavin2 is involved in the formation of
caveolae, and that it can induce tubulation of the plasma membrane when
over expressed (Hansen et al. [2009]).
3.3.3 Cavin3
Cavin3 was described as a Sdr-related gene product that binds to C-kinase
(SRBC), and as a phosphatidylserine-binding protein that is induced during
serum starvation (Izumi et al. [1997]). The association of cavin3 to cavin1
and their relation with caveolae was indicated in 2004 by Aboulaich and
coworkers using vectorial proteomics and indirect ﬂuorescence microscopy
(Aboulaich et al. [2004]).
3.3.4 Cavin4
In contrast to the three ﬁrst members of the cavin family, cavin4 is considered
to be muscle speciﬁc and was ﬁrst reported as a muscle-restricted, coiled-coil
protein (MURC) (Ogata et al. [2008]). Although that work reported already
a similar localization of cavin4 in striated muscle as the muscle speciﬁc cav3,
an explicit connection between these proteins was not shown until 2009 (Bas-
tiani et al. [2009]).
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3.4 The Assembly of Caveolae
3.4.1 Caveolin is Synthesized
in the Endoplasmic Reticulum,
and Assembles in The Golgi Apparatus
Caveolin is synthesized in the endoplasmic reticulum (ER), and oligomerizes
in the ER to form SDS-resistant homo-oligomers of 7-14 caveolin proteins
(Hayer et al. [2010] Fernandez et al. [2002]). Monier and colleagues con-
cluded from their experiments that caveolin oligomerizes to complexes of
14-16 proteins in the ER prior to completion of Golgi transit (Monier et al.
[1995]). At the other hand, there is evidence that free caveolin proteins ex-
ist in the Golgi. Bush and colleagues analyzed the labeling of caveolin by
diﬀerent antibodies, and reported, that some antibodies only recognize the
Golgi-pool of caveolin, whereas others recognize the plasma membrane pro-
teins assembled in caveolae. Since the antibody recognizing the CSD labeled
the Golgi-pool, it was suggested that caveolin oligomerizes after the Golgi,
which renders the CSD inaccessible for the antibody (Bush et al. [2006], Pol
et al. [2005]). Pelkmans and Zerial, and more recently Helenius and cowork-
ers conclude from their experiments that caveolin oligomerizes during its
way through the Golgi, assembles cholesterol and glycosphingolipids at the
Golgi membrane to form exocytic carrier vesicles. These vesicles are trans-
ported to the plasma membrane, where they fuse with it to form caveolae.
GFP tagged cav1 was used to analyze quantitatively the ﬂuorescent signal
of quantal caveolar structures at the plasma membrane, and the intensity of
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Figure 3.4: Assembly of caveolae involves transit of cav1 through the secretory pathway
and multiple oligomerization steps. Lipid-dependent oligomerization in the Golgi precedes
budding of nascent domains. Two alternative models are shown for the role of cavin1 in cave-
ola assembly. In model (1), invaginated caveolae are not induced, but stabilized by cavin1. In
model (2), cavin1 associates with previously flat cav1 domains to induce membrane curvature.
from Hayer et al. [2010]
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such a single quantum was estimated to correspond to 144 ± 39 cav1-GFP
molecules (Bauer and Pelkmans [2006], Pelkmans and Zerial [2005]).
At the stage of oligmerization, caveolins can either form homo-oligomers of
cav1 or hetero-oligomers of cav1 and cav2. As mentioned above, cav2 alone
cannot form caveolae, and it needs the association to cav1 to be transported
to the plasma membrane (Song et al. [1997]).
3.4.2 Cavin Enters the Stage for Caveola Formation
At which state of the caveola formation the cavins become important is not
very clear yet, but there is some evidence, that cavin1 interacts with cav1
and cav3 at or short after the Golgi-level, whereas cavin2 and cavin3 have
a localization more restricted to the plasma membrane (Hayer et al. [2010])
(Fig 3.4). A reduction of cavin1 results not only in a reduction of budded
caveolae, but also decreases the total amount of cav1 and cav3 proteins in the
whole cell. The size of caveolin agglomerates shrinks, whereas the fraction
of free caveolin proteins increases (Hill et al. [2008], Liu and Pilch [2008]).
Since cavin1 aﬀects not only cav1 but also the muscle speciﬁc cav3, animals
or humans with a defect in cavin1 show the phenotype of a cav1/cav3 double
knock-out (Liu et al. [2008], Hayashi et al. [2009]). The over expression of
cavin1 causes a higher number of budded caveolae without any change in the
expression of cav1 and cav3, respectively. These ﬁndings suggest that cavin1
acts as a regulator for the cell to tune the number of budded caveolae at the
plasma membrane.
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Figure 3.5: Cav1 is associated with both flat caveolar domains and cav1 scaffolds as well
as invaginated smooth plasma membrane vesicles or caveolae. Cavin1 and cavin2 are re-
quired for caveolae invagination and cavin3 for caveolae budding to form caveolar vesicles.
Overexpression of cavin2 induces enlarged caveolae and caveolar tubules, defining critical
roles for cavin family members in caveolae formation, morphology and dynamics. from Nabi
[2009]
A decrease in cavin2 expression results also to a reduction of budded
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caveolae due to both, a decrease of the cav1 level as well as of the level of
cavin1. This makes it more diﬃcult to isolate the eﬀect of cavin2 on caveola
formation, but it seems that cavin2 is responsible for the shape of caveolae,
whereas cavin1 is there to bud them in. An overexpression of cavin2 does not
increase the number of caveolae, but alters their appearance from a Ω-shape
to a more elongated structure up to tubule like structures with the caveolin
proteins at the tip. Another interesting ﬁnding shows, that cavin2 has to
interact with cavin1 to bind to the caveola membrane. (Hansen et al. [2009])
Cavin3 is the third partner of this complex involved in caveola formation, but
its role is even less clear. It co-precipitates together with cavin1 and cavin2,
and needs either cav1 or cav3 for binding at the plasma membrane. In con-
trast to cavin1 and cavin2, cavin3 binds also to other caveolin containing
structures such as caveosomes, and seems to play a role in the traﬃcking of
caveolin inside the cell. According to this, it was observed that intracellular
cav1 traﬃc is dramatically reduced in the absence of cavin3. (Hansen et al.
[2009])
Finally, the muscle speciﬁc cavin4 localizes together with cav3 and interacts
with cavin1 and cavin3 (Bastiani et al. [2009]). Overexpressions of cavin4
results in contractile dysfunction in heart muscle, and studies with a re-
duced expression of cavin4 are not yet published. At the Golgi, none of the
cavins localizes with caveolins, whereas it was shown by FLIM/FRET and
co-immunoprecipitation that cavins form a multimeric complex in the cytosol
which interacts at the plasma membrane with caveolin oligomers to form a
caveola (Bastiani et al. [2009], Hansen and Nichols [2010]) (Fig 3.5).
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3.4.3 The Lipid Composition of Caveolae
The lipid composition of caveolae is not very well studied, and the results
may depend on the way, how plasma membrane caveolae were separated
from the rest of the cellular membranes. Pike and colleagues studied the
composition of detergent resistant (considered as raft like) and nonresis-
tant membranes of human epidermal carcinoma cells without caveolae and
cells transfected with cav1 and containing caveolae. They found an increase
of cholesterol in the detergent resistant membranes of cells with caveolae,
i.e. ∼ 600 ± 200nmol/mgprotein of cholesterol in caveola/raft membranes
compared to sim500± 100nmol/mgprotein of cholesterol in raft membrane
without caveolae. Interestingly, there was no signiﬁcant change in the lipid
composition (Pike et al. [2002]). Örtegren and colleagues analyzed the lipid
composition of adipocyte caveolae, and report that each 100nm2 of caveo-
lar membrane contain 192 cholesterol molecules, 65 sphingmyolin lipids, 206
glycerophospholipids, and 6 protein molecules. Compared with the non-
caveolar membrane, caveolae are highly enriched in cholesterol and have
about twice the amount of sphingomyolin (see Fig 3.6)(Örtegren et al. [2004]).
Thus a caveola of 60µm diameter formed by 144 caveolin proteins contains
about 22000 cholesterol molecules, i.e. a cholesterol to caveolin ratio of about
157 : 1!
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Figure 3.6: Lipid composition of caveolar and non-caveolar membrane of adipocytes. from
Örtegren et al. [2004]
3.5 Caveolae Are Stable Structures
at the Plasma Membrane
Once a caveola is formed, it stays as a stable structure as it does not ex-
change single caveolin proteins with its neighbor caveolae or cytosolic cave-
olins. This stability was studied by several groups with FRAP (ﬂuorescence
recovery after photobleaching) experiments and analysis of caveola dynamics
with TIRF.
Thomsen and colleagues conducted the ﬁrst FRAP experiments on cells ex-
pressing GFP labeled cav1. After bleaching regions with several caveolae a
very slow recovery of the caveolin signal was observed (after 10 minutes, ﬂu-
orescence intensity recovered to ∼ 30%) (Thomsen et al. [2002]). This led to
the conclusion, that there is no exchange of single caveolin proteins between
a caveola and the cytosolic pool. Tagawa and colleagues studied this sta-
bility more precisely in bleaching single caveolae formed by cav1-GFP, and
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observed even after 15 minutes only little recovery of the ﬂuorescence signal.
In a second approach, they fused two cells, one expressing cav1-GFP, and
the other expressing cav1-RFP, which allowed them to follow the dynamics
of caveolin proteins between single caveolae. Already formed caveolae stayed
single colored even after long time (3hours)(Tagawa et al. [2005]). These
experiments aﬃrmed the idea, that the caveolin proteins are tightly held to-
gether in a caveola, and do not exchange with their environment.
Concerning the mobility of the caveolae, three populations of equal size were
observed. One staying stable on the plasma membrane over several min-
utes, one moving laterally on the plasma membrane and one shortly con-
necting and detaching to the plasma membrane (so called kiss and run move-
ment)(Pelkmans and Zerial [2005]). Alterations of the cytoskeleton dynamics
or altering the amount of cholesterol in the plasma membrane can inﬂuence
the caveolar dynamics.
3.6 Endocytosis of Caveolae
One of the proposed roles of caveolae is the endocytosis, i.e. uptake of cargo
into the cell. Several studies identiﬁed amongst others albumin, cholera toxin
B (Ctx-B), and simian virus 40 (SV-40) as cargoes using caveolae to enter
the cell, but none of them is speciﬁc for caveolae, i.e. they can also use other
pathways to enter the cell (Botos et al. [2007], Nabi and Le [2003], Pelkmans
et al. [2001]).
Caveola endocytosis depends on the phosphorylation of tyrosine residues of
proteins associated to the caveola and implies the activation of src-kinases.
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Thereafter, the surrounding actin ﬁlaments are disassembled to reorganize
as an actin patch at the caveola, followed by bursts of actin polymerization
forming transient actin "tails" (of 1.5µm length). Depending on the cargo,
dynamin is recruited to the neck of the loaded caveola and pinches it oﬀ
through hydrolyzation of GTP to GDP (Sverdlov et al. [2007]). Additionally,
cell polarization and migration seems to depend on the interaction of integrins
with cav1 and in the regulation of caveolar endocytosis (Grande-García and
del Pozo [2008], Echarri et al. [2007]).
3.7 Caveolae/Caveolin Proteins and Signaling
Processes
Many signaling proteins, and channels are reported to be enriched or clus-
tered in caveolae, which led to the picture that caveolae act as a signaling
platform. Additionally, cav1 is interacting through its caveolin scaﬀolding
domain (aa 82-101) with a variety of signaling proteins including src-family,
protein (PKA, PKB, PKC) and other kinases, the insulin receptor, eNOS,
H-Ras, G proteins and G protein coupled receptors (GPCR). (Patel et al.
[2008]) gives an overview of the supposed signaling processes which involve
caveolae, and a few examples will be presented in the following.
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3.7.1 Ion-pumps in Caveolae
Fujimoto showed 1993 in an electron microscopy study, that Ca2+-pumps
are 18-25 fold enriched in caveolar structures compared to the other plasma
membrane in several mouse cell types and in human ﬁbroblasts (Fujimoto
[1993]). Other studies report a localization of some K+-, and Na+-channels
in caveolae (Kristensen et al. [2008], Maguy et al. [2006], Daniel and Cho
[2006], Bergdahl and Swärd [2004], Taggart [2001]).
3.7.2 Regulation of eNOS
One of the most studied binding partners with caveolin is the endothelial
nitric oxide synthase (eNOS). The CSD interacts with eNOS and inhibits
its enzyme activity, and knock out of cav1 upregulates eNOS expression.
Caveolae concentrate cellular eNOS, which is thought to allow the cell to
inhibit eNOS activity under resting conditions, and to allow rapid activation
upon mechanical stimulation (Balligand et al. [2009]).
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3.8 Caveolae in Muscle Cells
Caveolae are very abundant in muscle ﬁbers and store about half of the
plasma membrane area (Dulhunty and Franzini-Armstrong [1975]). Brieﬂy,
the formation of muscle ﬁbers starts with the diﬀerentiation and fusion of
myoblasts to form myotubes. Myotubes are contractile, and bundles of them
constitute a muscle ﬁber (Cossu et al. [1996]). The expression pattern of
many proteins changes like the myogenic factors Myf5 or MyoD during the
diﬀerentiation of myoblasts and fusion to myotubes (Yamamoto et al. [2008]).
It is for note that in the case of skeletal and cardiac muscle cells the expres-
sion cav1, cav2 switches to cav3 during diﬀerentiation (Song et al. [1996]).
Additionally, the muscle speciﬁc cavin4 is expressed and associates with the
other cavin proteins at caveolae, but little is known about its role in caveola
formation (Bastiani et al. [2009], Ogata et al. [2008]). During contraction the
plasma membrane of muscle cells is injured by shearing stress and stretch, and
several strategies exist in muscles to avoid or to repair those injuries (Brown
and Glover [2007]). Besides the seal of breaches by muscle precursor cells
(Cornelison [2008]) myotube internal strategies ensure membrane integrity.
With respect to the scope of this work, the dystrophin-glycoprotein complex,
dysferlin, and cav3 are presented as well as related muscular dystrophies.
3.8.1 Interaction Partners of Cav3 in Myotubes
Besides the formation of caveolae, cav3 is found to be part of the dystrophin-
glycoprotein complex (DGC)(Song et al. [1996], Blake et al. [2002]) and to
co-localize with dysferlin at the plasma membrane (Lennon et al. [2003],
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Hernández-Deviez et al. [2006]).
The Dystrophin-glycoprotein Complex
The role of the DGC is to link the extracellular matrix with the cytoskeleton
and to provide structural stability to the plasma membrane (Durbeej and
Campbell [2002], Dalkilic and Kunkel [2003]). It is formed by dystrophin,
sarcoglycans, dystroglycans, sarcospan, syntrophin, dystrobrevin and cav3
(Blake et al. [2002]). β-dystroglycan is the only component of the DGC
which directly interacts with dystrophin. Cav3 binds to the same motif of
β-dystroglycan, and competes with dystrophin. The DGC is unstable in the
absence of dystrophin and cells become abnormally susceptible to damage
from contraction (Petrof et al. [1993], Danialou et al. [2001]). (Fig 3.7)
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DMD
Figure 3.7: The dystrophin-glycoprotein complex (DGC) and its associated proteins at the myotube plasma
membrane. Dystrophin and cav3 compete in binding to β−dystroglycan, and overexpression of cav3 destabilizes
the DGC. Arrows indicate diseases caused by the absence (−) or upregulation (+) of the indicated protein. DMD,
Duchenne muscular dystrophy; LGMDs, multiple forms of limb-girdle muscular dystrophy; LGMD-1C, limb-girdle mus-
cular dystrophy type 1C; nNOS, neuronal form of nitric oxide synthase; CSD, caveolin scaffolding domain; CBD,
caveolin binding domain. adapted from Galbiati et al. [2001]
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Dysferlin
Dysferlin is important for rapid membrane repair of muscle cells. The repair
depends on Ca2+ and ensures the addition of intracellular vesicles on a sub-
second to second timescale (Bansal et al. [2003], Lennon et al. [2003]). Dysfer-
lin interacts with annexins, calpain-3, and aﬃxin, which are involved in actin
cytoskeleton remodeling (Brown and Glover [2007]), but needs cav3 for the
transport to and correct organization at the plasma membrane Hernández-
Deviez et al. [2006]. (Fig 3.8)
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Figure 3.8: Dysferlin and the membrane repair complex in skeletal muscle. (A) In normal myotubes, dysferlin
is localized by its C-terminal transmembrane domain to cytoplasmic vesicles and the plasma membrane, where it is
associated with AnxA1 and AnxA2, AHNAK, affixin and cav3. Calpain-3 is rendered inactive through interaction with
titin at the N2A line. Annexins A2 and A1 are associated with lipid raft and nonraft membrane domains, respectively,
in heterotetrameric complexes with their respective S100-binding proteins. Annexin A2/S100A10 also forms a Ca2+-
regulated multimeric complex with AHNAK and actin at the plasma membrane. Affixin is found in both the cytoplasm
and the plasma membrane, where it binds to dysferlin. Cav3 is a principal component of caveolar membranes in
skeletal muscle and plays a role in post-Golgi dysferlin trafficking. (B) On injury of the membrane, Ca2+ influx raises
the intracellular Ca2+ concentration locally, triggering the patch repair response. Ca2+ influx is also the primary
activation signal for calpain-3. Calpain may contribute to the patch repair response by cleaving annexin proteins at
their N-termini or by cleaving cytoskeletal proteins such as talin and vimentin to mediate disassembly of the damaged
actin cytoskeleton. (C) Intracellular vesicles are aggregated by AnxA1 and AnxA2 to form an endomembrane patch
that is trafficked to the site of disruption. Vesicle trafficking is facilitated by affixin, through cytoskeleton reorganization
in the site surrounding the injury. (D) Dysferlin molecules present on repair vesicles and on the plasma membrane
mediate docking and fusion of the patch, sealing the membrane breach and preventing further influx of Ca2+ ions.
After repair, some antigens previously exposed only to the interior of cytoplasmic vesicles are now exposed to the
extracellular face of the muscle cell. Anx1, annexin1; Anx2, annexin 2. from Merlini et al. [2002]
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3.8.2 Muscular Dystrophies
Muscular dystrophies are genetically caused muscular disorders characterized
by progressive weakness and loss of integrity. Symptoms like high serum lev-
els of creatine kinase can occur from any age from birth to midlife (Laval and
Bushby [2004]). More than 30 gene loci related to muscular dystrophies were
identiﬁed reﬂecting the molecular diversity underlying muscle formation. In
the following the Duchenne Muscular Dystrophy (DMD) and dystrophies
related to cav3-mutations will be described.
Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is one of the most severe myopathies.
Patients are wheelchair bound before 12 years old and die in their third
decade of life. DMD is caused by a lack of dystrophin, which causes the
instability of the DGC and, thus, a higher fragility of the plasma membrane
of myotubes. The lack of dystrophin leads to a downregulation of the DGC
associated sarcoglycans and dystroglycans (Sicinski et al. [1989]). In contrast,
cav3 expression is 2− 3 fold upregulated (Vaghy et al. [1998]), and electron
microscopy studies showed an increase of plasma membrane caveolae (Bonilla
et al. [1981]). The reason for this upregulation of cav3 is not known.
Cav3-mutations and Related Muscular Dystrophies
Cav3 is important for the formation of myotubes, associates with the DGC,
forms caveolae and is necessary for proper dysferlin localization at the plasma
membrane. At the other hand are mutations of cav3 associated to diverse
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forms of muscular dystrophies such as limb girdle muscular dystrophy (LMGD),
rippling muscle disease (RMD), hyper-CKemia (HCK), long QT syndrome
and sudden infant death syndrome (table 3.9, Gazzerro et al. [2010]). The
three best studied diseases- LGMD, RMD and HCK- are described more
detailed in the following.
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LGMD is a heterogeneous group of muscular disorders which comprises
six autosomal dominant (type 1) and nine autosomal recessive (type 2) genes
(Bushby [1999]). LGMD is deﬁned by a weakness and wasting in the pelvic
and shoulder muscles starting in the second or third decade of life and with
relatively slow progression. Several mutations of cav3 were shown to cause
the autosomal dominant LGMD-1C (Galbiati et al. [2001]), of which four
were analyzed more carefully and reported to cause retention of cav3 in the
Golgi and an impaired targeting to the plasma membrane: (1) cav3-P104L is
a missense mutation within the membrane-spanning domain (Carozzi et al.
[2002]), (2) cav3-∆TFT lacks three amino acids within the caveolin scaf-
folding domain (Sotgia et al. [2003]), and the missense mutations in the
N-terminal domain (3) cav3-R26Q (Sotgia et al. [2003]), (4) cav3-A45T (Her-
rmann et al. [2000]). RMD is a rare autosomal muscular disorder, which
manifests by mechanical hyper-sensitivity, i.e. mechanical stimuli induce
contractions of electrically silent muscles. Additional symptoms are muscle
stiﬀness and exercise-induced cramps. Interestingly, amongst the cav3 mu-
tations found in patients were the point mutations R26Q, A45T and P104L,
which were also reported in cases of LMGD-1C (Betz et al. [2001]). HCK
describes elevated levels of serum creatine kinase, which is a general sign for
myopathies. Creatine kinase is a cytosolic muscle enzyme, which is released
into the blood after lysis or necrosis of muscle ﬁbers. However, HCK can oc-
casionally be found in healthy individuals. Patients with idiopathic HCK do
not show any muscle weakness or other abnormalities on neurologic examina-
tion, electromyography or muscle biopsy (Gazzerro et al. [2010]). The point-
mutation cav3-R26Q, which is also associated with LGMD-1C and RMD, is
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associated with HCK as well as cav3-P28L, which is a less severe mutation,
and leads to a 65% reduction of cav3 expression compared to wt cells (Mer-
lini et al. [2002]).
It is for note that the increasing numbers of diseases related to mutations of
caveolin are grouped as "caveolinopathies".
In summary, the reported muscular dystrophies associated to cav3-mutations
are less severe than the DMD. Why and how the muscular dystrophies occur
is not yet understood on a mechanical or molecular basis. According to the
role of the DGC to stabilize the plasma membrane, it is suggested that DMD
is due to a higher injury rate, which overwhelms the repair capacities of the
muscle, and thus leads to loss of it. The observed increase of caveolae could
be a reaction of the cell to compensate the increased stress of the plasma
membrane.
In the case of cav3-related mutations it is not clear, if the muscular dystro-
phies and HCK are due to an increased rupture of the plasma membrane
caused by the lack of a membrane reservoir formed by caveolae. Another
reason could be the lack of the repair mechanism established by dysferlin.
The study of the short time response of myotubes to acute mechanical stress
performed in this work aims to clarify this issue.
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Chapter 4
Mechanical Role of Caveolae
P. Sens and M. Turner (Sens and Turner [2005]) have recently proposed that
caveolae could act as a membrane reservoir, and thus play a role in cell tension
regulation. The core of the Sens and Turner model consists in investigating
the response of lipid domains that tend to be invaginated under low mem-
brane tension, and ﬂat under high membrane tension. We reproduce here
the key points of their reasoning, as presented in (Sens and Turner [2005]).
For simplicity, it is assumed that the membrane tension σ changes linearly
with its area variations. Extraction of membrane area AT (e.g. by pulling a
tether or stretching the cell membrane) increases the membrane tension, and
thus the rate of domain ﬂattening, which in turn releases membrane area,
and decreases membrane tension again. The variation of membrane tension
with the extracted tether area AT reads:
σ = σ0 +Km(AT + Ares − A(0)res) (4.0.1)
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with σ0 the membrane tension without a tether, and Km the stretching mod-
ulus of the membrane. Ares (without tether A
(0)
res) is the membrane reservoir
which is stored in the invaginated membrane domains (Fig 4.1).
Figure 4.1: Sketch depicting the mechanical response of a membrane to the pulling of
a tether. Pulling an area AT out of the cell either increases the membrane tension σ (the
length of the spring), or triggers membrane exchange with a reservoir (flattening of invaginated
membrane domains). From (Sens and Turner [2005])
The energy of a domain has three contributions arising from line tension,
bending and surface tension eﬀects:
f(β) = 2
√
piS γ
√
1− β + 8piκβ + σSβ (4.0.2)
= fγ,κ(β) + σSβ, (4.0.3)
where κ is the bending rigidity of the domain membrane, disfavoring the
budded state, γ is the line tension on the neck of the domain, promoting
invagination, and S is the area of a domain. The parameter β characterizes
the domain shape (β = 1 for a fully budded domain, and β = 0 for a ﬂat
domain).
At vanishing membrane tension (σ = 0), the budded state becomes ener-
getically favorable above a critical domain area Sc = pi(4κγ )
2. For biological
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typical values (κ = 20kBT , γ = 1
kBT
nm
) Sc is about 0, 02µm2, which is similar
to the size of a caveola (corresponding to a sphere with a diameter of 80nm).
With increasing membrane tension, the energy of a budded domain (β > 0)
increases, and above a critical membrane tension, σ?, the ﬂat state becomes
stable:
σ?S = fγ,κ (4.0.4)
(β = 0) = −fγ,κ (4.0.5)
(β = 1) = 2
√
piS γ − 8piκ (4.0.6)
Figure 4.2: Left: A sketch of a flat and an invaginated domain above an idealization for the domain shape;
a spherical cap of area S, radius R (curvature C = 2/R). The shape is defined by a single parameter 0 < β =
SC2/16pi < 1. Right: Energy of a domain for increasing value of the membrane tension. Small tensions favor
budded shape (β = 1), and large tensions favor flat shape (β = 0). At coexistence [membrane tension σ?, 4.0.6],
flat and budded domains have the same energy. The budded state remains a local minimum for high membrane
tension, and there exists an energy barrier ∆f to domain flattening. From (Sens and Turner [2005])
It is worth mentioning that, at higher membrane tensions, the budded
and ﬂat domain shapes are separated by an energy barrier. This allows a
coexistence between the two states of the domains, and is necessary for their
role as membrane tension regulators ((Fig. 4.2). Taking S = 0.1µm2, the
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energy scales of the system are
γ =
√
piS (4.0.7)
γ ' κ = 8piκ ' 500kBT σ = σS (4.0.8)
The ﬂat state becomes stable for σ = 500kBT corresponding to σ = 2·10−5 Jm2
(consistent to measured cell membrane tensions (Sheetz [2001]), and since
the energy barrier between ﬂat and budded state is big compared to the
thermal energy kBT , the transition between the two states is discontinuous,
and the domains snap open rather than continuously ﬂatten upon increasing
membrane tension.
Considering an ensemble of N domains, the membrane reservoir area reads
Ares = NSβbud (4.0.9)
with the fraction of budded domains . The total energy of the system is
F = N{f(βbud) + (1− )f(0)}+
∫
dAγ(A) (4.0.10)
= N{[
√
piSγ
√
1− βbud + 8piκβbud + σSβbud] + (1− )[
√
piSγ]}+
∫
dAγ(A)
(4.0.11)
Optimizing the energy for the fraction of budded domains ∂F/∂ = 0 leads
directly to the regulation of membrane tension to the value σ?, which depends
on the characteristics of the membrane reservoir (γ, κ, and S), but not on
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the extracted membrane area:
∂F/∂ = N{
√
piS γ
√
1− βbud + 8piκβbud + σS −
√
piS γ} = 0 (4.0.12)
With βbud = 1 expression (4.0.12) leads to the same membrane tension as σ?
in (4.0.6),
σ?S = 2
√
piS γ − 8piκ (4.0.13)
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To obtain the kinetic response of the system, the transition of the domains
between budded and ﬂat state is described as a classical Kramer's process,
where the transition time depends exponentially on the energy barrier ∆E,
that has to be overcome in the process:
τ = τ0 exp(∆E/kBT ), (4.0.14)
where τ0 is the characteristic time of ﬂattening or budding (here assumed to
be the same for both processes).
In a tether pulling experiment, where the extraction is performed at constant
velocity (vpull = 0, 5µm/s), we consider the reservoir response to the mem-
brane area extraction rate A˙T = 2pirtethervpull = 0, 08µm2/s (tether radius
rtether = 50nm). The force of such a dynamical perturbation is inﬂuenced
by the viscous dissipation (e.g. around the cytoskeleton anchors), and the
kinetic response of the reservoir. Here, we only account for the latter ef-
fect. In the case of a slowly applied perturbation (i.e. A˙T τ0  Ares), which
resembles the experimental situation, the reservoir has time to equilibrate.
Considering a constant membrane tension (∂σ
∂t
= 0) due to regulation during
tether extraction (Fig. 2.4), an analytical expression of the plateau height
can be obtained
σ1→0 = σ(0) − (1− βbud)−3/2
√
2σ kBT ln(
Ares
2A˙T τ0
), (4.0.15)
where βbud < 1 characterizes the ﬁnite neck size, and with the ﬂattening
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membrane tension
σ(0) = Sσ(0) = (1− βbud)−1/2γ − κ (4.0.16)
Thermal ﬂuctuations smooth the transition between budded and ﬂat state
with the consequence that the tension is not perfectly constant during the
transition, and the slope of mid plateau is of the order
∂σ?
∂AT|Plateau
' 4kBT
SAres
(4.0.17)
But in our case, for typical values S = 0, 1µm2 and Ares = 30µm2 this ef-
fect is negligible. This theoretical framework suggests that caveolae act as
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Figure 4.3: By Pulling a tether from a membrane with caveolae, the surface tension in-
creases (a) until it reaches the critical value. Further pulling then opens the caveolae, and
releases additional membrane, which allows the extraction of further membrane at constant
surface tension (b). If the reservoir is emptied, membrane pulling increases the membrane
tension (c)
a membrane reservoir, and may explain how they inﬂuence the membrane
tension of cells. To test this hypothesis, extraction of tethers and simul-
taneous monitoring of the tether force were performed on cells at rest and
after application of acute mechanical stress (e.g. hypo-osmotic shock). In
another approach, membrane vesicles containing caveolae were created, and
micropipette aspiration combined with monitoring of the membrane tension
were carried out to study more structural information about the membrane
reservoir formed by caveolae:
• the height of the force plateau is related to the energy required to
ﬂatten a domain, and depends on the properties of the domains (γ, κ,
and S)
• the length of the plateau corresponds to the size of the accessible mem-
brane reservoir that is the amount of budded domains
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Part II
Materials and Methods
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The main technique used in this thesis is the optical tweezers-assisted
tether pulling assay. This method was occasionally combined with other
techniques like micromanipulation with micropipettes and/or confocal or epi
ﬂuorescence microscopy. Additionally, cells were imaged by total internal
reﬂection ﬂuorescence (TIRF) microscopy, and cell biology techniques were
used extensively like addition of reagents altering speciﬁc cellular properties
or cell transfection to induce the expression of speciﬁc proteins. With the aim
to create an artiﬁcial model system, protein puriﬁcation and reconstitution in
lipid vesicles were tried, and speciﬁc cell treatments leading to the formation
of vesicles made from native membranes were performed.
The detailed protocols are delegated to the Appendix.
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Chapter 5
Cells and Reagents
5.1 Cell Types and Cell Culture
Experiments were done on four diﬀerent cell types:
• HeLa-PFPIG
• mouse lung endothelial cells (MLEC)
• mouse embryonic ﬁbroblast (MEF)
• human muscle cells
The cells were cultured and treated (transfection, plating on microscope
slides...) in the biology laboratory. At least 24h before tether extraction
experiments, cells were transferred to the physics laboratory and deposited
in the cell culture incubator.
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Figure 5.1: Immunofluorescence of fixed cells labeled with cav1-anit body. Starting from
left: wt-MLEC, wt-MEF, HeLa-PFPIG. Bar = 10µm.
5.1.1 HeLa-PFPIG
HeLa-PFPIG cells were developed, characterized and kindly provided by F.
Pinaud (Pinaud et al. [2009]). They stand out with their stable expression
of EGFP tagged cav1 allowing ﬂuorescence imaging studies (see Fig 5.1).
Cells were maintained in DMEM supplemented with 10% FBS (Invitrogen,
Carlsbad, CA) + 100U/ml penicillin + 100mg/ml streptomycin + 2mM
glutamine at 37◦C in 5%CO2.
5.1.2 Mouse Lung Endothelial Cells
Wild type (wt) and caveolin-1 negative (cav1−/−) mouse lung endothelial cells
(MLEC) were characterized by Sessa and coworkers (Murata et al. [2007])
and were kindly given by R. Stan (Dartmouth medical school, NH, USA). Wt
cells stand out with a very high caveola density (see Fig 5.1, 5.2), whereas
cav1−/− cells are devoid of caveolae. Both cell lines were very useful to gain
direct insight in the inﬂuence of the presence or absence of caveolae on the
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Figure 5.2: Immunoblotting labeling Cav1 of equal amounts of cell lysates: wt and Cav1−/−
mouse embryonic fibroblasts (MEF) and mouse lung endothelial cells (MLEC).
cellular response.
Cells were maintained in EGM-2 (Lonza, Basel, Switzerland) supplemented
with 20% fetal bovine serum (Thermo Fisher Scientiﬁc, Waltham, MA) +
100U/ml penicillin + 100mg/ml streptomycin at 37◦C in 5%CO2.
5.1.3 Mouse Embryonic Fibroblast
Wt and cav1−/− mouse embryonic ﬁbroblasts (MEF) were developed and
characterized by several laboratories (for example Razani and Lisanti [2001])
and were kindly provided by T. Kurzchalia (Max-Planck-Institute of Molec-
ular Cell Biology and Genetics, Germany). Wt cells express cav1 but at a
lower level than wt MLEC (see Fig 5.1, 5.2).
Cells were maintained in DMEM supplemented with 10% FBS (Invitrogen,
Carlsbad, CA) + 100U/ml penicillin + 100mg/ml streptomycin + 2mM
glutamine at 37◦C in 5%CO2.
5.1.4 Human Muscle Cells
Human muscle cells were prepared and provided by A. Bigot in the group of
G. Butler-Browne (Institut de Myology, Paris, France). While the wt cell line
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was immortalized, the other cell lines were obtained from biopsies of patients
with cav3 mutations and muscular dystrophies (the biological material came
from the Muscle Tissue Culture Collection, Munich, Germany):
• Cav3-R26Q: associated with LGMD [code: Bochum 62/01; male *1987;
mutation: not communicated]
• Cav3-p28l: associated with hyper-CKemia [code: Bonn 18/03; female
*1969; mutation heterozygote 27C>A (27 D>E)]
• Cav3-A45T: associated with RMD [code: Bochum 1/98; male *1936;
mutation: not communicated]
For proliferation, cells were maintained in X medium (64% DMEM + 16%
199 Medium + 20% FBS + 2, 5ng/ml HGF (all Invitrogen, Carlsbad, CA) +
50µg/ml gentamycin + 10−7M Dexamethasone (Sigma-Aldrich, St. Louis,
MO). Note that muscle cells are ﬁrst in a undiﬀerentiated state. These so
called myoblasts express cav1 and cav2, but no cav3. Diﬀerentiation can
be induced, during which 2 − 10 cells fuse to form myotubes, and shift to
cav3 expression (Halayko et al. [1999], Yamamoto et al. [2008]). For that
cells were densely plated on collagen covered glass slides and incubated for
> 7 days in diﬀerentiation medium (DMEM (Invitrogen, Carlsbad, CA) +
50µg/ml gentamycin + 10µg/ml of bovine insulin + 100µg/ml of human
apotransferrin (all Sigma-Aldrich, St. Louis, MO)) at 37◦C in 5%CO2.
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5.2 Treatments Altering the Cell
5.2.1 Expression of Proteins
MLEC were transiently transfected with DNA plasmid, and siRNA, re-
spectively, using AMAXA HUVEC nucleofector kit (Lonza, VPB-1002) fol-
lowing the manufacturer's instructions, and used for experiments 24-72 hours
post transfection. Brieﬂy, for each transfection 106 detached cells were di-
luted in 100µl of Amaxa-nucleofector reagent supplemented with 0, 5− 3µg
DNA plasmid, ﬁlled into a vial adapted for the transfection machine, and the
transfection was started (program A-34). Afterwards, the cells in solution
were put into a cell culture ﬂask (T-25) containing 10ml pre-warmed medium
and kept at 37◦ and 5%CO2.
Muscle cells were transfected with DNA plasmid using Fugene6 (Roche,
Indianapolis, USA) using a protocol adapted from (Malik et al. [2000]).
Brieﬂy, cells were grown to ∼ 80% conﬂuence on collagen coated glass slides
(2∗105 cells per 25mm diameter slide). For each transfection a mix of 9µl Fu-
gene6 with 3µl DNA plasmid in a ﬁnal volume of 1ml serum free medium was
prepared and incubated for 15min at room temperature. Then, cells were
rinsed with fresh serum free medium, gently covered with the Fugene-DNA
mix, and centrifuged for 30min at 1180g and 32◦C. Afterwards, cells were
left in the Fugene-DNA mix for 4h at 37◦C and 5%CO2 before the trans-
fection solution was replaced by fresh diﬀerentiation medium. Cells were
diﬀerentiated and ready for experiments 7− 10 days after transfection.
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DNA Plasmids and SiRNA used in this study:
• Cav1-EGFP (Pelkmans et al. [2001])
• Cav1-Y14F-EGFP (Orlichenko et al. [2006])
• Cav3-GFP (Hill et al. [2008])
• Cav3-P104L-YFP (Couchoux et al. [2007])
• Cavin-mCherry (Hill et al. [2008])
• Lifeact-mCherry (Riedl et al. [2008])
• Clathrin-heavy-chain siRNA (CLTC-siRNA, Thermoﬁsher)
5.2.2 Altering Actin Dynamics
In order to alter the actin ﬁlament structure and dynamics, cells were incu-
bated for 5-20 min in their culture medium supplemented with 0.1% BSA
and either 1µM Cytochalasin D (CD; Sigma-Aldrich, St. Louis, MO)(Schliwa
[1982]), 1µM Latrunculin A (Lat A; Sigma-Aldrich)(Rotsch and Radmacher
[2000]), and 1µM Jasplakinolide (Jas; Molecular Probes, Invitrogen, OR,
USA) (Senderowicz et al. [1995]), respectively.
5.2.3 ATP depletion
ATP depletion was performed by washing the cells with PBS++ (Phosphate
Buﬀer Saline + 1, 5mMCa2+ + 1, 5mMMg2+) followed by incubation for
30 min at 37◦C in PBS++ supplemented with 10mM deoxy-D-glucose and
10mMNaN3 (Römer et al. [2007]).
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5.2.4 Cholesterol Depletion
For cholesterol depletion of the plasma membrane cells were incubated for
50min in PBS++ supplemented with 5mM m-β-cyclodextrin (MβCD) (Sigma-
Aldrich) which resulted in ﬂattening of caveolae (Rothberg et al. [1992]).
91
5.3 Vesicles out of Cellular Plasma Membranes
One aim of the project was to study caveolae in a model lipid membrane
system, meaning independent of their cellular environment in order to discard
any interactions with cellular compartments. First, a classical ("bottom-up")
strategy was followed: the GST-cav1 and His-cav1 proteins were expressed
in bacteria and puriﬁed with Glutathione agarose or a Ni-resin. In a second
step, micelles and small unilamellar vesicles (SUV) of lipids, cholesterol and
the puriﬁed cav1 were produced, from which giant unilamellar vesicles were
formed via electroformation. Although the results of Lisanti and coworkers
(Li et al. [1996] could be reproduced in proving the association of cav1 protein
with the SUVs in using ultracentrifugation of a sucrose gradient (see Fig
5.3), there was no evidence that the cav1 protein was still present in the
electroformed GUVs and that they could form functional caveolae.
10 9 8 7 6 5 4 3 2 1
36 % 
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5 % 
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Cav1-His
Figure 5.3: Immunoblot with a cav1-AB of cav1 in small unilamellar vesicles (SUVs) loaded
on a sucrose step-gradient (fractions 1 : 40%, 2− 4 : 32%, 5− 10 : 5% sucrose). It is known
that SUVs localize at the sucrose concentration step (fractions 4 and 5), and positive cav1
labeling of these fractions indicate association of cav1 to lipids in SUVs.
A posteriori, this unsuccessful attempt is not surprising since cavin1 was
shown to be a caveolin partner protein that is necessary to the formation of
budded caveolae (Hill et al. [2008]). This led to a change in our strategy to
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obtain cytoskeleton-free model systems. In this new (top-down) approach,
the idea was to create plasma membrane vesicles from the cell itself. Several
protocols were developed to create vesicle-like structures from cells:
• The group of R. Scott produced giant plasma membrane vesicles (GPMV)
using a buﬀer containing DTT or NEM (Scott [1976], Holowka and
Baird [1983], Baumgart et al. [2007])
• H. Vogel and coworkers used cytochalasin D to produce blebs (Pick
et al. [2005])
• The K. Simons group produced plasma membrane spheres (PMS) using
simple PBS++ supplemented with glucose and Hepes (Lingwood et al.
[2008])
In Fig 5.4 a scheme of a bleb growing out of a cell is shown. All the above
mentioned protocols were tested and are detailed below as they were used in
our hands.
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Figure 5.4: Scheme showing the generation of vesicles out of the cell plasma membrane.
5.3.1 Giant Plasma Membrane Vesicles (GPMV)
Giant plasma membrane vesicles were produced from adherent cells following
the protocol introduced by R. Scott (Scott [1976]). Brieﬂy, conﬂuent cells
were washed twice in GPMV buﬀer (150mM NaCl + 2mM CaCl2 + 10mM
Hepes, all at 7.4 pH), then incubated in GPMV reagent (GPMV buﬀer +
2mM DTT + 25 mM Formaldehyde) under continuous shaking (∼ 80rpm)
at 37◦C and 5%CO2 for 40min. The liquid was afterwards collected with
a glass capillary (1mm diameter), transferred into a 0, 5ml Eppendorf and
kept there for 10− 40min to allow the vesicles to settle down. Vesicles could
then be collected with a glass capillary from the bottom of the Eppendorf
and transferred to the microscope stage for experiments.
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5.3.2 CytochalasinD-Blebs
Incubation of adherent cells in PBS supplemented with 10µM cytochalasin
D (CD) and 0.1% BSA for 1 h resulted in blebbing cells. The blebs could be
detached from the cells by shaking the dish, collecting the liquid with a glass
capillary and transferring it into an 1, 5ml Eppendorf. After 10 − 40min of
settlement, vesicles could be collected for experiment from the bottom of the
Eppendorf.
5.3.3 Plasma Membrane Spheres (PMS)
Plasma membrane spheres were obtained from adherent cells following a mod-
iﬁed protocol, which was originally introduced by K. Simons (Lingwood et al.
[2008]). Brieﬂy, conﬂuent cells were washed twice in PBS and then incubated
for 6 − 10h in PMS-buﬀer (PBS + 1, 5mMCa2+Cl2 + 1, 5mMMg2+Cl2 +
10mM Hepes) at 37◦C and 5%CO2. To improve the results, PMS-buﬀer was
supplemented with 10µM of MG-132 (Calbiochem, Germany), which is a pro-
teasome inhibitor (Rock et al. [1994]) stopping the degradation of proteins
such as caveolin (Sotgia et al. [2003]). This mixture was called Cav-bleb-
solution. PMS were separated from cells by shaking the dish, collection of
the liquid with a glass capillary into an 1, 5ml Eppendorf and transfer of vesi-
cles into the microscope chamber after 40min of settlement. Another option
was to run the PMS protocol on cells adherent on glass slides which after-
wards were mounted directly on the microscope (Epi-OT or Con-OT)(Fig
5.5). Vesicles could then be detached from cells using a micropipette.
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Figure 5.5: Confocal stack of a wt MLEC transfected with Lifeact-mCherry after 6h of incu-
bation in Cav-bleb-solution. Little amounts of cytosolic Lifeact-mCherry fill the blebs attached
to the cell, whereas it binds at high concentration to actin filaments in the cell body. Top:
Profile of the cell along the dashed, green line (see below). Bottom: Projection of the stack
showing the x-y-plane of the cell. Bar = 10µm
The presented results on cytoskeleton-free model systems were all ob-
tained with plasma membrane spheres, because this technique provided the
cleanest vesicles of a good size to work with.
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Chapter 6
Experimental Set-Up
6.1 Tether Extraction
Two diﬀerent set-ups were used for the extraction of tethers: 1) an optical
trap coupled into an inverted epi ﬂuorescence microscope (in the following
called Epi-OT) for experiments on cells and vesicles (Cuvelier et al. [2005]),
and 2) a confocal microscope equipped with an optical trap (in the following
called Con-OT) for quantitative experiments on vesicles (Sorre [2010]). In
both cases, the optical trap consisted of a single ﬁxed laser beam focused by
a 100X objective.
6.1.1 Epi-OT
The optical trap was created by steering a 1064 nm laser beam (Coherent,
Santa Clara, CA) into an inverted microscope (Axiovert 200, Zeiss), and was
directed through a high numerical aperture objective (100X, 1.3 NA) via a
hot mirror (Melles Griot) placed under the ﬁlter cube holder instead of a
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rotative analyzer (see Fig 6.1). This design allowed performing bright ﬁeld
or epi-ﬂuorescence imaging while trapping a bead. Analysis of thermal ﬂuc-
tuations of the bead revealed a trap stiﬀness of KEpi−OTx,thermal = 131(±6) pNµm·W ,
and KEpi−OTx,Stoke = 135(±4) pNµm·W using Stokes law (6.1.9, page 109, Bockelmann
et al. [2002]). Bright ﬁeld images were acquired with a CCD camera (XC-
ST70CE, Sony, Tokyo, Japan) at 25 Hz, recorded on a computer with a
video capture card (Piccolo Pro 2, Euresys, Angleur, Belgium) after contrast
enhancement (Argus image processor, Hamamatsu Photonics, Hamamatsu,
Japan). A mercury lamp served as the light source for epi-ﬂuorescence, and
images were acquired with a EM-CCD camera (Cascade-CCD 97, Roper Sci-
entiﬁc, GA, USA) controlled by Metamorph software (Molecular Devices, Ca,
USA). The observation chamber containing cells was mounted on a tempera-
ture controlled stage of the microscope (Tempcontrol 37-2 digital, Carl Zeiss),
and temperature was set to 37◦C through the whole course of experiments.
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Figure 6.1: Pictures of the Epi-OT. Top: Set-up showing the alignment of the laser beam,
which is broadened by the telescope and adjusted in height by two mirrors (beam lift) to enter
the microscope. The position of the EM-CCD (Cascade) and the CCD camera are visible also.
Bottom: A protection box was constructed to protect the optical components of the laser, and
to decrease the risk of accidents.
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6.1.2 Con-OT
A confocal microscope equipped with optical tweezers was used for experi-
ments with ﬂuorescently labeled vesicles, including micropipette aspiration
and membrane tension measurement using tethers (Sorre et al. [2009]). The
possibility of visualization of the sample in bright ﬁeld microscopy at video
frame rate during confocal ﬂuorescence acquisition was a special feature im-
plemented by B. Sorre during his PhD (2007-2010).
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Figure 6.2: Schematic view of the experimental set-up. It shows the three independent
channels used in the optical configuration. Confocal imaging uses visible light (rainbow beam,
port ]3), optical trapping is achieved by a 1070nm continuous wave laser light (black beam,
port ]1), and bright field microscopy uses near infra red light (brown beam, port ]2). From
(Sorre [2010])
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The set-up is based on a commercial Nikon TE2000 inverted microscope
(Nikon) modiﬁed with the optional stage riser (Nikon), in order to create an
extra port (see port ]1 in Fig 6.2). The confocal head was the eC1 confocal
system (Nikon) equipped with two laser lines (λ1 = 488nm;λ2 = 543nm).
Confocal microscopy, optical tweezers and bright ﬁeld microscopy are not
naturally compatible. Thus the light spectrum was split in three separate
channels. Confocal ﬂuorescence microscopy was performed in the visible
(400 < λ < 750nm), optical trapping in the infra red channel (λ > 900nm)
and ﬁnally bright ﬁeld microscopy was operated in the near infra-red channel
(750 < λ < 900nm). It was made using the ﬂuorescence illumination arm
as an imaging port. (for details see Sorre [2010]). Computation of the trap
stiﬀness using Stokes law revealed KCon−OTx,Stokes = 81(±2) pNµm·W (a description of
the calibration methods can be found below 6.1.9, page 109).
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Figure 6.3: Pictures of the Con-OT set-up. (a) General view of the setup. On the TV screen
the microscope’s field of view is displayed where one can distinguish the tip of the micropipette
(?). (b) Zoom on the home-made three-axis pipette manipulator (c) Zoom on the pipette diving
in the custom-made PMS chamber. (d) Zoom on the custom-made PMS chamber. Modified
from Sorre [2010]
6.1.3 Cell Stage and Pipette Holder
Since optical tweezers were not movable, cells and vesicles had to be dis-
placed in order to pull tethers with trapped beads. This controlled linear
displacement was performed with a piezo-stage (PI, Karlsruhe, Germany).
The Epi-OT setup (see Cuvelier [2005]) was ﬁrst designed to work with vesi-
cles, red blood, and other non-adherent objects, which were usually put into
a small volume of adapted medium sandwiched between two glass slides con-
nected to the cell stage. Then a micropipette connected to the piezo-stage
and to an aspiration control system was inserted to manipulate single vesicles
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or cells (Fig 6.4). This conﬁguration was similar for the Epi-OT and the
Con-OT set-up.
Figure 6.4: Picture of the chamber used for experiments with vesicles and micropipettes.
However, for adherent cells, the Epi-OTmicroscope could be modiﬁed. A
custom-made metal cell chamber was placed into a specially designed holder
(baptized "the spoon") connected to the piezo-stage. The aluminum allowed
an eﬃcient heat conductance from the temperature control stage to the cells.
This allowed us to perform all cell experiments at 37◦. (Fig 6.5)
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Figure 6.5: Picture of the home-made cell chamber connected to the piezo controlled mi-
cromanipulator via the "spoon".
6.1.4 Hypo-osmotic Shock System
To apply a hypo-osmotic shock while measuring variations in the membrane
tension, the switch from isotonic to hypotonic conditions had to be done
smoothly. To do that, a needle was connected to the cell chamber, through
which one ﬂuid (water) could be injected gently using a syringe. In addition,
a second syringe connected to a needle was used to aspirate the medium out
of the chamber (see Fig. 6.6). This home-made device allowed us to change
media without changing the total volume present in the cell chamber. To
avoid perturbing ﬂows in the cell chamber, small plastic brackets were placed
in front of the needles.
105
Figure 6.6: Left: Cell chamber with the hypo-osmotic shock system depicting the flow of
liquids. Right: More detailed view of the cell chamber showing the connected needles and the
position of the optional plastic brackets.
6.1.5 Fabrication of Micropipettes
Micropipettes were made from borosilicate capillaries (0, 8mm inner/1mm
outer diameter). Capillaries were ﬁrst pulled into ﬁne cones using a laser
pipette puller (P-2000, Sutter Instrument Co.). Then, they were cut open,
and micro forged at the desired inside diameter (3− 4µm). The micro forge
consisted of a glass bead heated by a titanium ﬁlament. The principle of the
forge was based on the lower melting temperature of the glass bead compared
to that of the pipette. After the pipette was pushed into the melted bead,
cooling resulted in a sharp break of the pipette. For the experiments, pipettes
were ﬁlled with PBS, and attached to the chucks of the micropipette holder,
which was connected to the micromanipulator. Further connection to the
suction pressure device enabled aspiration control.
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6.1.6 Aspiration Control System
Two aspiration systems were used. The ﬁrst was a simple syringe used to
clean or unblock the micropipette. The second, which allowed a controlled
aspiration, was based on the principle of communicating vessels. A water
ﬁlled reservoir was connected to the back of the pipette by a silicone tube.
This reservoir was mounted on a vertical rack, and its height was controlled
by a mechanical translator (M105, Physik Instrumente)(Rawicz et al. [2000])
(Fig. 6.7). The pressure diﬀerence at the entrance of the pipette between
the observation chamber and the outside is determined by the height of the
water reservoir ∆h relative to the position of zero pressure:
∆P = ρg∆h, (6.1.1)
where ρ is the density of the medium in the reservoir (ρwater = 103kgm−3),
and g = 9, 81ms−2 is the acceleration of gravity. The pressure used in the ex-
periments ranges between 0.1 and 100Pa (1Pa = 1 kg
ms2
). The surface tension
of the membrane of an aspirated vesicle with radius Rv can be determined
by applying the Laplace formula (Kwok and Evans [1981]):
σ =
∆PRp
2(1− Rl
Rv
)
, (6.1.2)
where Rl is the radius of the cap of the aspirated membrane along the pipette
axis (so called tongue) and Rp is the radius of the pipette.
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fFigure 6.7: Top: The two aspiration systems; left: syringe, right: vessel installed on a
rack. Bottom: Scheme of the vesicle aspiration with a micropipette connected to a water filled
reservoir.
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6.1.7 Beads and Bead-coatings
For all experiments 3µm diameter polystyrene beads (Polysciences Inc., PA,
USA) covered with concanavalin A (Sigma, MO, USA) were used.
6.1.8 Online Tracking with MatLab
Bead tracking could be performed online, i.e. during the experiment, thanks
to an algorithm based on Matlab (written by Gilman Toombes in the group).
Brieﬂy, a region of interest around the bead was chosen together with a
threshold. The software was designed to compute the center of gravity of
this region, which corresponds to the bead position (see Fig 6.8). The spatial
resolution was 0.1 pixel or equivalent to a force resolution of 1 pN for a trap
stiﬀness of 135 pN/µm. It is noteworthy that the acquisition rate of 25 Hz
was not limiting for the processes that we have investigated.
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Figure 6.8: View of the interface of the tracking software. The small window on the upper
right shows the region of interest, from which the center of gravity is computed.
6.1.9 Calibration
The stiﬀness of the optical trap was calibrated by two methods. The ﬁnest
one is based on the energy-dissipation theorem while the other is simply
based on Stokes' viscous drag force (Cuvelier et al. [2005], Bockelmann et al.
[2002], Svoboda and Block [1994]).
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Energy Dissipation Theorem
Using the energy-dissipation theorem, the position ﬂuctuations of a trapped
bead can be directly related to the trap stiﬀness.
1
2
kBT =
1
2
< ∆r2 > K, (6.1.3)
with < ∆r2 > the mean square of the ﬂuctuations and K the trap stiﬀness.
Hence:
K =
kBT
< ∆r2 >
(6.1.4)
This method is very precise for low laser powers, when thermal ﬂuctuations
are still big enough to be observed by video microscopy. At laser powers
below 100mW , the stiﬀness K increases linearly with the laser power Plaser
as shown in (Fig.6.9). At higher laser powers the trap becomes so stiﬀ that
the internal noise of the setup overwhelms the thermal noise of the bead.
Assuming, that the linearity between the laser power and the trap stiﬀness is
valid over the entire range of the laser power, we can use the slope obtained
for the low power regime to calculate the trap stiﬀness for the laser power
used in the experiment.
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Figure 6.9: Calibration of the optical trap with thermal fluctuation. The slope in the linear
regime (0, 01 − 0, 06mW ) is KP = 131(±6) pNµm·W . Above 0, 08W the thermal fluctuations of
the bead are overwhelmed by the noise of the data acquisition.
It is important to note, that in general the shape of the laser beam in
the focus is not perfectly circular. That leads to diﬀerent trap stiﬀness in
the x and y direction. We then need to deﬁne the bead displacement out of
the center of the trap ∆r by the Cartesian coordinates ∆x and ∆y. Hence
the total force exerted on the bead is composed of fbead,x and fbead,y, i.e. the
force in the x and y direction, respectively (Fig 6.1.9).
f
f f
fbead =
√
fbead,x
2 + fbead,y
2 =
√
KxPlaser∆x
2 +KyPlaser∆y
2, (6.1.5)
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where KxPlaser and KyPlaser are the trap stiﬀness in x and y directions,
respectively, for a given laser power Plaser.
Experimentally, the bead was only displaced along the x direction, and the
force exerted on the bead is given by:
Fbead = Kx Plaser ·∆x (6.1.6)
Stokes' Law
Another method to calibrate the optical trap is based on the controlled dis-
placement of the bead under external force. To do this, the ﬂuid surrounding
the bead is moved with a constant velocity v. In a ﬂuid of viscosity η, the
force acting on the bead is given by the Stokes formula:
FStokes = 6piηRv (6.1.7)
The bead position is obtained from the force balance ftrap = fStokes. Hence,
for a given laser power and a ﬂuid ﬂow in the x-direction, one ﬁnds
K =
6piηRv
∆x
(6.1.8)
To apply a constant ﬂow of ﬂuid to the bead, the observation chamber was
using the piezo-electric translation. To avoid shear eﬀects due to surface
interactions, the bead was positioned 3µm above the surface of the observa-
tion chamber. A triangular signal was applied to the piezo-electric element,
with an amplitude corresponding to a displacement of 20 − 150µm. The
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frequency of oscillation was ﬁxed. The bead changed between the two equi-
librium positions (separated by a distance of 2∆x) following the direction of
chamber displacement. Measuring the bead displacement at diﬀerent laser
powers Plaser, and distances of chamber displacement, allowed us to measure
the trap stiﬀness in a wide range of laser powers as shown in (Fig 6.10).
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Figure 6.10: Calibration of the Epi-OT optical tweezers with chamber dis-
placements at diﬀerent velocities. A linear ﬁt of the data gives the slope
Kx = 135(±4) pNµm·W .
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6.2 TIRF-microscopy
Total internal reﬂection microscopy (TIRF) was performed on cells in order
to visualize and to identify single caveolae at the plasma membrane. For
more detailed information about TIRF microscopy, see (Axelrod [2008]).
6.2.1 TIRF Set-up
TIRF microscopy is a method of choice to visualize ﬂuorescently labeled ob-
jects in the vicinity of a surface while increasing the signal to noise ratio if the
bulk phase also contains ﬂuorescent species. TIRF microscopy was performed
using a Zeiss Axiovert 200 inverted microscope. The diﬀerent wavelengths
(488 nm, 568 nm, 614 nm) of an argon-krypton mixed gas laser (Melles Griot,
Carlsbad, CA) were selected by an acoustic-optical tunable ﬁlter unit, routed
to the microscope by a single-mode polarization-maintaining ﬁber optic and
the TIR mode generated by illumination through the periphery of a high NA
objective (100X, 1.45 NA). Images were acquired by an EM CCD camera
(8µm pixel dimension, 1000 x 1000 pixels, C 9100-02, Hamamatsu Photon-
ics, Japan). For dual wavelength imaging, the emission light was passed
through a dual-view optical unit (Photometrics, Tucson, AZ) that splits the
separate wavelengths to diﬀerent parts of the CCD chip.
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Part III
Results
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At the onset of this work, it was investigated whether and how caveolae
might play a role in cell tension regulation. The ﬁrst part will be about
the eﬀect of caveolae on the membrane tension of cells at rest. Then the
caveola mediated response to acute mechanical stress will be studied. Fi-
nally will be mentioned our latest results on minimal membrane systems (i.e.
plasma membrane spheres) containing caveolae and on muscle cells (my-
otubes), which were aimed at establishing a possible link between caveolin-
mutations and muscular dystrophies. But, let us start with explaining how
a typical tube extraction experiment was performed.
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Chapter 7
Tether Extraction From
Adherent Cells
7.1 Typical Tether Force Traces
A typical tether extraction experiment will be described in this section. Un-
less otherwise stated, the results presented in the rest of the manuscript were
obtained following the same experimental procedure.
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Figure 7.1: Top: Video screenshots of the experiment showing the bead (center) and the
cell (right) at different steps of the tether extraction. Bottom: Corresponding force-time trace;
the roman figures indicate the different steps of tether extraction: (I) Reference force corre-
sponding to the position if the free, untethered bead. (II) Negative force corresponding to
impingement between bead and cell to establish an adhesive contact. (III) Tether nucleation.
(IV) Tether elongation at pulling velocity v ∼ 0.5µm/s (final length ∼ 10µm). (V) Tether force
relaxation down to the static force.
Fig 7.1 shows a representative force-time trace during a typical tether
extraction from an adherent cell (here a wt MLEC). This process is composed
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of 5 phases:
I After a cell was chosen for an experiment, the trapped bead was positioned
in front of the cell, and the image acquisition was started in order to capture
the position of the ﬂuctuating bead in the absence of a membrane tether.
This position sets the force reference (f = 0) via the trap stiﬀness (0-10
seconds in Fig 7.1).
II The bead was brought into contact with the cell by moving the cell
towards the bead. This pushed the bead out of its reference position (corre-
sponding to the negative force in Fig 7.1). Moreover, the bead was lowered in
z position in order to have a broader contact site with the cell membrane. A
contact time of 2-20 seconds was typically necessary to establish an adhesive
link between cell membrane and bead, depending on the cell type, the cell
treatment, and the freshness of the bead coating.
III After a few seconds of contact, the cell was moved away from the bead
slowly (a few µm). An adhesive contact between the bead and the cell
membrane resulted in a visible displacement of the bead in the direction of cell
displacement (positive force increase in Fig 7.1) until a tether was nucleated
(high peak). This force overshoot is the signature of tether formation. As
mentioned in 1.2.3 (page 26) the magnitude of the force peak depends on the
size of the adhesive contact (Koster et al. [2005]).
IV To ensure that only one single tether remained, the tether was further
elongated at constant speed (v ∼ 0.5µm/s), which resulted in a slow increase
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of the tether force. In the case of multiple tethers, the force increase would be
much steeper, and a broader "thread" (or bundle of tether) would be easily.
Eventually the rupture of single tethers with the corresponding steps in the
tether force would be observed.
V At t = 30 seconds, elongation is stopped. The tether force is observed to
relax to a plateau value. The static force was computed as the mean value
of the tether force measured during at least 10 seconds after relaxation.
7.2 Preliminary Remarks and Comments
on the Relation Between Tether Force
and Membrane Tension on Cells
The force overshoot associated to tether nucleation will be overlooked in this
work, although it is a particular feature in the force trace. It is mostly de-
pendent on the protocol details of force application (size of adhesion contact,
controled by contact time, impingement force, bead coverage...).
Our initial goal was to directly test the Sens and Turner model (Sens and
Turner [2005]) and use the tether pulling technique as a way of both, ex-
tracting membrane area in a controled manner (and thus applying a local
perturbation to the cell membrane), and measuring the resulting cell tension.
However, as seen during phase IV of tether extrusion and already reported by
others (Sheetz [2001], Heinrich et al. [2005]), elongation of tethers extracted
from living cells signiﬁcantly deviates from the behavior discussed for lipid
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bilayers. Instead of exhibiting a length-independent plateau value, the tether
force increases upon elongation even at small pulling velocities as small as
fractions of µm/s. This process very likely originates from viscous friction
between cytoskeleton and membrane, and from the ﬂow of membrane around
transmembrane proteins. A comprehensive physical mechanism of this dy-
namic contribution to the tether force is under current investigation since
the force velocity relationship is still debated.
In order to avoid the complexity inherent to dynamics of tether extrusion,
it was decided to focus on the static tether force, as measured after relax-
ation at constant length. As a consequence, our tether pulling assay will only
serve as a sensitive technique to probe the tension of the cellular interface.
In the following chapter, it will be ﬁrst investigated whether the presence of
caveolae at the cell plasma membrane directly contributes to the resting cell
tension. Then, by externally applying mechanical stresses (such as osmotic
shocks), variations of tether forces will be measured to assess the cell mem-
brane response under stress.
Finally, it is important to recall that measurements of tether forces yield
the cell tension, which is not the strictly the membrane tension of the cell.
As mentioned earlier in 1.2.3 (page 25) the force required to hold a tether
extracted from a lipid bilayer is a direct measure of the membrane tension
σ (providing that the bending rigidity is known). Contrastingly, in the case
of living cells, the same formalism can be conserved if σ is replaced with the
eﬀective cell tension, which is the sum of the plasma membrane tension σ and
the cytoskeleton-membrane adhesion energy density W0. Moreover, Sheetz
and coworkers have shown that σ  W0 in eukaryotic cells with intact actin
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cortex (Raucher et al. [2000]). In consequence, under identical experimental
and physiological conditions, diﬀerences in tether forces measured between a
wt and a mutant cell line will be mainly informative about how the muta-
tion alters W0. The best way to gain insight into the tension of the plasma
membrane itself is to investigate how the tether force is aﬀected by changes
in experimental conditions that do not signiﬁcantly impair the cytoskeleton-
membrane adhesion. As abovementioned, the caveola-mediated cell response
under hypo-osmotic shock will be studied, which may seem to be a harsh
treatment that also inﬂuences W0. However, at this stage, it is important
to keep in mind that our focus is on the short-term cell tension regulation.
It is thus assumed that hypo-osmotic shocks do not signiﬁcantly aﬀect W0
within the ﬁrst 5 minutes following the shock. This assumption has already
been made in previous works by Sheetz and coworkers (Dai et al. [1998])
and is supported by the fact that the morphology of the cytoskeleton is not
observed to be altered within this short 5 minutes duration (D'Alessandro
et al. [2002]).
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Chapter 8
Do Caveolae Contribute to
Setting the Resting Cell Tension?
In this chapter, two cell lines were selected, namely MLEC and MEF. In both
cases, the eﬀective cell tension of cells rich in caveolae (wt) and cells devoid
of caveolae (cav1−/−) will be compared in resting physiological conditions. It
will be also investigated how chemical and biological treatments impact on
the measured tether force.
8.1 The Eﬀective Tension of MLEC is Aﬀected
by the Presence Caveolae
The eﬀective cell tension of mouse lung endothelial cells in resting (physiolog-
ical) conditions was measured in extracting membrane tethers with optically
trapped beads as described in the previous section. The histogram in Fig 8.1
shows the distribution of the tether force for both wt and cav1−/− MLECs.
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These data correspond to diﬀerent tethers pulled from diﬀerent cells.
Tether force
Figure 8.1: Histogram of static tether force measurements on wt (black) and cav1−/−
(striped) MLEC.
For both cell lines, the mean of the distribution was computed. As it can
be seen in Fig 8.2 there is a signiﬁcant diﬀerence in the tether force between
the two cell types. In wt MLEC, the tether fore was fwt = 35 ± 1.4pN
(N = 46), whereas it was f cav1
−/−
= 18 ± 1.2pN (N = 32) for cav1−/−
MLEC.
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Figure 8.2: Left: Plot of the tether force in wt (N = 46) and cav1−/− (N = 32) MLEC. Data
represent mean ± standard errors. Right: Example of single experiments showing the static
tether force of a wt (black) and cav1−/− (grey) MLEC.
Transfection of cav1−/− cells with EGFP-cav1 restored the tether force to
fEGFP−cav1 = 38±1.8 (N = 34) in cells showing a caveolar pattern of EGFP
as observed with epi ﬂuorescence microscopy (Fig 8.3). This indicates that
the presence of caveolae indeed accounts for the measured diﬀerence in tether
force between wt and cav1−/− cells. It is for note that this twofold diﬀerence
in force means that wt and cav1−/− cells are characterized by eﬀective resting
tension that diﬀers by 4-fold (according to Eq. 2.5.2).
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Figure 8.3: Left: Plot of the tether force in cav1−/− MLEC transfected with cav1-EGFP
showing protein expression (+) or not (-). Data represent mean ± standard errors. Middle:
Two single experiments showing the static tether force of cav1-EGFP expressing cav1−/−
MLEC with caveolar like structures (+) or not (-). Right: Fluorescence images of cav1-EGFP
corresponding to the cells in the middle panel.
8.2 The Eﬀective Tension in MEFs Does not
Depend on the Presence of Caveolae
To check whether the eﬀect of caveolae on the cell tension observed in the
MLEC was a general trend, tether force measurements were also performed
on mouse embryonic ﬁbroblasts (MEF) were performed. As for MLEC, two
MEF cell lines were used: the caveolae containing wt form and the cav1−/−
variant. By contrast with MLEC, the measured tether forces in wt and
cav1−/− MEF did not exhibit any signiﬁcant diﬀerence (fwtMEF = 11 ±
1.7pN , N = 4, and f cav1
−/−MEF = 11 ± 1.4pN N = 4; Fig 8.4), meaning
that the eﬀective cell tension is not aﬀected by the presence of caveolae.
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Figure 8.4: Plot of the tether force in wt and cav1−/− MEF. Data represent mean± standard
errors.
8.3 Challenging the Eﬀective Cell Tension by
Chemical and Biological Treatments
To gain better insight into the possible contribution of caveolae to the ef-
fective resting tension of cells, another series of experiments was performed,
in which cellular components were disturbed by either chemical or biological
treatments.
The cytoskeleton was altered by several drugs like cytochalasin D (CD), la-
trunculin A (LatA), and jasplakinolide (Jas). The cell was also depleted
of energy (i.e. ATP), the plasma membrane was depleted of cholesterol by
m-β-cyclodextrin (mβCD) which is known to result in the ﬂattening of cave-
olae (Rothberg et al. [1992]), and the activity of src-kinase was hindered
by the phosphatase inhibitor PP2. Additionally, cells were transfected with
ﬂuorescently labeled caveolins displaying point mutations (cav1-Y14F-YFP,
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cav3-P104L-YFP, and cav3-GFP).
8.3.1 Alterations of the Cytoskeleton Decrease the Ef-
fective Cell Tension
The tether force, and thus the eﬀective cell tension of both wt and cav1−/−
MLEC decreased to similar values after treatment with the abovementioned
drugs disturbing the actin cytoskeleton (Fig 8.5), more precisely, when cells
were incubated for 10-20 minutes in
• 0.5µM CD, the mean tether forces were found to be: fwt,CD = 10.8±
0.9 (N = 22) in wt, and f cav1
−/−,CD = 8.5 ± 0.8 (N = 27) in cav1−/−
cells;
• 1µM LatA, fwt,LatA = 8 ± 1.7 (N = 6) in wt, and f cav1−/−,LatA =
6.0± 1.0 (N = 8) in cav1−/− cells;
• 1µM Jas, fwt,Jas = 16.0 ± 0.8 (N = 26) in wt, and f cav1−/−,Jas =
11.3± 0.9 (N = 18) in cav1−/− cells.
The three diﬀerent drugs perturbed the actin cytoskeleton in diﬀerent man-
ners, but in all case, the treadmilling of actin ﬁlaments was impaired. The
direct consequence was that the eﬀective cell tension signiﬁcantly decreased
as expected (W0 ∼ 0). The measured value was similar for wt and cav1−/−
cells.
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Figure 8.5: Histograms of static tether force measurements on wt (black) and cav1−/−
(striped) MLEC after 10-20 minutes treatment with 0.5µM CD (top), 1µM LatA (middle) or
1µM Jas (bottom). 130
8.3.2 ATP depletion Decreases the Membrane Tension
After 50 minutes of ATP depletion (see protocol in 5.2.3, page 89), the static
tether force was measured to be fwt, noATP = 3.8±0.5 (N = 12) in wt MLEC,
and fCav1
−/−, noATP = 5.0 ± 0.5 (N = 8) in cav1−/− cells (Fig 8.6). Upon
ATP depletion, the eﬀective cell tension thus decreased, irrespective to the
presence or absence of caveolae.
Tether force
Figure 8.6: Histogram of static tether force measurements on wt (black) and cav1−/−
(striped) MLEC after 50 minutes of ATP depletion.
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Figure 8.7: Plot showing the tether forces of wt (left) and cav1−/− (right) MLEC in control
conditions (Ctrl), with 0.5µM CD, 1µM LatA, 1µM Jas or after ATP depletion (no ATP). Data
represent mean ± standard errors.
8.3.3 Interaction of Cav1 with Src-kinase
One of the interaction partner with cav1 involved in the formation and en-
docytosis of caveolae are src-kinase proteins which phosphorylate tyrosine
14 of the cav1 protein. Inhibition of src-kinase was reported to reduce the
new formation of caveolae after the addition of epithelial growth factor (Or-
lichenko et al. [2006]). Two strategies were chosen to address the inﬂuence
of cav1-tyrosine 14 phosphorylation on the cell tension.
• wt MLEC were pretreated with 20µM PP2 to inhibit the activity of
src-kinase
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• Cav1−/− MLEC were transfected with the mutant cav1-Y14F-GFP
which cannot to be phosphorylated.
PP2 treatment of wt MLEC did not alter signiﬁcantly the cell tension, since
the static tether force remained at fwt,PP2 = 35± 3.7pN , N = 6). Similarly,
cav1-Y14F-GFP was able to restore the membrane tension of cav1−/− MLEC,
when it was expressed suﬃciently high (f cav1−Y 14F,+ = 38 ± 2.7pN , N =
6), whereas the membrane tension of cells with low expression remained at
cav1−/− levels (f cav1−Y 14F,− = 18± 2.0pN , N = 8). (Fig 8.8) These ﬁndings
suggest that the resting tension of MLECs is solely governed by caveolae
present at the membrane. The sole expression of cav1 is not suﬃcient to
re-establish the cell tension or the formation of new caveolae.
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Figure 8.8: Left: Epi fluorescence imaging of cav1−/− MLEC transfected with and ex-
pressing high (+) or low (-) levels of cav1-Y14F-GFP. Bar = 10µm Right: Plot showing the
mean tether forces of cav1−/− MLEC transfected with and expressing high (+) or low (-) lev-
els of cav1-Y14F-GFP (cav1-Y14F-GFP), and of wt MLEC pretreated with PPS (PP2). Data
represent mean ± standard errors.
8.3.4 Cav3 Re-establishes the Cell Tension of Cav1−/−
MLEC
Cav1−/− MLEC were transfected with cav3-EGFP to check the speciﬁcity
of the observed eﬀect of caveolae formed by cav1 on the cell tension. As
observed in epi-ﬂuorescence, transfected cells showed the same membrane
pattern of cav3-EGFP as the cav1-EGFP. moreover, the eﬀective tension
of these cells was restored to the level of wt MLEC, as revealed by tether
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extraction experiments (f cav3−EGFP = 34 ± 1.9pN , N = 13). Thus, cav3,
which is the natural caveolin isoform for muscle cells, was also able to form
caveolae in MLEC, and these caveolae have similar eﬀects on the resting cell
tension.
Cav1−/− MLEC were also transfected with the point mutation cav3-P104L
(analogue to the cav1-p132l mutation), which is unable to exit the Golgi
apparatus and is a dominant negative mutation. Within transfected cells,
not any could be found with a caveolar plasma membrane pattern of cav3-
P104L-YFP. As expected, the eﬀective tension of these cells remained at the
level of cav1−/− MLEC (f cav3−P104L = 22± 1.5pN , N = 12). (Fig 8.9)
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Figure 8.9: Cav1−/− MLEC transfected with cav3-EGFP and cav3-P104L-YFP. Left: Plot
showing the mean tether forces of cells transfected with cav3-EGFP (wt) and cav3-P104L-YFP
(p104l). Data represent mean ± standard errors. Right: Fluorescence images showing the
localization of cav3-EGFP and cva3-P104L-YFP, respectively.
8.4 Summary
The main ﬁndings cav be summarized as follows:
• The presence of caveolae in untreated MLECs increases the eﬀective
cell tension, as compared with MLECs devoid of caveolae.
• This diﬀerence vanishes in cells that exhibit an altered (decreased)
cytoskeleton-membrane adhesion energy density.
• The inﬂuence of caveolae on the eﬀective cell tension is cell line depen-
dent, since wt and cav1−/− MEFs are characterized by the same cell
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tension.
These results suggest that caveolae do not per se aﬀect the resting tension
of the cell plasma membrane. Instead, their presence may have a detectable
inﬂuence on the cytoskeleton-membrane adhesion, as revealed by our data
on MLECs. This ﬁnding is consistent with the fact that caveolae directly or
indirectly interact with the actin machinery, as mentioned in 3.5 (page 60).
Yet, this trend cannot be generalized to all cell lines (see e.g. MEF). The
presence of caveolae or their suppression may have indeterminate eﬀects on
W0. The interaction of caveolae with the actin cortex may thus be enhanced
or compensated by other alterations of the cytoskeleton-membrane interac-
tion due to genetic mutations. This intricate eﬀect is diﬃcult to predict.
137
Chapter 9
Caveola-mediated Membrane
Tension Buﬀering Upon
Acute Mechanical Stress:
Experiments on Cells
In this chapter, it is investigated how caveolae may contribute to the cell
response upon mechanical stress. The results presented hereafter are the
core of a submitted manuscript.
9.1 Application of Acute Mechanical Stress and
Cell Response Observed by TIRF and EM
Several ways exist to expose cells to an acute mechanical stress, like
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• shear stress induced by liquid ﬂow
• uniaxial stretch induced by elongation of elastic cell substrates, on
which cells are pated
• swelling upon application of hypo-osmotic shock.
The application of hypo-osmotic shock was chosen mainly, because it al-
lowed us to easily combine the application of stress with tether extraction.
To demonstrate that the results described below were not speciﬁc to os-
motic shocks, the fate of caveolae upon both hypo-osmotic shock and uniaxial
stretch was studied by TIRF microscopy in cav1-EGFP expressing cells (ex-
periments performed by B. Sinha). The results obtained with both kinds of
mechanical stress are comparable, which supports the physiological relevance
of osmotic shock application at short time scales (∼ 5 minutes).
9.1.1 Mechanical Stress Leads to the
Partial Disappearance of Caveolae
from the Plasma Membrane
First the eﬀect of the hypo-osmotic conditions on the cell volume was tested
with HeLa-PFPIG cells (expressing cav1-EGFP). Switching from an osmo-
larity of 300mOsm to 30mOsm resulted in an immediate increase of cellular
volume visualized by 3D confocal microscopy. Quantitative image analysis
further showed that the cell volume increased by about 35%, peaking within
the ﬁrst 5 min. The cell volume was then observed to decrease slowly while
hypo-osmotic conditions were maintained. Moreover, on reversing the exter-
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Figure 9.1: RICM image of cells before (Iso) and after hypo-osmotic shock of 5 minutes
(Hypo). Upon hypo-osmotic shock, the proximity of the plasma membrane to the glass surface
is increased (expansion of the central dark patch) ruling out the possibility of loss of contact
between the plasma membrane and glass surface. Bar = 5µm.
nal osmolarity back to 300mOsm after 30 minutes of hypotonic shock, the
volume decreased to a value below the initial cell volume. These two lat-
ter observations support the existence of a compensatory cellular mechanism
known as regulatory volume decrease, which originates from the enhanced ac-
tivity of ions channels to restore the osmotic balance, as previously reported
(D'Alessandro et al. [2002]). The data however suggest that this process is
not dominant during the ﬁrst 5 minutes following hypo-osmotic shock. (Fig
9.3 A, B). TIRF microscopy was used to visualize plasma membrane caveo-
lae. A dedicated image analysis platform enabled to follow the dynamics of
caveolae upon hypo-osmotic shock (LabView program written by B. Sinha).
Upon switching the osmolarity from 300mOsm to 30mOsm, the ﬁrst strik-
ing observation was that the number of caveolae present at the cell surface of
individual cells signiﬁcantly decreased by about 30% at the surface of indi-
vidual cells within minutes of hypo-osmotic shock (Fig 9.3 C,D). This eﬀect
was not due to a detachment of the cell during the hypo-osmotic shock, as
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it was checked by Reﬂection Interference Contrast Microscopy (RICM) (Fig
9.1).
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Figure 9.2: Top: Snapshot of the stretching device with the following components marked
out: a) linear actuator for pulling b) detachable mount for PDMS sheet with cells c) resistors
for temperature control. Bottom: Phase contrast image of micro patterned adhesive patches
on PDMS for regulating cell shape and orientation. PDMS sheets (100µm thick) thus micro
patterned (light blue) are joined to a thicker (1mm thick, shown as darker blue) sheet with a
central window, so as to make a chamber for plating cells. The chamber is then assembled
on the stretching device. provided by B. Sinha
Then, a stretching device was designed by B. Sinha and build by the
Curie-workshop. This device was based on the use of a thin transparent sil-
icone substrate, and was compatible with TIRF microscopy (Fig 9.2). This
set-up enabled high imaging of caveolae dynamics by TIRF in a given cell
before and after stretch. Additionally, to allow quantitative analysis, the
use of stretchable substrates was combined with micro patterning technology
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(Chen et al., 1997) to control the adhesion area and geometry of the cell
as well as its orientation with respect to the stretching axis. As shown on
Fig 9.3 F and G, the number of caveolae present at the basal footprint of
Cav1-EGFP HeLa cells was decreased upon stretching, and the loss of cave-
olae correlated with the extent of cell stretching (Fig 9.3 H). Remarkably,
caveolae disappearance follows a similar pattern upon hypo-osmotic shock or
membrane stretching (Fig 9.3 E and H).
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Figure 9.3: (A) Hypo-osmotic shock causes cell swelling. YZ maximum-intensity projection of confocal stacks
of HeLa cells stably expressing cav1-EGFP. Top panel is the projection of 4 cells under iso-osmotic conditions (Iso),
middle panel shows the same cells under hypo-osmotic conditions (Hypo) 5 minutes after switching osmolarity from
300 to 30mOsm, and the bottom panel shows the cells 3 minutes after returning to 300mOsm (Rec) subsequently
to hypo-osmotic shock for ∼30 min. Bar = 5µm. Dashed lines mark out the cell boundary for the iso-osmotic
condition. (B) Volume of HeLa cells stably expressing cav1-EGFP tracked from iso-osmotic conditions to different
time points after hypo-osmotic shock (30mOsm, t = 0min) and upon returning to iso-osmolarity (300mOsm,
t ∼ 29min). Arrow indicates the volume measured upon recovering iso-osmolarity. Data derived from multiple
measurements (N = 5) in 3 independent experiments. Error bars represent standard deviations. (C) TIRF images of
HeLa cav1-EGFP cells under iso-osmotic conditions (Iso) and after hypo-osmotic shock (4 min) (Hypo). Dotted line
marks out the cell footprint. Bar = 5µm. (D) Change in the number of caveolae for single HeLa cav1-EGFP cells
after hypo-osmotic shock (Hypo) normalized to the number counted before hypo-osmotic shock (Iso) (N = 18). Error
bars represent standard deviations (p = 4E − 11). (E) Evolution of the loss of caveolae per cell with decreasing
osmolarity. The same HeLa cav1-EGFP cells were exposed to decreasing osmolarities during ∼ 1min for each
osmolarity. Error bars represent standard deviations (N = 3). Data are representative of 3 independent experiments.
(F) TIRF images of a single cav1-EGFP HeLa cell on the stretching device at 0% (left), and 20% stretch (right). Dotted
lines mark out cell boundaries before and after stretch. Note that transverse contraction is negligible. Bar = 5µm.
(G) Change in number of caveolae for single HeLa Cav1-EGFP cells after stretching (15 ± 1%) normalized to the
number counted before stretching (N = 7). Data derived from multiple measurements (N = 7) in 7 independent
experiments (p = 0.00033). (H) Evolution of the number of caveolae for single HeLa cav1-EGFP cells stretched
to different lengths. Stretching was calculated from the change in the lateral dimension of the cell footprint in the
direction of the stretch as (L−L0)/L0 where L0 was the initial length and L was the final length of the cell footprint.
Each point represents the loss of caveolae for a particular cell. The number of caveolae is found to be negatively
correlated to the amount of stretch (N = 7, r2 = 0.85) as measured in 7 independent experiments.
9.1.2 Partial Disappearance of Caveolae
Observed by EM
Electron microscopy (EM) studies were performed on wt MLEC at iso-
osmotic conditions, and upon hypo-osmotic shock, to study on the ultra
structural level the fate of caveolae upon acute mechanical stress. Two EM
techniques were applied, 1) EM of ultrathin cryosections combined with gold
particle immuno-labeling showing lateral cuts of cell membrane parts (in col-
laboration with G. Raposo), and 2) deep-etched EM showing the structure
of the basal cell membrane adherent to the cover slide viewed from inside the
cell (Morone [2010], in collaboration with N. Morone). While the fraction of
lost caveolae quantiﬁed by EM on ultrathin cryosections was in agreement
with values obtained by TIRF (9.4), deep etched EM allowed us to observe
"ghosts" of ﬂat caveolae (Fig 9.5).
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Figure 9.4: Left: Ultrathin cryosections of wt MLEC before (Iso) and 5 min after (Hypo)
switch to hypo-osmotic medium (30mOsm) examined by electron microscopy. Right: Quan-
tification of caveolae detected per µm of plasma membrane on ultrathin cryosections of MLEC
in iso- or hypo-osmotic conditions reveal a significant decrease in the number of caveolae per
µm after hypo-osmotic shock. Total membrane used for quantification was 76 and 67µm
for iso- and hypo-osmotic conditions, respectively. Data represent mean ± standard errors
(p = 0.047).
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Figure 9.5: Left: Deep-etched EM images of wt MLEC under iso-osmotic (Iso), hypo-
osmotic (Hypo) and recovered iso-osmotic (Rec) conditions. Bar = 200nm. Left insets depict
representative images of clathrin-coated pits. Right images depict representative images of
caveolae. Bar (insets) = 100nm. Right: EM anaglyph of example caveolae picked from the left
panel. Using view glasses (left = red), the three dimensional form of budded and flat caveolar
structures becomes visible. Bar = 100nm.
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9.2 Membrane Tension Measurements During
Hypo-osmotic Shock
In parallel with the visualization of caveolae upon cell exposure to hypo-
osmotic shock or stretch (EM and TIRF), we used tether extraction experi-
ments during hypo-osmotic shock to study the evolution of the cell tension,
which is likely to reﬂect the variations of the membrane tension (see Eq.
1.2.6). As discussed in chapter 8, the eﬀective cell tension of cells mea-
sured in iso-osmotic conditions signiﬁcantly varied with the cell type (MEF,
MLEC) and chemical treatments (ATP depletion, actin drugs, cholesterol
extraction), and diﬀerences may also arise from the presence or absence of
caveolae (in the case of MLEC). Here, our goal is to probe the variations in
cell tension upon hypo-osmotic shock. For the sake of comparison, all the
data will be expressed as the relative change of force with respect to the
initial tether force f0 measured in iso-osmotic conditions. The parameter of
interest is thus:
y =
f − f0
f0
(9.2.1)
9.2.1 Caveolae are Required for Buﬀering the Tension
Surge Due to Hypo-osmotic Shock
As shown in Fig 9.6 the measured tether force remained constant upon switch
from iso- to hypo-osmotic conditions in wt MLEC, whereas it increased signif-
icantly in cav1−/− cells. This implied that the increase of membrane tension
measured in cav1−/− MLEC upon hypo-osmotic shock was buﬀered in wt
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MLEC due to the presence of functional caveolae. Accordingly, the expres-
sion of functional caveolae by transfection of cav1-EGFP in cav1−/− MLEC
re-established the buﬀering of membrane tension surge in these cells. Further-
more, when cells were pretreated by m-β-cyclodextrin, a treatment known
to ﬂatten caveolae through membrane cholesterol depletion (Rothberg et al.
[1992]), the membrane tension increased upon hypo-osmotic shock both in
wt and cav1−/− MLEC (9.6 A and B), conﬁrming that the ﬂattening of
the invaginated structure of caveolae was required for buﬀering the surge in
membrane tension.
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Figure 9.6: (A) Representative force curves for tethers extracted from wt MLEC, cav1−/− MLEC, cav1−/−
MLEC transfected with cav1-EGFP, and wt MLEC treated with mβCD exposed to hypo-osmotic shock. After extraction
of a tether in iso-osmotic conditions (0min < t <∼ 1min), medium is diluted with water until the osmolarity reaches
150mOsm (break from 1.34 to 2.7min indicated by arrow). The membrane tether is maintained at constant length
for the whole course of the experiment. The curve represents the relative change of the tether force f with respect to
the initial force f0 measured before hypo-osmotic shock. (B) Relative change of the tether force after hypo-osmotic
shock (5min) for wt and cav1−/− MLEC in control conditions (N = 9, p = 0.01502), and treated with mβCD
(N = 4, p = 2E − 6 for wt, and N = 4, p = 0.045 for Cav1−/−). f0 is the resting tether force as measured in
iso-osmotic conditions and f is the tether force after hypo-osmotic shock. Data represent mean ± standard errors.
Finally, it was checked whether the buﬀering eﬀect of caveolae is a pe-
culiarity in MLEC or could be generalized to other cell lined. Thus, the
same experiments were repeated with mouse embryonic ﬁbroblasts (MEF)
derived from mice lacking or expressing cav1, and with HeLa PFPIG cells.
Similar results were obtained with a buﬀering of membrane tension upon
hypo-osmotic shock in wt MEF and HeLa PFPIG, and a membrane tension
surge in cav1−/− MEF (Fig 9.7).
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Figure 9.7: Relative change of the tether force after hypo-osmotic shock (5min) for wt
(N = 9), and cav1−/− MLEC (N = 9, p = 0.01502), wt (N = 3) and cav1−/− MEFs (N = 4,
p = 8E− 4) and HeLa cells (N = 4). f0 is the resting tether force as measured in iso-osmotic
conditions and f is the tether force after hypo-osmotic shock. Data represent mean± standard
errors.
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9.2.2 Clathrin Coated Pits do not Buﬀer the Membrane
Tension
It was tested whether other membrane invaginations such as clathrin-coated
pits could play the a similar role in buﬀering of membrane tension surge
during hypo-osmotic shock. To do that, membrane tension measurements
were performed on wt MLEC where clathrin was selectively knocked down by
RNA interference. Clathrin RNAi led to the inhibition of clathrin-coated pits
function as shown by the eﬃcient inhibition of transferrin uptake (Fig 9.8 A).
However, membrane tension was buﬀered to the same extent whether clathrin
was expressed or knocked down (Fig 9.8 B). Contrastingly, cav1−/− MLEC
having clathrin-coated pits but no caveolae could not buﬀer the membrane
tension increase under hypo-osmotic shock.
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Figure 9.8: (A) Epi fluorescence imaging of transferrin-Alexa594 endocytosis after 5 min-
utes of incubation in wt MLEC transfected with scrambled siRNA (scrb-siRNA, top) or clathrin
heavy chain siRNA (CHC-siRNA, bottom). Cells with no transferrin uptake were considered as
efficiently transfected with CHC-siRNA, and used for further tether extraction and hypo-shock
experiments. Bar = 10µm. (B) Relative change of the tether force f after hypo-osmotic shock
(5min) with respect to the force in iso-osmotic conditions f0 in wt-MLEC transfected with
scrambled siRNA (scrbsiRNA, N = 7) or clathrin heavy chain siRNA (CHC-siRNA, N = 9),
and in cav1−/− MLEC (N = 10, p = 3E − 4) devoid of caveolae, but having clathrin-coated
pits. Data represent mean ± standard errors.
These results ruled out a role for clathrin-coated invaginations in mem-
brane tension buﬀering and were consistent with our ﬁnding that dynasore,
which also blocks clathrin-coated pits' endocytosis, did not aﬀect the response
of caveolae to hypo-osmotic shock (Fig 9.9). Altogether, these results suggest
that caveolae behave as primary stress-responsive membrane structures.
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Figure 9.9: Force curves for tethers extracted from wt and cav1−/− MLEC treated with
80µM dynasore exposed to hypo-osmotic shock. After extraction of a tether in iso-osmotic
conditions (0min < t <∼ 0.3min), medium is diluted with water until the osmolarity reaches
150mOsm (break from 0.3 to 0.7 min indicated by arrow). The membrane tether is maintained
at constant length for the whole course of experiment. The curve represents the relative
change of the tether force f with respect to the initial force f0 measured before hypo-osmotic
shock.
9.2.3 Disassembly of Caveolae During Mechanical Stress
Then, it was tested whether the membrane tension buﬀering eﬀect was actin
dependent or an intrinsic property of caveolar invaginations. Cells were thus
treated with cytochalasin D to disrupt the cytoskeleton. TIRF imaging how-
ever revealed that cytochalasin D did not alter signiﬁcantly the organization
of plasma membrane caveolae nor decreased their number. Additionally,
upon hypo-osmotic shock, the disappearance of caveolae was not prevented
(Fig 9.10 A). In another series of experiments, cells were depleted in ATP.
TIRF imaging revealed that the loss of caveolae observed in ATP depleted
cells upon hypo-osmotic shock was the same as in untreated cells (Fig 9.10
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A). As previously described, these treatments decrease the eﬀective cell ten-
sion (8.3 on page 127). In line with these results, hypo-osmotic shock did
not result in an increase of membrane tension in wt MLEC pretreated with
cytochalasin D or depleted in ATP. Contrastingly, a drastic membrane ten-
sion surge was observed in cav1−/− MLEC subjected to the same treatments
(Fig 9.10 A). These results indicate that membrane tension buﬀering is an
intrinsic mechanical property of caveolae i.e. that does not require any active
cellular machinery.
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Figure 9.10: (A) TIRF image of cav1-EGFP in a HeLa cell pretreated with cytochalasin D (CD) at iso-osmotic
(Iso) and 5min after switch to hypo-osmotic (Hypo) conditions. Dashed line marks the footprint of the cell. (B)
Number of caveolae per cell after hypo-osmotic shock (Hypo) normalized to the number counted in cells before hypo-
osmotic shock (Iso) in control (Ctrl; N = 18), cytochalasin D (CD; N = 10, p = 2E− 5), latrunculin A (Lat; N = 21,
p = 7E − 11), jasplakinolide (Jas, N = 11, p = 6E − 8) treated cells, and ATP depleted cells (no ATP; N = 10,
p = 2E−5). Data represent mean± standard deviations. (C) Relative change of the tether force f after hypo-osmotic
shock (5min) with respect to the force in iso-osmotic conditions f0 for wt and cav1−/− MLEC for control (Ctrl; N = 9
for wt, and for cav1−/− N = 5, p = 0.015), cytochalasin D treated (CD; N = 9 for wt, and for cav1−/− N = 10,
p = 3E − 5), and ATP depleted (no ATP; N = 6 for wt, and for cav1−/− N = 5, p = 2E − 4) cells. Note
that the increase in tether force upon hypo-osmotic shock is significant in each condition where caveolae are absent.
Data represent mean ± standard errors. (D), (E) Representative force curves for membrane tethers extracted from
wt MLEC (black) and cav1−/− MLEC (grey) treated with (D) cytochalasin D (CD) or (E) ATP depleted (no ATP) and
exposed to hypo-osmotic shock. A membrane tether is first extracted in iso-osmotic conditions (0min < t <∼ 1
min), and maintained at constant length during the whole course of the experiment. Medium is diluted with water until
the osmolarity reaches 150mOsm (break from 1 to 2min indicated by arrow). The curve represents the relative
change of the tether force f with respect to the initial force f0. Whereas the magnitude of force increase in cav1−/−
MLECs is conserved from one experiment to another, the kinetics of force increase is variable.
9.3 Correlation Between the Observed Loss of
Caveolae and the Excess of Membrane Area
Required to Buﬀer Membrane Tension
In order to check if the observed loss of caveolae corresponds to the release
of additional membrane area required for the membrane tension buﬀering,
the expected membrane area corresponding to the tension increase in caveola
free cells will be estimated. To do that, the fact is exploited that the area
change of a (reservoir-free) lipid bilayer is directly related to its membrane
tension through the Helfrich relation (see 1.1.3):
σ
σ0
= exp{8pi κ
kBT
∆A
A0
} (9.3.1)
where σ0 is the initial (resting) membrane tension, σ is the membrane ten-
sion of the stressed membrane, kBT is the thermal energy, κ is the bending
rigidity (∼ 40 kT as measured on plasma membrane spheres) and A0 and ∆A
are the initial membrane area and change in area, respectively. This relation
is an approximation for small area strains and describes the entropic regime,
in which bending ripples are progressively smoothened out. We neglect here
the elastic regime, in which the membrane exhibits a limited microscopic
extensibility, which then leads to lysis. In order to ﬁnd experimental condi-
tions in which this relation can be reliably used, we selected ATP-depleted
or CD-treated cav1−/− MLECs. As abovementioned, the contribution of the
cytoskeleton-membrane interaction to the eﬀective cell tension is minimal (or
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negligible) upon CD treatment or ATP depletion. The tether force thus di-
rectly yields the bilayer tension. Cav1−/− MLECs exhibit a signiﬁcant tether
force increase during shock. By measuring f0 and f , the tether forces in iso-
osmotic conditions and after hypo-osmotic shock, we derive σ0 and σ (since
σ =
f 2
8pi2 κ
and thus ∆A/A0, which corresponds to the fractional change
in area that cav1−/− MLECs experience during hypo-osmotic shock. Using
the numbers obtained for the tether force before and after the hypo-osmotic
shock, calculation gives
∆A/A0 = 0.28± 0.08%
for ATP-depleted cells (CD treated cells reveal 0.18± 0.06% change). Since
wt MLECs do not exhibit any tether force increase upon hypo-osmotic shock,
our assumption at this stage is that the calculated area change observed with
cav1−/− MLECs is assigned to caveolae ﬂattening. Now it will be checked,
whether this value is close to the eﬀective area released by all the lost cave-
olae. Analysis of EM pictures on wt MLEC gave the number of caveolae per
µm of membrane section. Calculating the expected number of caveolae (for
example) per 100µm2 both in iso-osmotic and hypo-osmotic conditions, and
then assuming the area per caveolae to be 0.02µm2 (80nm diameter sphere),
it is found that caveola ﬂattening leads to 0.38±0.14% change in area. Here,
diﬀerences of osmolarity between tether force and EM experiments still have
to be corrected. Tether forces have been measured at 150mOsm while EM
was done on samples at 30mOsm. Using the measured relation between
caveola loss and osmolarity (Fig 9.3 E), one can expect that caveolae will re-
158
lease a membrane area that corresponds to 0.3±0.1% of the total membrane
area at 150mOsm. Finally, the estimated area change in cav1−/− MLECs
and the fraction of area added by caveolae in wt MLECs are identical within
the errors. Although the derivation of these numbers is not direct, the agree-
ment does not seem to us to be coincidental, and supports our proposed
mechanism.
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Chapter 10
Caveola-mediated Membrane
Tension Buﬀering upon
Mechanical Stress:
Experiments on Plasma
Membrane Spheres
Next, we sought to unambiguously establish that membrane tension buﬀering
is an intrinsic mechanical property of caveolae, i.e. that it does not require
any active cellular machinery. To do this, we turned to lipid vesicles, a sim-
pliﬁed system to study membrane mechanics. The Bassereau group has a
large experience in the reconstitution of membrane proteins into giant unil-
amellar vesicles (GUVs). The ﬁrst attempt was the reconstitution of caveolae
in GUVs starting from puriﬁed cav1 and lipids. However, repetitive failures
160
together with the ﬁrst publications about cavin1 as a protein required for
the formation of functional caveolae (Hill et al. [2008], Nabi [2009], Hayer
et al. [2010]), were the reasons to change our strategy. The idea was to pro-
duce caveolae containing vesicles directly from cells that are rich in caveolae.
Techniques to obtain such vesicles from the native plasma membrane of cells
have been developed in the last 40 years (Scott [1976], Holowka and Baird
[1983]). Most of the existing methods imply the use of chemical reagents like
formaldehyde or DTT, which can crosslink membrane proteins or drastically
alter the intracellular compartments. After our test of these protocols to pro-
duce Giant Plasma Membrane Vesicles (GPMV), as described by E. Scott
(Scott [1976]) and more recently by T. Baumgart and coworkers (Baumgart
et al. [2007]), no caveolae could be observed in the vesicles, but a homo-
geneous distribution of cav1. In contrast, a more gentle protocol based on
the long incubation of cells in phosphate buﬀer saline (PBS) supplemented
with 1.5mM Ca2+ and 1.5mMMg2+ (Lingwood et al. [2008], Kaiser et al.
[2009]), allowed us to observe dotted structures that look like caveolae at the
membrane of vesicles. These vesicles obtained from detached cellular blebs
were named Plasma Membrane Spheres (PMS) by K. Simons. The amount
of cav1 found in PMS could be further increased by the use of proteasome
inhibitor MG132 (Lee and Goldberg [1998]), which inhibits the degradation
of proteins by the proteasome.
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10.1 Plasma Membrane Spheres
Contain Caveolae and Are
Devoid of Actin Filaments
10.1.1 Production of PMS from HeLa-PGFPIG
HeLa PFPIG cells expressing cav1-EGFP were ﬁrst selected to produce PMS
in order to directly assess the presence of caveolar structures in PMS by ﬂuo-
rescence microscopy. After 6− 10 hours of incubation of cells in PMS-buﬀer,
cav1-EGFP clusters could be observed in cells by epi ﬂuorescence indicating
that the treatment did not disassemble caveolae. Similar structures could
also be observed in blebs. In a next step, PMS had to be disconnected from
the cell in order to manipulate them with a micropipettes and to pull tethers
with optical tweezers. In a ﬁrst attempt, the petri dish containing the cells
with the PMS was gently shaken after 6 − 10 hours of incubation, and the
liquid, which was ﬁrst collected in an eppendorf tube, was injected into the
manipulation chamber placed on the microscope stage. Using this protocol,
tether extraction experiments were diﬃcult to perform over longer time peri-
ods (i.e. > 1min), because of the amount of debris and detached cells which
were ﬂoating around. Additionally, many PMS were "dirty", i.e. vesicles
with pieces of rigid structures (Fig 10.1).
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Cav1-EGFP
Figure 10.1: Bright field and epi fluorescence image of a "dirty" PMS from a HeLa PFPIG.
Figure 10.2: Z-stack projection of a "clean" PMS obtained from a HeLa PFPIG. Bar = 10µm.
Since only few PMS were needed for the experiments, there was no need
to obtain a high yield of detached blebs. The protocol was thus changed in
such a way that the micropipette was directly used to separate PMS from
cells or to pick up free ﬂoating PMS. To perform experiments on the Con-
OT set-up, a new chamber had to be designed based on thick microscopy
glass slides, which could be used both for cell treatment in the incubator and
for PMS manipulation on the microscope stage (Fig 10.3).
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Figure 10.3: Snapshot of the home made chamber for PMS generation, which could be
placed into the cell incubator, and then was mounted on the Con-OT.
10.1.2 Production of PMS from MLEC
PMS could also be generated from wt and cav1−/− MLEC using the same
protocol. Although previous reports have shown that PMS were devoid of
ﬁlamentous actin (Lingwood et al. [2008]), this ﬁnding was double checked by
us. To do this, cells were transfected with Lifeact-mCherry, a cytosolic pep-
tide which binds selectively on polymerizing actin. Transfected cells treated
for PMS production showed a clear labeling of actin ﬁlaments inside the cell,
whereas the PMS attached to the cell had only a faint signal of the cytosolic
Lifeact-mCherry indicating the absence of ﬁlamentous actin (Fig 10.4).
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Figure 10.4: Confocal images of a MLEC transfected with Lifeact-mCherry and subjected
to PMS production. Lifeact labels the actin filaments in the cell body (left), whereas only a
faint signal of cytosolic Lifeact is detected in the PMS sitting on top of the cell (right) indicating
the absence of polymerizing actin in PMS.
In order to test the presence of functional caveolae in PMS, MLECs were
transfected with cav1-EGFP and cavin1-mCherry. Visualization of orange
dotted structures in transfected cells indicate co-localization of both proteins,
and was taken as the signature of invaginated caveolae (Hill et al. [2008]).
PMS produced from these cells also showed co-localization of cav1-EGFP
and cavin1-mCherry at the membrane (Fig 10.5 A).
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Figure 10.5: (A) Confocal images of a MLEC transfected with cav1-EGFP and cavin1-mCherry and after
incubation for 6 hours in PMS buffer(left). Cav1 and cavin1 can be found on the membrane of the PMS, even after
aspiration by a micropipette (solid white lines) and extraction of a tether by an optically trapped bead (white filled
circle)(right). Bar = 10µm. (B) Intensity line scan of the aspirated PMS in (A) at an aspiration pressure of 5Pa (left)
and 30Pa (right). Arrows indicate colocalization of cav1 (green) and cavin1 (red). (C) Plot of the tether force of the
PMS from (A) (black) and a PMS obtained from a cav1−/− MLEC (red) in respect to the aspiration pressure. Note
that the force of the cav1 containing PMS stays constant until 25Pa, whereas the force of the PMS lacking cav1
shows a force steadily increasing with the aspiration pressure.
10.2 Micropipette Aspiration of PMS Induces
Disassembly of Caveolae
Application of osmotic shock to vesicles is especially delicate because minute
shocks are likely to trigger complex changes of the vesicle shape. Instead,
micropipette aspiration was used to apply a mechanical stress to PMS. Our
goal was to combine simultaneous visualization of caveolae upon aspiration
and mechanical characterization of the PMS membrane. In a ﬁrst set of semi-
quantitative experiments, PMS were aspirated under increasing suction pres-
sure. Ideally, 3D imaging of PMS should be performed at a given aspiration
pressure to obtain a precise estimate of the number of functional caveolae.
However, in the absence of cytoskeleton, the diﬀusion of these structures was
too fast to enable confocal z-stack reconstitution. To circumvent this diﬃ-
culty, the density of caveoale detected at the equator of the vesicle (within a
slice of ∼ 0.8µm was checked to be constant in time for a given pressure, and
was representative of the overall density of caveolae. Then, quite remarkably,
the number of cavin/caveolin co-localization sites within the equatorial slice
was observed to decrease upon aspiration (Fig 10.5 B). Further, when mem-
brane tube extraction was simultaneously carried out, the tether force was
observed to remain constant in the case of PMS containing caveolae while
it was increasing for PMS produced from cav1−/− cells. This observation
suggests that caveolae disassemble when the PMS is pressurized, as observed
in cells submitted to hypo-osmotic shocks. Note that the tether force only
remains constant over a limited range of pressure. In the case shown in Fig
10.5, the tether force starts to increase above ∆P = 25Pa. According to
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the Sens and Turner model (Sens and Turner [2005]), which is presented in 4
(page 74), this tension increase at higher aspiration pressure would suggest
that all caveolae are disassembled. Yet, line scans around the PMS perimeter
still reveals the presence of cavin/caveolin co-localization sites (Fig 10.5 B,
right), suggesting either that some co-localization sites are coïncidental or
that a fraction of caveolae is not able to unfold.
10.2.1 Quantitative Analysis of Micropipette
Aspiration of PMS
Micropipette aspiration of PMS from cav1−/− MLEC in combination with
tether force measurements allowed to estimate the bending rigidity of PMS
from MLECs as κMLEC = 36± 6kBT (N = 7, mean ± standard error) using
the relation 1.2.6 and assuming that the membrane area of cav1−/− PMS is
constant, thus, that the membrane tension is set by the aspiration pressure
(equation eq:aspiration-pressure). In the case of PMS from wt MLEC, the
height and the length of the observed force plateaus were analyzed. The
height of the force plateau is supposed to depend on the mechanical properties
of a caveola, whereas the length of the plateau would correspond to the
number of caveolae, which contributes to the buﬀering of membrane tension.
Analysis of the Height of the Force Plateau
Corresponding to equation 4.0.16 the energy of an invaginated caveola is
σ(0) = Sσ(0) = (1− βbud)−1/2γ − κ. (10.2.1)
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The height of the force plateaus of 12 vesicles was at fplateau = 15.7± 0.3pN
(mean ± standard error). With a bending rigidity of PMS of ∼ 40kBT (as
measured for cav1−/− PMS) the membrane tension corresponding to the force
plateau is
σ =
f 2plateau
8pi2 κ
= 1.9 · 10−5N/m. (10.2.2)
Considering, that this is the membrane tension of a budded caveola, one
obtains from 4.0.16
γ =
Sσ(0) + 8piκ√
(1− βbud)
(10.2.3)
and with β = 0.9 and S = 0.02µm2
γ = 1.5 · 10−19J. (10.2.4)
This corresponds to a line tension of
γ =
√
piS · γ ⇒ γ = γ√
piS
= 6 · 10−13N. (10.2.5)
In summary, the values for the membrane tension of an invaginated caveola
and the corresponding line tension are in a realistic range.
Analysis of the Length of the Force Plateau
The additional membrane area necessary for the observed membrane tension
buﬀering is supposed to be provided by the ﬂattening of caveolae. The as-
piration pressure until which the force plateau could be observed, was in 12
experiments Pcrit = 26 ± 2Pa (mean ± standard error), and the starting
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aspiration pressure was P0 = 5Pa.
Considering a lipid membrane vesicle without any membrane reservoir any
change in membrane tension is directly related to its areal change by the
Helfrich relation (in the entropic regime):
σ
σ0
=
P
P0
= exp{ 8piκ
kBT
∆A
A0
} (10.2.6)
Using the values obtained from the experiments with PMS from wt MLEC,
i.e. Pcrit = 26Pa, P0 = 5Pa, κ = 40kBT , one obtains for a vesicle of with
radius Rv = 8µm an area increase of
∆A =
4piR2v kBT
8piκ
ln(
Pcrit
P0
) = 1.3µm2. (10.2.7)
Thus, the ﬂattening of
Nflat cav =
∆A
S
= 65 (10.2.8)
caveolae (of area S = 0.02µm2) would provide the additional membrane area
required to buﬀer the membrane tension. Accordingly to this, the tongue
length of three individual PMS from wt-MLEC showing a force plateau upon
a similar range of aspiration pressure could be measured, and revealed an area
increase of ∆A = 2.5± 1.2µm2 (mean ± standard deviation). At the other
hand, the number of caveolae in a PMS can be estimated. The confocal
image (Fig 10.5 A, right) shows an equatorial cut of thickness e = 0.8µm
and a radius of Rv = 8µm. For ∆P = 5Pa N5Pa = 25 co-localization sites of
cav1-EGFP and cavin1-mCherry could be counted, and for ∆P = 30Pa (at
the end of the force plateau) the number of co-localizations was N30Pa = 15.
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Note, that N = 0 would be expected at the end of the plateau, meaning that
the cavin/caveolin co-localization may be coïncident and does not reﬂect the
existence of functional caveolae.
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Figure 10.6: (A) Sketch a PMS depicting the equatorial plane of thickness e scanned with
the confocal microscope, and how to estimate from there the number of caveolae in the whole
PMS. (B) Sketch of the different section of the line scan of the PMS membrane showing parts
with cav1 (green), with cavin1 (red) and with co localization of both (orange). The latter could
correspond to multiple caveolae whose number can be estimated in dividing the length of the
patch lpatch by the diameter of a caveola 2Rcav (see zoom of the circle).
Nevertheless, consider that the force plateau corresponds for the ﬂat-
tening of ∆Neq = 10 caveolae at the equator of the vesicle with the width
e = 0.8µm and the radius Req = 8µm. Assuming a constant linear caveola
density, λ, one gets
λ =
∆Neq
2piReq
= 0.2µm−1 (10.2.9)
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That means for the whole vesicle (see Fig. 10.6)
∆Nves = 2pi Req λ+ 2
Req/e∑
n=1
2pi(Req − en)λ
= 2
∫ Req/e
0
2pi(Req − en)λ∂n
= 4pi λ(
R2eq
e
− 1
2
R2eq
e
)
= 2pi λReq
Req
e
= ∆Neq
Req
e
= 100
(10.2.10)
caveolae would have ﬂattened upon the increase of aspiration pressure from
5Pa to 30Pa. This number matches the number of caveolae necessary for
the membrane buﬀering calculated in 10.2.8. Another way to estimate the
caveola number in the PMS example is to analyze the length of co-localization
sites (orange parts) and to put this in relation to the size of a caveola (Rcav =
50nm), which would provide an upper limit. At ∆P = 5Pa, the 25 patches
have a mean length of
l5Papatch = 0.4± 0.2µm
and cover a total length of
L5Papatch = 10.3µm.
Interestingly, the mean length of the 15 patches at ∆ = 30Pa increased to
l30Papatch = 0.7± 0.2µm
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, so that the total length remains at
L30Papatch = 9.9µm.
Using equation 10.2.10 one could give an upper limit of the number of cave-
olae present in the PMS at 5Pa (Fig 10.6 B):
Nupper limitves =
L5Papatch
2Rcav
Req
e
= 1030. (10.2.11)
Taking into account the number of caveolae at the basal cell membrane de-
tected through TIRF microscopy (N =∼ 100), the presence of 50 − 100
caveolae in a PMS would be realistic, and could explain the observed mem-
brane tension buﬀering. The high number of colocalization patches could be
due to coïncidence and to the mobility of caveolae which can be high in a
free membrane without an underlying cytoskeleton. Nevertheless, the obser-
vation that the number of co-localization sites decreased, while their mean
size increased, indicates that some of the patches corresponded to functional
caveolae which disassemble upon mechanical stress.
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Chapter 11
Experiments on Muscle Cells
The Role of Caveolin-3 Mutations
in Muscular Dystrophy
After showing that caveolae play a mechanical role in the response to acute
mechanical stress, at short time scales, our focus turned to diseases associ-
ated to caveolin mutations, and the question, whether they could originate
from the impossibility of altered caveolae to perform this task. The most ev-
ident candidates were muscular dystrophies for which many cav3 mutations
were reported (see 3.8.2). In collaboration with the laboratory of G. Butler-
Browne (Institut de Myologie, Paris), three diﬀerent muscle cell lines were
obtained from biopsies of patients with muscular dystrophies and caveolin-3
mutations (Fig 3.9):
• cav3-R26Q: associated with LGMD, RMD and HCK
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• cav3-P28L: associated with HCK
• cav3-A45T: associated with LMGD, RMD
This allowed us to study the case of > 90% reduction of cav3 reported for
cav3-R26Q and -A45T, and the less severe 60− 80% reduction reported for
cav3-P28L. Additionally a muscle cell line with wt cav3 was used as a control.
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Figure 11.1: Bright field image of wt muscle cells after 7 days in differentiation medium.
Myotubes can be identified by their long stretched geometry. Bar = 20µm
11.1 Tether Force of Diﬀerentiated Muscle Cells
Tether extraction on muscle cells revealed that undiﬀerentiated myoblasts
could be distinguished from diﬀerentiated myotubes (Fig 11.1) by the tether
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force. It was in the case of wt cells, fwt,myoblast = 19 ± 1.1pN (N = 14) for
myoblasts, and fwt,myotube = 31±1.2pN (N = 21) for myotubes (after 7 days
of diﬀerentiation). Additionally, the tether force of myotubes from the three
cell lines with cav3 mutations were similar to the one of wt myotubes, i.e.
(Fig 11.2)
• fR26Q,myotube = 32± 1.1pN (N = 18)
• fP28L,myotube = 31± 1.6pN (N = 20)
• fA45T,myotube = 29± 0.7pN (N = 18).
Thus, the eﬀective resting tension of myotubes was unaﬀected by the presence
of functional or mutated caveolae.
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Figure 11.2: Plot showing the tether force of myotubes (Mt) expressing wt cav3 or one of
the mutations cav3-R26Q (R26Q), cav3-P28L (P28L), and cav3-A45T (A45T), respectively.
The tether force of myotubes is significantly different from undifferentiated wt myoblasts (Mb).
11.2 Reaction of Myotubes with Cav3-Mutations
upon Acute Mechanical Stress
Following the procedure described in section 9.2, the response of myotubes
to hypo-osmotic shock was tested.
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1 min
Figure 11.3: Bright field image sequence of a wt myotube during the switch from iso-osmotic
(Iso) to hypo-osmotic (Hypo) medium through careful addition of 1mlH2O to 1ml cell culture
medium during 1 min. The bead measures 3µm in diameter.
Myotubes are elongated plurinuclear cells (∼ few 100µm long and ∼
10µm wide)(Fig 11.1). Upon hypo-osmotic shock, a drastic increase of cell
volume was observed, irrespective of the cell line (Fig 11.3). The plot in
Fig 11.4 shows that the tether force, and thus the membrane tension of wt
myotubes is buﬀered during hypo-osmotic shock. Contrastingly, tether forces
are observed to increase upon osmotic shock for all the investigated cell lines
with cav3-mutations, even though this increase is less drastic than the one
reported for MLEC.
Figure 11.4: Plot showing the relative change of the tether force f after hypo-osmotic shock
(5 min) in respect to the force in iso-osmotic conditions f0 in wt, cav3-Q26R (Q26R, N = 10,
p = 1E − 7), cav3-P28L (P28L, N = 13.p = 8E − 7), and cav3-A45T (A45T, N = 7,
p = 4E − 7) myotubes. Data represent mean ± standard errors.
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11.3 Contracting Myotubes
Occasionally, myotubes started to contract when a tether was extracted with
or during addition of water. The contractions lasted for 10-20 seconds and
were observed in wt as well as in cells with cav3-mutations (Fig 11.5). This
observation has not been exploited further yet.
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Figure 11.5: Example of a tether force measurement from a contracting myotube. The
contractions can be easily identified in the oscillation of the tether force.
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Part IV
Discussion
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Chapter 12
Caveolae as a Security Device for
the Cell Membrane
When acute mechanical stresses induced by hypo-osmotic shock or stretch-
ing are applied to cells, the resulting increase of the cell membrane area is
expected to lead to an increase of the membrane tension unless additional
membrane is released. The main message of the present work is that caveolae
may play the role of sacriﬁcial membrane reservoirs to buﬀer any membrane
tension surge at short time scales. In this context, caveolae can be regarded
as security devices that prevent the cell membrane from rupturing under
acute mechanical stress. This link between mechanical stress, caveola disas-
sembly and membrane tension buﬀering was deciphered using a combination
of several microscopy based techniques. By TIRF-microscopy (mainly per-
formed by my colleague B. Sinha), single caveolae containing cav1-EGFP
and co-localizing with cavin1 could be identiﬁed at the basal membrane.
Application of mechanical stress resulted in a decrease of cav1/cavin1 co-
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localization, a disappearance of caveolae, and an increase of free cav1, which
suggests that caveolae disassemble. This process was independent of ATP
and of the actin cytoskeleton. Imaging with EM techniques (performed in
collaboration with G. Raposo at the Institut Curie, Paris, and N. Morone
at the National Center of Neurology and Psychiatry, Tokyo) allowed similar
observations at the ultra structural scale, and showed structures resembling
ﬂat caveolae. Finally, experiments of membrane tube extraction with opti-
cally trapped beads revealed for the ﬁrst time that membrane tension surges
were buﬀered in the presence of caveolae, and support the hypothesis that
ﬂattening and disassembly of caveolae provide a membrane reservoir that is
readily available. In line with the results of TIRF experiments, the mem-
brane tension buﬀering was independent of ATP and actin dynamics, but
was impaired when caveolae were disrupted by m-β-cyclodextrin. Accord-
ingly, cells devoid of caveolae were not able to buﬀer the membrane tension
surge upon mechanical stress. Additionally, the production of plasma mem-
brane spheres containing cav1 and cavin1 served as a simpliﬁed model system
to investigate the inﬂuence of caveolae on the mechanical properties of the
plasma membrane in the absence of active cellular mechanisms. As observed
in cells, caveolae present at the membrane of PMS buﬀered the membrane
tension upon increasing micropipette aspiration pressure.
The study of the mechanical response of caveolae was completed by the
observation of caveola reassembly after return from hypotonic to resting con-
ditions. These ﬁndings gave rise to the following model of caveola reaction
upon mechanical stress which is presented in Fig 12.1.
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Figure 12.1: Cells Respond to Acute Mechanical Stresses by Rapid Disassembly and
Reassembly of Caveolae. In resting conditions, caveolae present at the plasma membrane
are mostly invaginated. Magnification shows oligomerized cav1 and cavin1 in the caveolar
structure. Upon acute mechanical stress (hypo-osmotic shock or stretching), caveolae flatten
out in the plasma membrane to provide additional membrane and buffer membrane tension.
Magnification shows disassembly and diffusion of cav1 in the plasma membrane and loss of
interaction between Cav1 and Cavin1. Return to resting conditions allows the reassembly of
the caveolar structure together with Cavin1 interaction. This cycle represents the primary cell
response to an acute mechanical stress.
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12.1 Comparison of Experimental Data
with the Theoretical Model (Sens and Turner)
Part of the inspiration for the present work originated from the Sens-Turner
theoretical model. Before pointing out how it compares to our experimen-
tal results, the main assumptions of this theoretical work will be recalled. In
this model, invaginated (caveola-like) structures act as a "hidden" membrane
reservoir both to set the equilibrium membrane tension and to accommodate
tension changes. Brieﬂy, the cell resting state is supposed to be associated
with a given number of buds (i.e. functional caveolae), which in turn sets
the membrane tension. This claim is straightforward providing that two as-
sumptions are fulﬁlled: i) the plasma membrane tension is determined by the
fraction of ﬂat (or non-invaginated) membrane (hence the term "hidden" for
the reservoir of budded structures); ii) at low tension, buds spontaneously
form, which means that the budded state is favored in the absence of ex-
ternal source energy. Then, if tension is increased, buds ﬂatten to release
membrane area and buﬀer the expected tension surge. On the contrary, a
drop in membrane tension favors the formation of new buds from the plasma
membrane. Therefore, the bold prediction of the model is that the membrane
tension remains constant as buds disappear or appear, when the mechanical
stress applied to the membrane is respectively tensile or compressive. In the
case of a tensile stress, this buﬀering process stops when the reservoir of buds
is completely depleted.
On the basis of our experimental results, we show that, upon the applica-
tion of an acute mechanical stress, membrane tension is buﬀered by caveolae
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disassembly. At ﬁrst sight, these ﬁndings are in line with the Sens-Turner
theoretical framework. Yet, closer examination reveals striking diﬀerences.
From the theoretical point of view, the equilibrium membrane tension is set
by the number of buds. However, it is of note that Sens and Turner have only
considered a lipid bilayer and neglected any interaction with the cytoskele-
ton. In this case, the "eﬀective membrane tension" strictly equals the tension
of the bilayer (adhesion energy W0 = 0). Conversely, we have long discussed
about the inﬂuence of the cytoskeleton-membrane adhesion energyW0 on the
eﬀective cell tension that is derived from tether pulling experiments (see 2.5,
page 41). First, this term dominates the contribution of the bilayer tension.
Second, as seen from our experiments on diﬀerent cell lines, because it is
already diﬃcult to predict the inﬂuence of the presence of caveolae on W0,
it is hopeless to think that W0 could be detectably calibrated by the number
of caveolae. In brief, from an experimental point of view, the eﬀective mem-
brane tension seems to be uncorrelated with the number of caveolae.
Second, more importantly, the theoretical model was critically tested by ap-
plying hyper-osmotic shocks to cells by adding increasing amounts of D-
sorbitol to the growth medium used during imaging (data not shown, ob-
served by B. Sinha). No signiﬁcant change in the number of caveolae was
observed. This insensitivity to cell deﬂation is in disagreement with the the-
oretical model, which means that the conversion between functional caveolae
and disassembled caveolae is not a symmetrical process. Along this line, also
note that the theoretical model is based on a transition between buds and ﬂat
pieces of membrane similar to raft-like domains. Although it cannot be ruled
out that, upon hypo-osmotic shock or cell stretching, some of the remaining
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caveolae are ﬂat (as suggested by deep-etched EM), the fraction of lost cave-
olae was unambiguously assigned to a molecular disassembly of caveolae. In
other words, caveolae are not stable structures in a ﬂat state: they quickly
disassemble (within the duration of application of the mechanical stress, 1-2
minutes) instead of remaining as "rafts". These observations indicate that
caveolae do not spontaneously self-assemble from free caveolins available in
the membrane, which was a basic hypothesis of the theoretical model (see as-
sumption ii). Finally, although the Turner-Sens model was initially inspiring,
it turned out that it could not account for all observations.
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Chapter 13
Mechanical Stress and the
Role of Caveolae in Signaling
A recent study on cardiac myocytes reported that the presence of caveolae
in the plasma membrane leads to a decreased activation of mechanosensitive
channels upon application of a mechanical stress (Kozera et al. [2009]). This
observation is consistent with our ﬁnding: the activation of mechanosensitive
channels is directly dependent on the membrane tension; in consequence,
buﬀering the membrane tension inhibits the activation of the channels.
More generally, several proteins and channels implied in signaling pathways
were reported to be present in caveolae, and to interact with caveolin proteins
(Patel et al. [2008], Balijepalli and Kamp [2009]). Some need functional
caveolae to be activated upon mechanical stress (Rizzo et al. [2003], Park
et al. [2000], Sedding et al. [2005]), whereas others show higher sensitivity to
mechanical stress in the absence of caveolae (Albinsson et al. [2008], Trouet
et al. [1999]). It might be interesting to study, whether these ﬁndings can be
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connected to the mechanical role of caveolae presented in this study following
the rationale that
• channels, whose activation depends on membrane tension, are less ac-
tive in the presence of caveolae
• proteins, which need the interaction with the CSD of single caveolins,
would be more activated after caveola disassembly giving rise to higher
activation levels in the presence of caveolae (Head and Insel [2007])
• proteins, which are concentrated and inactive inside caveolae, would
become activated after caveola disassembly (like it is supposed for
eNOS)(Patel et al. [2008])
Moreover, it would be important to clarify the role of cavins. On which
molecular basis do they associate with caveolin proteins upon caveola for-
mation? Are the cavin proteins (beside cavin1) released from caveolae upon
application of a mechanical stress? Do the released cavin proteins activate
signaling processes? Cavin1 was ﬁrst identiﬁed as the polymerase 1 and
transcript release factor (PTRF) protein (Jansa et al. [1998]) and as a BF-
COL1 (binding factor of a type-1 collagen promoter) binding protein (BBP)
(Hasegawa et al. [2000]). Cavin1 could thus be a link between mechanical
stress at the plasma membrane and the regulation of gene transcription in the
nucleus. This would imply a transport of cavin1 from the plasma membrane
to the nucleus, which still has to be investigated.
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Chapter 14
Towards a Better Understanding
of Muscular Dystrophies
In the case of muscle cells, the cav3 isoform and its partners are of special
interest. Beside the caveolae formed by cav3, this protein is also part of the
dystrophin glycoprotein complex (DGC), which is considered to stabilize the
plasma membrane (Lapidos et al. [2004]), and cav3 colocalizes with dysferlin
at the plasma membrane, which is important for membrane repair (Brown
and Glover [2007]). The molecular mechanisms of muscular dystrophies are
far from being understood, but one of the reasons could be altered mechan-
ical properties of muscle cells (Wallace and McNally [2009]). Many forms
of muscular dystrophies occur together with hyper-CKemia, which indicates
leaks or ruptures of muscle cell plasma membranes. These dystrophies are as-
sociated with mutations of cav3, dysferlin, and members of the DGC, which
led to the idea that mutations of these proteins cause an increased rupture
of the cell plasma membrane.
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In the case of defects of the DGC, the plasma membrane could be more
sensitive or more exposed to mechanical stress which results in more rupture
events. The DGC connects the extracellular matrix to the cytoskeleton, such
that the muscle cells could move "en bloc" together with their extracellular
matrix in a muscle ﬁber. In the case of a lacking link between actin and the
extracellular matrix, the movement of muscle cells would be harmonized me-
chanically, and would pull the extracellular matrix with it. This would lead to
an increased friction between the muscle cell plasma membrane and its envi-
ronment, and lead to more plasma membrane ruptures. This would explain,
why the disruption of the actin cytoskeleton evokes the same phenotype as
dystrophin lacking cells. The observation of an elevated cav3 expression and
caveola density in those cells could indicate a mechanism to compensate the
higher membrane stress.
In the case of dysferlin mutations (associated with LGMD-2B) the lack of
the rapid membrane repair system established by dysferlin would explain an
increased membrane rupture rate (Dowling et al. [2008]).
In the case of caveolinopathies (i.e. diseases associated with caveolin muta-
tions), the lack of a membrane reservoir would be the reason for more frequent
membrane ruptures. The present study on myotubes with three diﬀerent
cav3 mutations (R26Q, P28L and A45T) showed a decreased buﬀering of the
membrane tension upon hypo-osmotic shock compared to wt cav3 expressing
cells. This could indeed suggest a decreased resistance ot mechanical stress.
Because cav3-mutations also alter the dysferlin expression, and its transport
to the plasma membrane, further experiments are required to clarify, if the
present results are due to the lack of caveolae or to a lack of rapid membrane
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repair. Monitoring the membrane tension on cells lacking dysferlin, and the
study of plasma membrane dysferlin in cells with cav3-mutations upon hypo-
osmotic shock would provide information about the action of dysferlin upon
mechanical stress. The use of ﬂuorescently tagged cav3 and dystrophin or
dysferlin would allow studying their interaction at the plasma membrane us-
ing FLIM/FRET. Additional periodic stretch would imitate the situation in
real muscles, and would provide information how the muscle adapts to pe-
riodic mechanical stress. Monitoring the integrity of the plasma membrane
upon acute mechanical stretch could reveal, if the membrane ruptures more
easily in cells with defects in the caveola formation and/or if the membrane
repair is aﬀected.
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Chapter 15
Other Caveolin Related Diseases
Besides the muscular dystrophies other diseases exist which are related to
caveolin mutations or dysfunction of caveolae. For example, a young woman
was found recently, who lacked caveolin1 totally and showed amongst others
the loss of adipose tissue, increased free tri-cholesterol and lipid levels in the
blood (lipodystrophy), and insulin resistance (Kim et al. [2008]). Another
interesting observation was that people lacking cavin1 lack all caveolae (nei-
ther formed by cav1 nor by cav3 in muscle), and thus suﬀer from muscle
dystrophy, lipodystrophy, insulin resistance (Hayashi et al. [2009]). But be-
sides these rare and extreme cases, there are mutations of caveolin related to
pulmonary hypertension and to cardiac hypertrophy, which are more com-
mon (Patel et al. [2008], Mercier et al. [2009]). Another big ﬁeld where the
role of caveolin is not understood is cancer. It is thought, that caveolin acts
as a tumor suppressor in the early stage of cancer, whereas it is found to be
a promoter in metastatic and multiple drug-resistant (MDR) cancers (Goetz
et al. [2008]). Since the growth of cancerous tissue implies an increased pres-
195
sure for the neighbor healthy cells, taking into account mechanical aspects
could help to better understand the problem of cancer development. A re-
cent theoretical study of Joanny and coworkers suggested that cells can be
transformed to cancer cells by increased pressure, and the study of the role
of caveolae in this will be done in our laboratory (Basan et al. [2009]).
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Appendix A
Cell Speciﬁc Protocols
A.1 General Cell Handling
The following protocols were used for all cell types
A.1.1 Cell Culture
Cells grow on either plastic, gelatin or ﬁbronectin in culture medium, which should be
changed every 2− 3 days.
Thawing Cells
• defrost the cells at 37◦C
• dilute cells in 10ml culture medium
• spin down the cells and discard the supernatant
• resuspend cells in culture medium and seed them in a cell culture dish or a ﬂask
• change medium after 24h
Cell Freezing
• detach cells (see Cell Passage)
• count about 1 million cells per freezing vial
• spin them down and discard supernatant
• resuspend them in 0.1ml DMSO + 0.9ml FBS per vial
• store vials at −80◦C for 24h
• transfer vials into a liquid nitrogen tank for long time storage
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A.2 Mouse Lung Endothelial Cells
A.2.1 Cell Type Description
MLEC-wt-PV1, wild type with increased PV1 expression. MLEC-CavKO-PV1, Cav-1
knockout with increased PV1 expression. These are immortalized endothelial cells that
were selected on CD31, VE Cadherin and high PV1 expression. CD31 and VE Cadherin (or
Cadherin 5) are endothelial cell markers. Immortalization brings up PV1 in the endothelial
cells.
A.2.2 Reagents
Culture medium
• EGM2 from Lonza (CC-3162)
• 15% FBS (Hyclone, heat inactivated: 45 min at 55s
,
C followed by 30 min on ice)
• 100U/ml penicillin
• 100mg/ml streptomycin
• 4mM glutamine
Transfection Reagent
• HUVEC nucleofector kit from Lonza/AMAXA (VPB-1002)
A.2.3 Cell Culture
Cells grow on either plastic, gelatin or ﬁbronectin in culture medium, which should be
changed every 2-3 days.
Cell Passage
• wash cells twice with PBS
• either trypsinize cells for about 15min, or incubate them in PBS + 5mM EDTA
for 20 min
• add the same amount of medium and rinse the ﬂask bottom until all cells are
detached
• collect the cells in a tube
• spin down the cells and discard the supernatant
• resuspend cells in culture medium and redistribute them into new ﬂasks or on cover
slides
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A.2.4 Transfection
• passage cells two days before nucleofection; Passage number < 10, cells should be
80% conﬂuent before nucleofection
• wash cells twice with PBS
• either trypsinize cells for about 15 min, or incubate them in PBS + 5mM EDTA
for 20min
• add the same amount of medium and rinse the ﬂask bottom until all cells are
detached
• take ∼ 1million cells per nucleofection
• spin down cells gently (10min at 200rpm) and discard supernatant
• resuspend cells in HUVEC nucleofector Solution to a ﬁnal solution of 1million cells/100µl
• Important: Perform the next steps for each sample separately
• mix 100µl of cell suspension with 1 − 4µg DNA plasmid (e.g. 2µg cav1-EGFP
plasmid)
• put this solution in an Amaxa vial; use a broadened 1000µl pipette cone (cut the
tip of the pipette), make sure that the sample covers the bottom of the vial, avoid
air bubbles while pipetting. Do not incubate HUVEC longer than 5 min in
HUVEC Nucleofector Solution
• select the Nucleofector program A−34 or U−01, insert the vial into the Nucleofector
and press the "X" button
• immediately after the program has ﬁnished, add 500µl pre-warmed culture medium
to the sample using the Amaxa pipettes, and transfer to a T-75 cell culture ﬂask
ﬁlled with 10 ml pre-warmed medium
• press any key to reset the nucleofector
• repeat steps x-xx for the remaining samples
• after two hours of incubation viability of cells can be evaluated by proportion of
cells attached to the culture wells
A.3 HeLa andMouse Embryonic Fibroblast Cells
A.3.1 Reagents
Culture medium
• DMEM (Invitrogen, 61965-026)
• 10% FBS
• 100U/ml penicillin
• 100mg/ml streptomycin
• 4mM glutamine
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A.3.2 Cell Culture
Cells grow on plastic in culture medium, which should be changed every 2-3 days.
Cell Passage
• wash cells twice with PBS
• trypsinize cells for about 5 min
• add the same amount of medium and rinse the ﬂask bottom until all cells are
detached
• collect the cells in a tube
• spin down the cells and discard the supernatant
• resuspend cells in culture medium and redistribute them into new ﬂasks or on cover
slides
A.4 Muscle Cells
A.4.1 Cell Type Description
Human muscle cells were obtained from the laboratory of G. Butler-Browne (Institut
de Myologie, Paris). The cell types expressing mutations of cav3 were obtained from
biological samples provided by the Muscle Tissue Culture Collection (Munich, Germany).
Undiﬀerentiated muscle cells are called myoblasts, diﬀerentiated ones myotubes
• LHCN-ML: wt human myoblasts, control cell line
• R26Q: human myoblasts with cav3-R26Q mutation, Ref: Bochum 62/01; male
*1987; LGMD 1C (Caveolinopathie)
• P28L: human myoblasts with cav3-P28L mutation, Ref: Bonn 18/03; female *1969;
LGMD 1C (Caveolinopathie). This cell type was also immortalized via a virus
infection.
• A45T: human myoblasts with cav3-A45T mutation, Ref: Bochum 1/98; male *1936;
LGMD 1C (Caveolinopathie)
A.4.2 Reagents
X medium
• 64% DMEM
• 16% 199 Medium (Invitrogen, 41150020)
• 20% FBS
• 2.5ng/ml HGF (Invitrogen, PHG0254)
• 50µg/ml gentamycin (Invitrogen, 15750-045)
• 10−7M dexamethasone (Sigma, D4902)
201
Diﬀerentiation medium
• DMEM
• 50µg/ml gentamycin
• 10µg/ml bovine insulin (Sigma, I5500)
• 100µg/ml human apotransferrin (Sigma, T4382)
Transfection reagent
• FuGENE6 (Roche)
A.4.3 Cell Culture
Myoblasts grow on either plastic, matrigel or collagen in X medium, which should be
changed every 2-3 days.
Cell Passage
• wash cells twice with PBS
• either trypsinize cells for about 5-10 min
• add the same amount of medium and rinse the ﬂask bottom until all cells are
detached
• collect the cells in a tube
• spin down the cells and discard the supernatant
• resuspend cells in culture medium and redistribute them into new ﬂasks or on cover
slides
Diﬀerentiation of myoblasts into Myotubes
• use dishes or glass slides coated with collagen type I (Sigma, )
• seed 1−2 ·105 cells per 25mm dish or glass slide (e.g. 25mm glass slides in a 6-well)
• once the cells are very conﬂuent, rinse one time with DMEM
• add diﬀerentiation medium
• cells can be left in this medium about 6-8 days. If more time is needed for myotube
formation, replace carefully half of the diﬀerentiation medium after 7 days.
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A.4.4 Transfection
• use dishes or glass slides coated with collagen type I (Sigma, )
• seed 1−2 ·105 cells per 25mm dish or glass slide (e.g. 25mm glass slides in a 6-well)
• once cells are conﬂuent, they can be transfected using FuGENE6
• for each 25mm glass slide, prepare a mix of 9µl FuGENE6 with 3µg of DNA plasmid
in a ﬁnal volume of 1ml of DMEM
• leave this mix at room temperature for 15 min
• rinse cells with pre-warmed DMEM
• add gently the DNA-FuGENE mix
• centrifuge cells for 30 min at 1180g and 32◦C
• incubate cells together with the DNA-FuGENE6 mix for 4 hours at 37◦C and
5%CO2
• replace the DNA-FuGENE6 mix with pre-warmed diﬀerentiation medium
• change diﬀerentiation medium after one day
• cells can be left in this medium about 6−8 days. If more time is needed for myotube
formation, replace carefully half of the diﬀerentiation medium after 7 days.
203
Appendix B
Cav1-Reconstitution in Lipid
Vesicles
The present protocol and the GST-cav1 and GST-cav11−101 DNA-plasmids were estab-
lished and kindly provided by Lisanti and coworkers (Li et al. [1996], Park et al. [2000]).
B.1 Puriﬁcation of Cav1-GST
B.1.1 Reagents
STE Buﬀer
• 150mM NaCl (MW58.44)
• 50mM Tris pH 8.0 (MW121.14)(Fisher Scientiﬁc, BP 152-1)
• 5mM EDTA pH 8.0 (MW372.29)(Sigma, ED2SS)
TNET
• 150mM NaCl
• 50mM Tris pH 8.0
• 5mM EDTA pH 8.0
• 1% Triton X-100
TNE
• 150mM NaCl
• 50mM Tris pH 8.0
• 5mM EDTA pH 8.0
204
TNE + octylglucoside
• TNE
• 60mM n-octylclycoside (MW292.4)(Roche Diagnostics, 10634425001)
Elution Buﬀer
• TNE + octyglucoside
• 20mM glutathione (MW307.3)(Sigma, G-4251)
• 100mM Tris
LB-Amp
• 100µg/ml Ampicilin in LB
IPTG
• 1M stock of IPTG in H2O
Glutathione Agarose Slurry
(GE Healthcare, Glutathione Sepharose 4B)
• centrifuge glutathione agarose slurry and remove supernatant cautiously
• wash 3 times with 5 ml TNET (centrifugation at 1000rpm for 1 min)
• storage at 4◦C, the beads must be completely covered
Protease Inhibitor
(Roche Diagnostics, complete Mini, 11836153001)
Lysozyme
(Sigma, L7001, Lysozyme Grade III from chicken egg white)
DTT
(Invitrogen, 15508-013)
Column
• put some cotton in a 5ml syringe
• rinse syringe with saline solution
Bacteria
• E.Coli BL 21, lacking lon and ompT protease (Novagen)
• transformed with GST-cav1 or GST-cav11−101 plasmids
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B.1.2 Puriﬁcation
• grow colonies of transformed E.coli BL21 on agar plate with 100µg/ml Ampicilin
(in LB)
• inoculate preculture over night in 5mlLB −Amp
• the next morning, dilute 1:100 in LB-Amp and grow culture at 37◦C for 2-4 hours
• check the OD at 600 nm: once, the culture has OD 0.2− 0.6 induce protein expres-
sion for 1 hour by addition of 1mM IPTG
• refrigerate STE and Lysis buﬀer
• spin cells down at 6000rpm in a pre chilled GS3 rotor for 15 min
• everything from now on is done on ice
• remove supernatant, and wash in 30ml of STE-Buﬀer (no protease inhibitors)
• transfer to a 50ml tube
• spin down cells again for 10 min, and remove supernatant
• pellets can be snap frozen in liquid nitrogen at this stage and kept frozen at −20◦C
• resuspend pellet in 30ml of STE
• add fresh 1mM protease inhibitor
• add 3g lysozyme (0.1mg/ml ﬁnal concentration)
• incubate on ice for 10 min
• add 150µl DTT (5 mM ﬁnal concentration)
• add 10ml of 5% N-lauryl-sarcosyl stock (approximately 1.5% ﬁnal concentration)
• homogenize solution, e.g. with a polytron (medium setting, 30 sec). Cells should
appear as white suds.
• add 5ml of 20% Triton X-100 to 2% ﬁnal
• transfer to 2 SS34 tubes and centrifuge at 10000rpm for 10 min. If a clearly deﬁned
gray pellet is not observed, one may want to homogenize and spin again.
• transfer supernatant to a 50ml tube
• add 1ml of glutathione-agarose slurry (approximately 0.5ml bead volume)
• incubate for 30 min at 4◦C with gentle agitation
• spin tube for 5 min at 1000 rpm and 4◦C in a table top centrifuge
• suck oﬀ supernatant carefully! Glutathione Agarose is not a ﬁrm pellet
• wash once with 5ml TNET
• centrifugation at 1000rpm, 4◦C for 5 min
• wash twice with 5ml TNE + octylglucoside (centrifugation at 1000rpm, 4◦C for 5
min)
• add 1ml TNE + octyglucoside to pellet, resuspend and transfer to column
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• discard ﬂow through
• elute three times each with 1ml elution buﬀer and collect ﬂow through in three
eppendorfs
• storage at −20◦C
B.2 puriﬁcation of Cav1-His
His-tag proteins can readily be puriﬁed from bacteria by using Ni nitrilotriacetic acid
aﬃnity chromatography. Proteins are eluted using imidazole. Note that in protein quan-
tization, it is necessary to remove the imidazole.
B.2.1 Reagents
ST Buﬀer
• 150mM NaCl (MW58.44)
• 50mM Tris pH 8.0 (MW121.14)(Fisher Scientiﬁc, BP 152-1)
STE Buﬀer
• ST buﬀer
• 5mM EDTA pH 8.0 (MW372.29)(Sigma, ED2SS)
LB-Amp
• 100µg/ml Ampicilin in LB
IPTG
• 1M stock of IPTG in H2O
Buﬀer A
• 150mM NaCl
• 10mM Tris pH 8.0
• 1% Triton-X-100 (or dialyzable detergent like N-octylglucoside)
Buﬀer B
• 150mM NaCl
• 10mM Tris pH 8.0
• 60mM N-octylclycoside (MW292.4)(Roche Diagnostics, 10634425001)
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Elution Buﬀer
• 150mM NaCl
• 10mM Tris pH 8.0
• 60mM N-octylclycoside
• 4001000mM imidazole (MW68.08)(Sigma, I0125)
Ni-resin
• Ni-resin (Quiagen, Ni-NTA Agarose, RA9709)
• take 100µl of beads per 100ml of the starting culture
• wash beads in buﬀer A twice (centrifugation at 1000rpm for 1min)
• for storage at 4◦C the beads must be completely covered
Protease Inhibitor
(Roche Diagnostics, complete Mini, 11836153001)
Lysozyme
(Sigma, L7001, Lysozyme Grade III from chicken egg white)
Column
• put some cotton in 5ml syringe
• rinse syringe with saline solution
B.2.2 Puriﬁcation
• grow colonies of transformed E.coli BL21 on agar plate with 100µg/ml Ampicilin
(in LB)
• inoculate preculture over night in 5mlLB −Amp
• the next morning, dilute 1:100 in LB-Amp and grow culture at 37◦C for 2-4 hours
• check the OD at 600 nm: once, the culture has OD 0.6− 0.8 induce protein expres-
sion for 2 hours by addition of 0.25mM IPTG
• refrigerate STE and Lysis buﬀer
• spin cells down at 6000rpm in a pre chilled GS3 rotor for 15 min
• everything from now on is done on ice
• remove supernatant, and wash in 30ml of STE-Buﬀer (no protease inhibitors)
• transfer to a 50ml tube
• spin down cells again for 10 min, and remove supernatant
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• pellets can be snap frozen in liquid nitrogen at this stage and kept frozen at −20◦C
• resuspend pellet in 30ml of STE
• add fresh 1mM protease inhibitor (without EDTA)
• add lysozyme to 0.1mg/ml
• incubate on ice for 15 min
• add 10ml of 5% N-lauryl-sarcosyl stock (approximately 1.5% ﬁnal concentration).
Do not add DTT when working with Ni beads because it will reduce the beads and
make puriﬁcation impossible.
• homogenize solution, e.g. with a polytron (medium setting, 30 s). Cells should
appear as white suds.
• transfer to 2 SS34 tubes and spin out insoluble material at 15000rpm for 10 min.
If a clearly deﬁned gray pellet is not observed, one may want to homogenize and
spin again.
• transfer supernatant to a 50 ml tube
• add 1ml of Ni resin (approximately 0.5ml bead volume)
• incubate for 3-4 hours (ideally over night) at 4◦C with gentle agitation
• spin tube for 30 sec at 1000rpm and 4◦C in table top centrifuge
• remove supernatant carefully! Ni resin is not a ﬁrm pellet. One may want to save
supernatant and undergo second binding with bead to increase yield. Beads can be
re-used up to three times.
• wash gently three times with buﬀer B (centrifugation for 1 min at 1000rpm and
4◦C)
• add 1ml buﬀer B + 30mM imidazole to pellet, resuspend, and transfer to column
• discard ﬂowthrough
• elute three times each with 1ml elution buﬀer and collect ﬂow through in three
eppendorfs
• storage at −20◦C
B.3 Incorporation of Cav1 in Lipid Vesicles
B.3.1 Reagents
Lipid Mix
• 150mM NaCl
• 50mM Tris
• 60mM n-octylclycoside
• 1µg/ml DOPC (MW786.15)(Avanti Polar Lipids)
• 0.5µg/ml cholesterol (MW386.7)(Sigma, C 8667)
• 1µg/ml BSM (brain sphingomyoline, MW738)(Sigma, S7004)
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Cav1-GST Stock
• 8mg/ml cav1-GST, i.e. 3mg/ml cav1
• in TNE + 60mM n-octylglucoside
Cav1-His Stock
• Cav1-His (unknown concentration)
• in 10mM Tris pH 8, 150mM NaCl, 60mM n-octylglucoside, 500mM imidazole
Biobeads
• Biotechnology Grade Bio-Beads SM-2 Adsorbent ,20−50 mesh (Bio-Rad, 152-8920)
B.3.2 Procedure
• add protein in detergent to lipid mixture and incubate under agitation for at least
1h (e.g. 80µg cav1 in 1ml lipid mixture)
• add biobeads to a ﬁnal concentration of 400µg per ml solution
• incubate for 2-4 hours under agitation
• let biobeads sediment and recuperate supernatant in eppendorf
• sonnicate lipid-caveolin mix with micro tip for 1 min at 30% to produce small
vesicles (put eppendorf in ice-water to avoid heating of sample)
• lipid-caveolin mix can now be used for GUV formation
B.4 GUV Electro formation
B.4.1 Reagents
Lipid-Caveolin Mix
ITO-Glass Slides
• rinse ITO-glass slides twice with ethanol
• rinse once with water
• clean with lens cleaning paper and chloroform until no traces of dust are left
• it is advisable to mark on the non-conductive side the site of lipid deposition
Hamilton-Syringe
• rinse a 25µl Hamilton syringe 10 times with chloroform
Sucrose Solution
• 150mM sucrose in H2O
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Glucose Solution
• 150mM glucose in H2O
B.4.2 Procedure
• take 25µl of lipid-caveolin solution with the Hamilton-syringe
• put it on the slide taking care of the homogeneity of the lipids on the slide. It is
advisable to spread the lipid solution evenly keeping the needle parallel to the slide.
The scratching of the lipids ﬁlm should be avoided.
• put the slides in pairs (with the conducting surface facing each other) into a Petri
dish protected with aluminum foil.
• leave the slides in the vacuum chamber for two hours
• prepare vitrex rods of about ten centimeters from about the sixth of a vitrex pack
• take the slides from the vacuum chamber
• stick copper tapes on two face sticky tape (the sticky tape used as a spacer for the
slides)
• surround the lipid ﬁlm on one of the slides with the vitrex rod, and place the pair
slide on top of it (care should be taken to leave 1.5cm of the vitrex rod on each side
as they would be needed later to seal the chamber)
• squeeze them together in order to ensure contact between the copper tape on one
slide and the conductive surface of the other slide
• ﬁll the chamber with sucrose using a syringe with a needle. To avoid the presence
of bacteria one can place a ﬁlter between the syringe and the needle prior to the
injection. Put the needle on the side of the chamber while injecting in order to
prevent destroying the lipid ﬁlm. Take care not to introduce bubbles in the chamber.
• seal the chamber with the vitrex rod
• connect the copper stripes with crocodile clips from the generator (custom-made).
The generator must deliver sinusoidal signal at a frequency of about 12 Hz. The
tension has to increase from 20 to 60mV , then 0.1; 0.2; 0.3; 0.5; 0.7; 0.9; 1.1 and
maximum voltage 1.3V . Protect the chamber from light. Wait for 3 hours.
• for experiments, transfer electroformed vesicles into an observation chamber ﬁlled
with the glucose solution
B.5 Check of Cav1 Association with Lipids
B.5.1 Reagents
Sucrose Solutions
• prepare TNE 68% sucrose solution
• prepare TNE 36% sucrose solution
211
• prepare TNE 5% sucrose solution
• check concentration by refractometry, and keep everything at 4◦C
TCA-stock
(100% (w/v))
• Dilute 500g Trichloroacetic acid (TCA) into 350ml dH2O
Sample Buﬀer
(3X stock for SDS page)
molecular weight marker
• 20µl prestained protein marker (Biolabs)
• with 10µl of 3X sample buﬀer
PBS-milk
• 500ml PBS
• 25g milk powder
• 0.5ml Tween 20%
B.5.2 Cav1-SUVs
• put 100− 300µl of the GST-cav1 puriﬁcation into an 1.5ml eppendorf
• add 0.5ml of lipid-mix [DOPC:Chol:BSM, 1:1:1]
• add Bio Beads and incubate under agitation at 4◦C for 4-8 hours to reduce n-
octylglucoside concentration
• spin down biobeads and collect supernatant into an 1.5ml eppendorf
• short sonnication improves SUV formation
B.5.3 Run Sucrose Gradient
Everything is done at 4◦C (on ice).
• load ultra centrifuge tube (Beckmann, 14x89mm2) with sample (200 − 800µl of
cav1-SUV solution)
• add 68% sucrose solution to 40% ﬁnal concentration
• vortex brieﬂy
• add 6ml 36% sucrose (it helps to put before a little piece of polystyrene on top of
the sucrose to avoid mixing of the diﬀerent density layers during ﬁlling)
• add 3, 5ml 5% sucrose
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• load SW 41 Rotor with sample tubes
• run centrifugation on Beckmann L 80 at 38000rpm and 4◦C for 15 hours
• take sample tubes out carefully
• aliquot fractions of 1ml from the top of the gradient (in 200µl steps with P200)
• vortex the diﬀerent fractions
• fractions can be stocked at −20◦C or be kept at 4◦C for further analysis
B.5.4 TCA precipitation and Western Blot
For a sample of 1ml:
• add 6µl of Na deoxycholate (25mg/ml), vortex and leave for 5 min on ice
• add 60µl of TCA stock, vortex and leave on ice for 10 min
• run centrifugation at 13000rpm and 4C for 15 min
• discard supernatant and TCA thoroughly
• resuspend in 200µl of sample buﬀer with DTT
• add 10µl of 1M Tris pH 8 to neutralize pH
• it helps dissolving pellets by leaving open tubes in ammoniac vapors for a while
B.5.5 SDS Page
Use a 8% polyacrylamide stacking gel
• heat TCA precipitated fractions for 5 min at 56C
• heat molecular weight marker for 5 min at 56C
• vortex and spin shortly all samples
• load in each lane of the gel one fraction ending with the molecular weight marker
• run gel
B.5.6 Western Blot
• transfer the gel on an immobilon membrane for 1 h at 10 V
• check transfer with ponceau rouge (10min incubation and rinse with water)
• block non-speciﬁc binding in PBS-milk for 1hour at RT or overnight at 4◦C
• wash in PBS-milk
• add primary antibody in PBS-milk and incubate for 40-60 min at RT
• wash twice for 15 min in PBS-milk
• add secondary antibody in PBS-milk and incubate for 30 min at RT
• wash twice for 15 min in PBS-milk
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• wash in PBS + 0.1% Tween for 10 min
• wash twice in PBS
• dry membrane with a Kimwipe and place it on a foil
• drop 3ml of ECL mix and leave it for 1 min in the dark
• wrap membrane into a fresh foil and put it into a light protection case
• go to dark room to expose and develop the ﬁlm
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Referat
Caveolae sind charakteristische Plasmamembraneinstülpungen die in vie-
len Zelltypen vorkommen, deren biologische Funktion weiterhin umstritten
ist. Die besondere Form und das hohe Vorkommen von Caveolae in Zellen, die
starken mechanischen Belastungen ausgesetzt sind, führten zu der Annahme,
dass Caveolae die Plasmamembran vor mechanischen Belastungen schützen
und als Membranreservoir dienen. Dies sollte mit dieser Dissertation exper-
imentell geprüft werden. Zunächst wurde der Einﬂuss der Caveolae auf die
Membranspannung von Maus Lungen Endothelzellen (MLEC) im Ruhezu-
stand untersucht. In einem zweiten Schritt wurden die Zellen mechanisch
belastet. Mit Fluoreszensmikroskopie wurde ein Verschwinden von Caveo-
lae nach Strecken der Zellen oder nach einem Wechsel von iso- zu hypo-
osmotischem Medium beobachtet. Messungen der Membranspannung vor
und unmittelbar nach dem Wechsel von iso- zu hypo-osmotischem Medium
zeigte dass Caveolae einen Anstieg der Membranspannung verhindern, unab-
hängig von ATP und dem Cytoskelett. In einem physiologisch relevanteren
Fall, wurden Muskelzellen (mit muskelspeziﬁschem Caveolin-3) untersucht.
Zellen mit Caveolin-3 Mutationen, die mit Muskelschwundkrankheiten in
Zusammenhang stehen, waren weniger resistent gegenüber mechanischen Be-
lastungen als gesunde Zellen. Schliesslich konnten Membranvesikel mit Cave-
olae erzeugt werden. In diesem vereinfachten Membransystem ausserhalb der
Zelle konnte wieder die Rolle der Caveolae als Membranreservoir gezeigt wer-
den. Zusammenfassend wird mit dieser Dissertation die These bestärkt, dass
Caveolae einem Anstieg der Membranspannungen entgegenwirken. Dass dies
in Zellen und in Vesikeln unabhängig von Energie und Cytoskelett geschieht,
gibt Hinweis auf einen passiven, rein mechanisch getribenen Prozess. Diese
Erkenntnis ist ein grosser Schritt vorwärts im Verständnis der Rolle von Cave-
olae in Zellen, und kann dem besseren Verständnis von Krankheiten bedingt
durch Caveolin-Mutationen, wie z.B. Muskelschwundkrankheiten, dienen.
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